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ABSTRACT
ENDOTOXIN REMOVAL FROM PROTEIN SOLUTIONS
BY IMMOBILIZED METAL ION AFFINITY CHROMATOGRAPHY
by
Yun Kang
In the biotechnology/pharmaceutical industry, The removal of endotoxins from final
protein product has always been a challenge. A novel method for endotoxin removal
from protein solutions, immobilized metal (ion) affinity chromatography (IMAC) has
been developed in this study. Fe 3+
 was charged to a chelating gel that contains
iminodiacetic acid (IDA). The IDA-Fe 3+
 IMAC column was exploited to remove
endotoxin from protein solutions. This method involves the adsorption of the endotoxin
on IMAC column. More than 99% endotoxin is removed and protein yield is higher than
90%. IDA-Fe 3+ IMAC has proved to be an economical and efficient method to remove
endotoxin from protein solutions.
The study consists four segments: endotoxin assay method development, the
evaluation of current endotoxin removal methods, adsorption isotherm and capacity study
regarding IMAC column, and process development including a leaching study.
First, to properly detect endotoxin content in experimental solutions, the effect of
protein on Limulus Amebocyte Lysate (LAL) test was discussed. Subtraction of protein
absorbance from total LAL reaction mixture is a very efficient way. The inhibition of
phosphate ion on LAL test was observed. This was circumvented by a proper sample
dilution before the test.
Second, the currently available technology, Sterogene Acticlean Etox was used in
a comparison study. The column capacity for endotoxin is very low (less than 100 EU/ml
gel). The efficiency to remove endotoxin from protein solution with IMAC column has
proved to be better.
Third, adsorption isotherms for both endotoxin and bovine serum albumin on
IDA-Fe3+ IMAC were investigated. This IMAC column has a high capacity for
endotoxins: more than 10,000 EU/ml gel. It was found that endotoxin adsorption
mechanism was due to the interaction between Fe 3+ and phosphate group in lipid A, one
of the important parts of endotoxins. The IMAC resin also has high capacity for proteins.
The column adsorbs endotoxins more strongly than proteins at certain condition. The
buffer conditions for selectively removing endotoxins from protein solutions were
determined.
Fourth, the endotoxin or protein elution process was developed. Different elution
schemes were investigated including buffer pH, ionic strength, and elution competing
agent. The change of solution ionic strength and introduction of NH4C1 in elution buffer
are not efficient to elute protein from the IMAC column. N-octyl-P-D-glucopyranoside
(OBDG) at a low concentration could not elution protein while at a high concentration
ferric ion leaching was observed. It was found that phosphate buffer was a very efficient
elution agent. To prevent the leaching of metal ion from the column, elution buffer pH
should be lower than 5.5.
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CHAPTER 1
BACKGROUND AND RATIONALE
ENDOTOXINS AND ENDOTOXIN REMOVAL
1.1 Endotoxins
1.1.1 Structure and Origin of Endotoxins
Bacterial endotoxins (ET) are lipopolysaccharides (LPS), which is a main component of
outer cell membranes of Gram-negative bacteria (Shiba, 1983), such as Escherichia coli,
Salmonella typhosa, Salmonella typhimurium and Bordetella pertussis. LPS is a large
amphipathic molecule consisting of three distinct regions: lipid A, the core
oligosaccharides, and the 0-antigenic polysaccharide side chain as shown in Figure 1.1.
The hydrophobic lipid A section is made of six or seven saturated fatty acid chains linked
to two phosphorylated glucosamine residues. This region has been shown to be
responsible for the toxic properties of LPS (Galanos et al., 1977). The hydrophilic
polysaccharide portion is made of a core oligosaccharide and an antigenic polysaccharide
0 side chain. The 0 side chain consists of repeating units of four or five sugar sequences
and is unique to each bacterial serotype. The core oligosaccharide is structurally less
diverse than the 0 chain, yet both contain a number of sugars that are rarely seen
elsewhere in nature (Shiba, 1983).
LPSs derived from wild-type bacteria are classified into three categories based on
their molecular structures. Type I LPS is composed of an 0-antigen-specific
polysaccharide, outer and inner core polysaccharides, and lipid A, and is found in
Enterobacteriaceae and Pseudomonas species. Type II LPS, which lacks an 0-antigen-
specific polysaccharide, is distributed in Hemophilus influenzae, Acinetobacters and
1
2Figure 1.1 Lipopolysaccharide core structure and location in the bacterial membrane
3Bordetella pertussis. The type III LPS as seen in Chlamydia consists only of inner core
oligosaccharide and lipid A. Type I LPS is tightly polymerized and is not easily
depolymerized by heat exposure, while aggregates of type II LPS are heat labile.
Furthermore the molecular size of monomeric form of type II LPS is much smaller than
that of type I LPS and seems more difficult to reject via sieving (Rietschel et al., 1993).
Many kinds of endotoxins with different origins are involved in previous
researches such as Haemophilus influenzae type b (Hib) (Rienstra et al., 1990),
Enterobacteriaceae coli (Issekutz, 1983; Hou and Zanieski, 1990; Hirayama et al., 1994;
Evans-Strickfaden et al., 1996; Petsch et al., 1997), Salmonella typhimurium (Aida et al.,
1990), Bordetella pertussis (Hirayama et al., 1992) and Pseudomonas aerugiosa (Felice
et al., 1993).
1.1.2 Endotoxin and Toxicity
Endotoxins can be an indirect cause of fever because they stimulate host cells to
synthesize and release endogenous proteins. These proteins then interfere with the
mammalian thermoregulatory brain center to produce fever. Endotoxins are very toxic.
After intravenous application at concentrations less than 1 ng/ml (10 -9 g/m1) endotoxins
produce fever in human beings and animals that in extreme cases resulted in death. As
little as 150 endotoxin can be lethal to a horse (Li, 1999). The physiopathological
effects shown by infected humans or animals include pyrogenicity, endotoxemia,
leucopenia, leucocytosis, lower blood pressure, allergic reactions, sepsis, septic shock and
multiorgan dysfunction syndrome. Every year more than 500,000 hospitalized patients in
United States develop the sepsis. An estimated 200,000 sepsis patients develop septic
4shock and nearly one-half die from multiple organ dysfunction syndrome. It was
estimated that 400,000-500,00 episodes of sepsis resulted in 100,000-175,00 human
deaths in the U.S. alone in 1991 (Mitzner et al., 1993; Lonergan et al., 1994). Annual
costs associated with septicemia and septic shock range as high as 10 billion dollars per
year (caused by the extra length of intensive care unit (ICU) stay and the intensity of
clinical management, which includes antibiotics, cardiovascular support (intravenous
agents), ventilatory support, kidney dialysis, and in some cases, surgery to remove the
source of infection).
Besides from Gram negative bacteria, endotoxins are also possibly derived from
the Gram positive bacteria and fungi. The toxicity or pyrogen function of ET is related to
its origin and structure. The endotoxin from the fungi is the most lethal to human beings
and animals (Kodama et al., 1997) as shown in Table 1.1. The structure and toxic effects
of endotoxins from the Gram positive bacteria and Fungi should be investigated.
Table 1.1 Phase 3a clinical trial: treatment of critically ill patients contaminated with
endotoxins with different origins (adapted from Kodama et al., 1997)
Clinical Trial	 Survival Rate
28 patients with Gram negative infections 	 61%
9 cases of Gram positive infections 	 56%
2 cases of fungal infections	 0%
13 cases of concomitant Gram positive and Gram negative infection 	 38%
4 cases of concomitant Gram positive and fungal infection 	 0%
3 cases of concomitant Gram negative and fungal infection 	 0%
3 cases of combined Gram positive, Gram negative and fungal infection 	 0%
51.2 Endotoxin Contamination
The solutions contaminated with endotoxins can be divided into five categories: aqueous
solutions, parenteral solutions, bacteria filtrates, products / biomolecular solutions and
plasma, according to molecular weight and the complexity of solution composition.
These solutions can be found in following processes: biotech/pharmaceutical processes,
pharmacy processes and therapeutic processes.
1.2.1 Biotechnological/Pharmaceutical Processes
(1) Process water
Different methods have been used to remove endotoxin from process water. Less than
0.02 EU/ml ET in water was achieved with Milli-Q system from Millipore Incorporation
by the author's test. The endotoxin removal from Water for Irrigation was achieved by
using the 6000 MW cutoff Polyacrylonitrile (PAN) and Polysulfone (PS) ultrafilters
(Evans-Strickfaden, et al., 1996). The high quality endotoxin free water was provided by
various manufacturers such as BioWhittaker Incorporation, Cape Cod Associates, etc.
(2) Buffers and raw materials
Different buffers or raw materials are used in biotech/pharmaceutical processes. Various
methods should be taken to prevent the contamination of endotoxins.
(3) End products
Biotechnology provides variety of ways to produce bioproducts such as proteins. The
most striking method is to express various proteins with recombinant DNA techniques in
6different hosts, 90% of which is E. Coli. Endotoxin removal is key issue in downstream
processing. The endotoxin removal process was studied by different researchers for
various products, namely, conjugated vaccine Pedvax HIB (Rienstra et. al, 1990),
filamentous hemagglutinin and pertussis toxin (Hirayama et al., 1992), albumin (Hou and
Zaniewski, 1990; Aida, and Pabst, 1990; Hirayama et al., 1994; Anspach and Hilbeck,
1995; Morimoto, 1995; Wakitu, 1996; Sakata, 1996; Legallais et. al 1997; Petsch et al.,
1997), y-globulin (Hou and Zaniewski, 1990; Hirayama et al., 1994; Morimoto et al.
1995), IgG (Petsch et al., 1997; Legallais et. al, 1997), cytochrome C (Aida and Pabst,
1990; Hirayama et al., 1994; Morimoto et al., 1995), catalase (Aida and Pabst, 1990),
myoglobin (Hirayama et al., 1994; Morimoto et al., 1995), lysozyme (Petsch et al., 1997),
β-lactoglobulin (Sakata, 1996), Insulin (Sakata, 1996), superoxide dismutase (SOD), and
amylopectin (Held, 1997).
1.2.2 Pharmacy: Parenteral Solutions and Diagnostics/dialysis Buffer
Parenteral solutions and diagnostics/dialysis buffers can be depyrogenated mainly by
membranes. Endotoxins from the peritoneal dialysis solutions were removed using
polysulfone ultrafilter (Rafiee-Tehrani et. al, 1996) and hemodialysis processes
(Yamamoto and Kim, 1996) with semipermeable membrane. The endotoxin removal
from the bicarbonate dialysis buffer was investigated by Cappelli et al. (1993). Brown
studied depyrogenation of water for injection, lohexol 350 mgI/m1 active and placebo
with submicron filters (1993).
71.2.3 Therapeutic Processes
Extracorporal endotoxin removal from the plasma or blood was used to treat the sepsis,
septic and multiorgan failure (Lonergan et al., 1994; Shoji et al., 1998; Jaber et al., 1998).
It is the only practical method to treat the diseases caused by endotoxin contamination.
In summary, endotoxin removals from water, buffer solutions and dialysates have
been carried out successfully. However, endotoxin removal from biological solutions
such as proteins and plasma proved to be very difficult due to several reasons. First,
proteins form complexes with endotoxins, which are difficult to break down; Second, the
interaction mechanism between the endotoxin and protein is not clear; Finally the
endotoxin exists in different aggregation states, which are function of solution conditions.
1.3 Endotoxin Removal Methods
1.3.1 Traditional Methods
Traditional methods for endotoxin removal include chemical decomposition of pyrogen
with acids, alkali, or oxidizing agents, which is commonly practiced in sterilization (Hou
and Zaniewski, 1990), distillation, reverse osmosis (Evans-Strikfaden et. al, 1996) and
adsorption by asbestos or other media.
Distillation and reverse osmosis are currently used to produce endotoxin free
water (low endotoxin contents) for injection. However, distillation processes are highly
capital intensive and expensive to operate. Reverse osmosis offers a less expensive
method of pyrogen removal but presents substantial problems of cleaning,
depyrogenating, and maintaining a non-pyrogenic permeate over extended operational
time periods. Distillation and reverse osmosis have the further drawback that neither can
8be used to depyrogenate parenteral solutions or targeted bioproducts (Evans-Strikfaden et
al., 1996).
1.3.2 Filtration and Membrane Separations
1.3.2.1 Ultrafiltration membrane (1 to 200 nm)
In aqueous solutions a majority of endotoxin molecules aggregate into vesicles ranging
from 300,000 to 1,000,000. In their lowest aggregation states, endotoxins exist in
monomeric form (10,000 to 20,000). Theoretically endotoxins may be removed by
ultrafiltration membranes.
Ultrafiltration membranes with low molecular weight cut-off may be more
effective than submicron filters because of their ability to remove pyrogens based on size
exclusion in addition to adsorption to the membrane. Ultrafiltration has been approved
for the manufacture of water for injection (WFI) in Japan, and for WFI quality rinse water
in Europe (Evans-Strikfaden et al. 1996). Several companies in U.S. have commercial
products to produce water with very low endotoxin contents, such as Millipore's Milli-Q
system with an ultrafiltration (MW cutoff 5,000) to reduce the pyrogen from high
endotoxin level in tap water to an endotoxin content of lower than 0.02 EU/ml
(determined by the author). However, the ultrafiltration processing has some
disadvantages: low filtration rates, especially for viscous products (e.g. iodinated
radiopaque products) and thus time consuming, as well as high cost of ultrafiltration
equipment. Ultrafiltration membranes have no specificity to bind endotoxin. Other
contaminating particles are also removed from the solution, which results in fouling.
9Tetta et al. (1993) evaluated the long-term (360 h) efficacy of ultrafiltration in the
reducing endotoxin using a polysulfone ultrafilter, and the impact of daily routine
sterilization on the ultrafilter efficacy. The removal of endotoxin from bicarbonate
dialysis fluids by ultrafiltration is an efficient, reliable, and only practical on-line
procedure to circumvent microbial contamination during a conventional dialysis, on-line
hemofiltration and hemodialfiltration. Bacterial products reactive to LAL test were
always below the level of 0.125 EU/ml in all post-ultrafilter samples. However, the issue
of endotoxin (or its subunits) permeability through polysulfone membranes has been a
matter of controversy.
Polyacrylonitrile (PAN) and polysulfone (PS) hollow fiber ultrafilters with 6,000
MW cut-off are useful (Evans-Strikfaden et al. 1996) in endotoxin removal from the
water for irrigation based on size exclusion. The high-flux polysulfone ultrafilter
(dialyzer) represents an efficient system to remove Lipid A and Pseudomonas aeroginosa
endotoxin from the dialysis fluids (the contaminated peritoneal solutions) to produce
endotoxin free dialysate (Refiee-Tehrani et al., 1996). The effect of ion activities in
hemodialysis solutions on the efficiency and behavior of polysulfone ultrafilters was not
significant.
1.3.2.2 Submicron filters
The majority of ET molecules in aqueous solutions aggregate into vesicles ranging from
300,000 to 1,000,000. Endotoxins may be removed by ultrafilters with MW cut-off > 300
K (Li and Luo, 1999) or by submicron membrane filters (Brown and Fuller, 1993). The
use of submicron filtration in place of ultrafiltration would provide significant cost
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benefits in terms of less filtration time and equipment costs. The removal of pyrogen by
the positively charged membranes with nominal pore sizes much greater than the
pyrogenic material in solution has been documented. However, the filters were not shown
to be efficient for removing ET when electrolytes or proteins were present in the solution
(Pearson, 1985). The pyrogen removal by adsorption to submicron filters was examined.
Endotoxin level after removal varies depending on the process conditions (Evans-
Strikfaden et al. 1996). Brown et al. (1993) evaluated the practicality of increasing the
MW cut-off of ultrafilters and efficiency of endotoxin removal using submicron filters,
including a Pall Posidyne charge modified filter. The submicron filter may be capable of
efficiently removing the endotoxins from the pharmaceutical products. However, the
endotoxin aggregate size increases as the ionic strength increases, which is different with
the results of most other researchers.
1.3.2.3 Membrane Adsorber
Ultrafiltration methods using four different hollow fiber membranes: polyester polymer
alloy (PEPA), polymethylmethacrylate (PMMA), polyacrylonitrile (PAN) and
polysulfone were investigated to examine the LPS rejection capability (Yamamoto and
Kim, 1996). Complete rejection of LPS can be achieved by hydrophobic membrane of
high adsorption capacity with an appropriate sieving property due to hydrophobic
properties of lipid A. Membrane absorbers have the advantage of high throughput
compared to traditional adsorption beds.
Anspach et al. (1997) prepared membrane adsorber, isotropic Nylon
microfiltration membranes coated with Dextran, hydroxyethyl-cellulose (HEC), and
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polyvinyl alcohol (PVA) as the matrix, and immobilized histidine (His), histamine (Him),
polymyxin B (PMB), a-amylase, poly-L-lysine (PLL), polyetheleneimine (PEI),
deoxycholate (DOC) as the ligands. The Nylon has advantages of high mechanical
properties and low non-specific adsorption. The prepared membrane adsorber was used to
remove ET from the buffers and protein solutions. To remove endotoxin from protein
free solutions (20 mM PBS, pH7), all ligands comprising a net positive charge show very
good endotoxin removal except the Bis:Him. In contrast, for the negative charge ligand,
almost no endotoxin is removed. Mechanism for endotoxin removal is electrostatic
attraction due to the negative charge properties of LPS in experimental pH range.
Varying the solution ionic strength and pH results in the changes of the charge
distribution of both ligands and endotoxin molecules and thus affects of endotoxin
removal efficiency.
For the endotoxin removal from protein solutions, the interaction of protein with
the positively charged adsorber should be considered. The poor endotoxin recovery in the
presence of basic proteins was found. This was explained by masking of lysozyme on the
endotoxin activity (Anspach et al., 1997). In other words, protein-bound endotoxin is not
LAL-active. This is questionable. The low recovery could be an inhibition of LAL test
by phosphate ions, which will be discussed in the later chapter.
The depyrogenation of different IgG solutions using the histidine-linked hollow
fiber membrane was presented (Legallais, et al., 1997). Endotoxin removal from the
1 mg/ml non histidine-binding mouse monoclonal IgG1 (MabCD4) solution was achieved
in the presence of acetate buffer (pH 5.0) without any protein loss. The mechanism of
endotoxin removal was considered as selective adsorption and adsorption replacement.
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1.3.3 Adsorption & Chromatography
1.3.3.1 Adsorption
Ultrafiltration requires a large size difference between product and contaminant. It is not
effective when the contaminant binds with proteins strongly (Anspach and Hilbeck,
1995). To remove endotoxin from protein solution, adsorption has proven to be the most
effective method (Morimoto et al., 1995).
Commercial available adsorbents, such as immobilized histidine and polymyxin-
Sepharose, have high endotoxin adsorption capacity at low ionic strength. As the ionic
strength increases, endotoxin adsorption capacity decreases. Endotoxin adsorbents
capable of retaining a high endotoxin capacity over a wide range of ionic strength
conditions are not available. The adsorption of acidic proteins such as BSA follows the
same adsorption behavior as that of endotoxins. Commercially available beads can not
selectively remove endotoxin from these protein solutions.
Rienstra et al. (1990) used a hydrophobic resin HP 20 (highly porous polymer of
styrene and divinylbenzene copolymer in the form of 20-50 mesh beads) to develop a
method for endotoxin removal from the conjugated vaccine PedvaxHlB®, in which Hib
polyribosylribitol phosphate capsular polysaccharide (PRP) is covalently bound to outer
membrane protein complex of B 11 strain of Neisseria meningitidis serogroup B. Treating
LPS with chelating agents (sodium citrate) can disaggregate LPS into micelles which can
be further reduced with detergents (sodium deoxycholate) to its primary molecular size of
10,000 to 20,000. It was presumed that under these conditions, LPS would be small
enough to enter the pores of a macroreticular resin and bind hydrophobically to the non-
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ionic surface with the ionic PRP remaining free in the solution. Optimal conditions are 6-
7% sodium citrate dihydrate, 0.75 % DOC and pH above 8.0 in order to prevent DOC
gelation. Low endotoxin level and high PRP yield can be achieved using HP20
adsorption process.
Hirayama et al. (1992, 1994, and 1996) developed various affinity resins for
endotoxin removal from different solutions. The poly (y-methyl L-glutamate) (PMLG)
spheres with diaminoethane as a ligand have a high endotoxin-removing activity even at
high ionic strength (µ=0.2-0.8). It is suitable for the endotoxin removal from antigenic
proteins in the culture supernatant of Bordetella pertussis and tetanus and diphtheria
toxoids, which are vulnerable substances and sometimes aggregate at low ionic strength
(p, =0.01-0.1 M) because of their hydrophobicity (Hirayama et al., 1992). However, the
adsorbent regeneration is not satisfactory.
A cross-linked N, N-dimethylaminopropyacrylamide (DAA) spherical adsorbent
was prepared by suspension copolymerization of N, N — dimethyl amino propyacrylamide
(DMAPAA) with N-allylacrylamide (AAA) (Hirayama et al., 1995). When Mu m < 300,
and amino group content was 4.5 meq./g, DAA adsorbent showed endotoxin-removing
activity at 11=0.05-0.4 and pH = 5-9. It could selectively adsorb endotoxin from BSA
solution at a low ionic strength. However, the adsorption capacity for endotoxin is low.
PEI-cellulose fiber, which is suitable only for low ionic strength condition
(Morimoto et al., 1995) has higher adsorbing capacity than histidine-immobilized
cellulose and polymyxin-immobilized Sepharose.
All above affinity resins are suitable to remove endotoxins from specific
solutions. The functional group NH2 has interactions with the proteins, which is
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responsible for the non-specific binding. The protein recovery is low. Endotoxin was
considered to be adsorbed on the surface of the resin while the protein molecule was
adsorbed in pores. The adsorption behaviors of resins with different pore sizes: 4,000
(Sakata et al., 1996), 5,000 (Morimoto et al., 1995), 300 (Hirayama et. al, 1994) indicates
that this mechanism is problematic.
Lipid membrane has been receiving considerable attention as a model for various
chemical investigations in the areas of chemical sensing and separation due to its
hydrophilic and hydrophobic properties. A method using carboxylated porous supports
and ligands such as cationic lipid membrane of N-octadecylchitosan consisting of 2-
deoxy-2-octadecylamino-D-glucopyranose(G1cNC18),2-amino-2-deoxy-D-glucopyranose
(G1cN), 2-acetamino-2-deoxy-D-glucopyranose (G1cNAc) to remove endotoxin from the
protein solutions was developed (Wakitu et al., 1996). LPS were selectively adsorbed
with 99.2% to 99.9% removal efficiency and 91% to 100% recovery of BSA. The
residual LPS concentration varied with the pH and ionic strength.
Anspach et. al (1995) removed endotoxins by using histamine, histidine,
polymyxin B and poly-L-lysine and DEAE-Sepharose affinity adsorbents. Immobilized
histamine, histidine and polymyxin B were effective for endotoxin removal from the E.
coli filtrate. However their effectiveness decreased dramatically in the presence of
proteins. DEAE-Sepharose was the most suitable adsorbent for the decontamination of
positively charged proteins, such as lysozyme. Clearance of negatively charged proteins
is always problematic.
At very high endotoxin contamination, direct application of protein solutions to
these adsorbents is not effective. In such extreme cases ultrafiltration should be used as
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an initial step in order to reduce the endotoxin concentration, especially for large
agglomerates of endotoxins, whereupon the endotoxin-specific adsorbents can be
employed in subsequent step.
1.3.3.2 Ion-exchange
The charge character of a biomolecule can be either enhanced or inhibited by a proper
adjustment of solution conditions, with pH level and salt concentration as major
controlling factors (Hou and Zaniewski, 1990). The enhanced adsorption of endotoxin in
the presence of 100 mM salt concentration may be due to aggregation of endotoxin
molecules. As the salt concentration further increases, reduction in endotoxin removal
caused by the salt counterions is observed.
In process development of endotoxin removal, original source and existing form
of endotoxin as well as the nature of protein molecules contaminated with pyrogen
dominate the efficiency and level of pyrogen reduction. The importance of pH, salt and
flow dynamics in pyrogen removal by anion-exchange filters should be considered.
1.3.4 Phase Separation
Phase separation was widely used in the separation and purification of protein products. It
provides a rapid and gentle method for removing endotoxin from protein solutions.
Protein treated by this unit operation retains its normal functions. Endotoxin
contamination of protein solutions was reduced by a phase separation technique using a
detergent, Triton X-114 (Aida and Pabst, 1990). The disadvantage of this method is that
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small amount of detergent persists in the aqueous phase after the separation and is very
difficult to remove.
1.3.5 Miscellaneous Methods
In pharmaceutical or biotech industry a variety of methods were used to remove pyrogen
from the raw materials, intermediates and final products. Two case studies of endotoxin
removal from the SOD and amylopectin by Held et. al (1997) gave us a very good
example.
1.3.6 Treatment of Sepsis, Septic Shock and Septic Multiple Organ Failure
by Extracorporeal Endotoxin Removal Methods
Antibiotics can not prevent the toxic effects of lipid A in endotoxins.
	 Current
therapeutic strategies such as anti-ET, anti-cytokine have not been shown to be
consistently beneficial in reducing the morbidity/mortality of patients suffering from
sepsis. The complexity of inflammatory network, and lack of clinical success with the
use of specific inhibitors of mediators, have kindled interest of extracorporeal therapies
for treatment of sepsis (Jaber et al., 1998). Lonergan et al. (1994) induced an endotoxic
shock in an animal model and attempted to treat it by direct hemoperfusion over a
modified anion sorbent column. It has been shown that the reversal of septic shock
correlates with the efficiency of extracorporeal endotoxin removal.
Kodama et al. (1997) summarized the methods of treating critically ill patients
and their efficacy. Attempts have been made to remove the endotoxin, the main cause of
sepsis, from the circulation using polymyxin B immobilized fiber, charcoal
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hemoperfusion, and plasma or whole blood exchange. Attempts have also been made to
remove proinflammatory cytokines, eicosanoides, and coagulative factors from the
circulation in human body. Hemofiltration has been applied to treat severe sepsis and
septic multiple organ failure (MOF). The low MW of the serum mediators can be
removed by hemofiltration. However, no clinical study has shown its direct effect on
severe sepsis. Plasma or whole blood exchange in child may be helpful because it
reduces the concentration of endotoxins, amines, cytokines, and protein bound toxins.
However, to reduce concentrations effectively, a large amount of whole blood or plasma
must be used. Furthermore, post perfusion complications such as hepatitis or acquired
immuno-deficiency syndrome may occur. Toraymyxin, a biomaterial prepared by fixing
polymyxin B to polystyrene fibers, is now widely used in Japan. It has the potential for
the treatment of septic patients and those with endotoxemia, which leads to MOF.
However, Toraymyxin still has some unsolved problems (Kodama et al., 1997).
Polymyxin B immobilized Fiber Cartridge (PMX-F) (Shoji et al., 1998) could
detoxify many kinds of endotoxins in vitro, due to its interaction with the lipid A portion
of endotoxin. Utilization of fibrous adsorbents enabled Shoji et al. (1998) to design the
PMX cartridge with a large surface area and low blood pressure drop in the blood flow
compartment and to apply it safely to the direct hemoperfusion procedure. Multicenter
clinical studies indicate that the blood endotoxin level has been significantly decreased
with the application of this method. Hemodynamic abnormality such as low blood
pressure and low systemic vascular resistance were significantly improved. However,
polymyxin B has strong neurotoxity and nephrotoxicity.
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1.4 Endotoxin and Endotoxin-Protein Complex
1.4.1 Endotoxin Aggregates and Pyrogenicity
The structure of bacterial LPS is apparently stabilized by divalent cations, because
removal of Ca2+ and Mg2+
 with EDTA causes the bilayer to break down into what appears
to be micelles of 300,000 to 1,000,000 molecular weight (Sweadner et al., 1977). The
micelles exist as small rods or disks in the electron microscope. The micelles can be
further broken down in the presence of detergent or bile salts. The particles can then no
longer be seen in the electron microscope, but the size and shape, as calculated from
sedimentation velocity, density, and viscosity measurements are 0.8 to 1.2 nm in diameter
and 20 to 70 nm long, consistent with what is known of their chemical structure. Their
molecular weight is 10,000 to 20,000.
Rienstra et al. (1990) investigated resin adsorption to remove endotoxin from the
conjugated vaccine PedvaxHlB. Treating LPS with chelating agents (sodium citrate) can
disaggregate the LPS into micelles, which can be further reduced with detergents (sodium
deoxycholate) to its primary molecular size of 10,000 to 20,000.
After sonication, the size of endotoxin aggregation became smaller, and was
within the range of 10 nm to 20 nm (Sawada et al., 1986; Komuro et al., 1987).
Biological activity of LPS is greatly affected by the particle size or state of
dispersion (Komuro et al., 1987). The sonication of LPS for 2 or 3 min significantly
enhanced its pyrogenicity. Sonication might disperse the LPS aggregates into smaller and
more uniform particles with optimum size for manifesting biological activity in aqueous
medium, resulting in an enhancement of pyrogenicity (Komuro et al., 1987). However,
Sawada et al. (1986) reported that LPS with a small size has less reactivity to LAL test
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and low pyrogenicity in rabbits. This phenomenon (Sweadner et al. 1977) is also
noteworthy because action of surfactants such as sodium deoxycholate, dissociates the
aggregates of LPS mainly by chemical forces into subunits and simultaneously reduces
the pyrogenicity (Oroszlan and Mora, 1963; McIntire et al., 1969; Sweadner et al. 1977).
There is a possibility that active sites of LPS are masked by forming a complex with
surfactants (Reynolds, et al., 1968; Hannecart-Pokorni et al. 1973; Sweadner et al. 1977),
resulting in a reduction of pyrogenicity. Therefore the relationship between the biological
activity and the size has to be further elucidated.
1.4.2. Endotoxin-protein Complex
It is shown that LPS associates with some proteins to form complex through electrostatic
and hydrophobic interactions. There are several methods to determine if there is a
complex formed between endotoxin and biomolecule such as protein.
Spectrophotometer scanning
This method is qualitative. First, the absorbance scanning of pure protein and pure
endotoxin was conducted to get the base line of wavelength scanning. Second, these two
pure solutions are mixed. The mixture has the same amount of endotoxin or protein as the
pure endotoxin or protein control solution. If there is no complex formed, addition of
absorption of two pure substances should be same as that of mixture. Otherwise, the
complex formed. The scanning experiments were done in this research. The results
were shown as Figure 1.2 and Figure 1.3 for bovine albumin serum (BSA)-LPS and
human hemoglobin Ao (HbAo)-LPS respectively. This result matches the research of
Miyagawa (1991) and Kaca (1994).
Figure 1.2 Absorbance spectrum of BSA, ET and ET-BSA complex.
LPS concentration: 2 EU/mL BSA concentration: 100 IA g/mL
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Figure 1.3 Absorbance spectrum of HbAo, ET, HbAo-ET complex. LPS
concentration: 2 EU/ml. HbAo concentration: 100µg/mL
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Dynamic light scattering (Hofer et al., 1991)
Scattering intensity and diameter can be obtained by light scanning instrument. In the
presence of BSA, scattering intensity and LPS diameter decrease with the increase of
BSA concentration. The aggregation states of endotoxins were changed when the BSA
was added into LPS solution.
Ultrafiltration membrane (Li and Luo, 1997)
If the molecular weight of the protein is known, e.g. HbAo, M.W. 68.5 K, a membrane
with MW cutoff of 100K could be used. First, HbAo is applied to the membrane and the
HbAo concentration in the filtrate is measured as the control. Second, mixture of the
HbAo and endotoxin is applied to the membrane. If the HbAo concentration in the
filtrate is quite different from the control, the complex forms. The regenerated cellulose
membrane can be used due to its low protein binding.
1.4.3 Dissociate the Endotoxin-biomolecule Complex
In separation of proteins from the subcellular components, such as membrane, which is
phospholipid, mild ionic or nonionic detergents such as deoxycholate, Brij, and the Triton
compounds (polyoxyethylene ethers) must be used at low concentration, sometimes with
gentle sonication to aid dismantling the subcellular structure (Scope, 1987, 1994).
LPS is believed to be arranged in a bilayer, analogous to phospholipid, in which
the hydrophilic components are exposed to the aqueous environment while the
hydrophobic fatty acid tails are sandwiched together in the center of the bilayer
(Sweander et al., 1977). Similar to protein dissociation from lipid membranes, the same
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method can be used to dissociate the endotoxin from the protein complex. Then
endotoxin can be removed from the protein solution by phase separation with the aid of
Triton-114 (Aida and Pabst, 1990). The main problem of this technique is that small
amount of detergent persisted in the aqueous phase. When the detergent is removed from
the solution, the small sized endotoxins will re-aggregate into a larger size of ET (Sawada
et al., 1986).
Detergents such as DOC, SDS or triton X-100 are not recommendable since they
disturb the LAL test with a concentration as low as 0.1% (Petsch et al., 1997). SDS is
difficult to remove because of its low critical micelle concentration (CMC) (Karplus et
al., 1987). Sodium deoxycholate (Issekutz, 1983) may be an effective eluent because it
extensively dis-aggregates endotoxins. However, through its detergent action, it may
interfere with the lipid A affinity and binding to resins. Furthermore, these detergent
methods would also be unsatisfactory when one wishes to remove endotoxin from a
solution, which contains other desirable high molecular weight components.
All of the above mentioned chemical methods have the following problems.
Chemicals have some effects on pyrogenicity of LPS or LAL test results. The masking of
LAL test by the surfactants were reported (Hannecart-Pokorni et al., 1973; Sweadner et
al. 1977). The effects of chemicals on the targeted biomolecular products should be
determined. Removal of chemicals has proved to be time-consuming and somewhat
ineffective.
Ultrasonic irradiation was shown to be an effective way to dissociate the
endotoxin aggregates and has been effects on the LAL test results (Sawada et al.,1986;
Komuro et al., 1987). Haga et al. (1987) reported that effect of ultrasonic irradiation on
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dissociation of antigen and antibody complex, which may be used to dissociate the
endotoxin-protein complex due to the similarity of ET-protein and antigen-antibody.
Microwave radiation (2450 MH) was found to potentates the lethal effects of
endotoxin in mice (Smialowicz et al., 1980; Riddle et al., 1982). McCullough et al.
(1993) used microwave to dissociate antigen-antibody complex.
When antigen-antibody complex was dissociated with super critical fluid (SCF),
good results were obtained (Howlett et al., 1992). The ET-protein complex may be
dissociated with SCF. However, the effects of SCF on the structure and function of
protein or ET, should be elucidated first.
1.5 Summary
Methods for removing endotoxins depend on the origin, structure and molecular weight
of endotoxins, as well as the nature and molecular weight of biomolecules such as
proteins. The structure and toxic effects of endotoxins from the Gram positive bacteria
and fungi should be investigated. The relationship between the biological activity and the
size of endotoxin has to be elucidated. The characterization and dissociation of
endotoxin-protein should be finished before the effective separation.
The chemical decomposition of endotoxins with acids, alkali, or oxidizing agents
is commonly practiced. However, such methods cannot be used for blood, blood
products and bioproducts. Approaches of endotoxin removal from the aqueous solutions
include physical methods such as ultrafiltration by size or MW differences, and chemical
methods such as adsorption to activated carbon and ion exchange resins. Hemofiltration
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has been used to treat septic shock and multiple organ failure. However, it has some
problems.
Adsorption of endotoxin from target solutions by affinity resin or membrane
adsorber appears to be a practical way to remove ET from the biological products.
Adsorption is based on either the charge induced from phosphoryl groups or hydrophobic
interaction. The resin applicable to endotoxin removal from all the biomolecules is not
available. A special affinity resin which can dissociate endotoxin-protein complex and
selectively remove the endotoxin from protein solution needs to be developed. The
present investigation focuses on this aspect.
CHAPTER 2
BACKGROUND AND RATIONALE
IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY
2.1 Historical Background
The separation of biomolecules is as old as the human history. There are no records for
the year when first product separation was made. The invention of chromatography
makes it easy to separate and purify protein products. Martin and Synge (1941)
introduced the chromatographic concept. Ion exchange chromatography, size exclusion
chromatography, affinity chromatography or affinity partition and hydrophobic
interaction chromatography were introduced gradually afterwards. All the separations by
chromatography were based the properties of proteins such as charge, size or shape and
surface characteristics. The ion exchange chromatography is based on the charge of
protein. Gel filtration or size exclusion chromatography uses size or shape difference of
proteins to separate and purify them. The protein surface properties such as contents of
hydrophobic residues provide the basis of the hydrophobic interaction chromatography.
Affinity chromatographic separation is also based on the surface properties of proteins.
In 1975 Porath and his collaborators introduced an approach for protein fractionation,
metal chelate affinity chromatography, which is now well known as the immobilized
metal (ion) affinity chromatography (IMAC, Porath et al., 1983). IMAC is based on
metal and protein interactions.
Metal-protein interaction is a very important phenomenon in biochemistry. There
are two types of metal-protein interactions. First, the metal ion is an integral part of the
protein structure, as in the case of metalloprotein such as hemoglobin. Second, a protein
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forms a reversible complex with a metal ion, as in the case of metal chelate. The latter
case was used to purify proteins from the solutions. In an efficient purification process,
the protein retarded by the metal ion can be recovered by changing solution conditions.
IMAC was developed using a rigid microporous stationary phase in which metal ion was
immobilized. It can be used to purify bioproduct via chelating functional groups bound to
their surface.
2.2 Immobilized Metal Affinity Chromatography
2.2.1 Principle
Metal ions are highly solvated in an aqueous solution as a result of coordination of water
molecules (Sulkowski, 1985). In solution, metal ions can be considered as a Lewis acid
(electron-pair acceptor) and the water molecule as Lewis base (electron pair donor). The
water molecule can be replaced by a stronger base, resulting in a metal complex. The
group combining with the metal ion is called a ligand (electron pair donor group). A
donor atom (N, S, 0) with a free pair of electrons constitutes a simple or monodentate
ligand. When two or more donor atoms are present in one ligand molecule, such a ligand
is polydentate and its coordination with the metal ion results in a metal chelate. The
binding of metal ion to a ligand is much stronger in a metal chelate than in a metal
complex. The principle of metal chelating is shown in Figure 2.1. The commonly used
chelating ligand for metal ion immobilization in IMAC is iminodiacetic acid (IDA)
(Porath and Olin, 1983) and tris (carboxymethyl) ethylene diamine (TED) as shown in
Figure 2.2. Binding metal ions such as Cu2+ , Zn2+ and Ni2+ are often used.
Figure 2.1 Metal chelating principle
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Figure 2.1 Metal chelating principle (Continue)
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Figure 2.2 Structure of IMAC (Scope, 1994), P is the support, Me is metal ion and X is
protein
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The amino acids such as histidine and their residues form complexes with many
transition metal ions. Therefore immobilized metal ions on the matrix will selectively
retain proteins if amino acid residues such as histidine are exposed on the surface of the
protein.
2.2.2 Application
IMAC is generally used to characterize protein structure or separate the histidine residue
containing proteins from other constituents in a solution (Sulkowski, 1985). IMAC has
been applied in the purification of variety of proteins. Examples include serum proteins
(Porath et al., 1975, 1983), interferons (Edy et al. 1977; Bollin and Sulkowski, 1978;
Chadha et al., 1979; Krempien et al., 1985; Coppenhaver, 1986), phosphoproteins
(Muszynska et al., 1986; Shriner and Brautigan, 1987; van Heusden et al., 1991; Jiang et
al., 1999), lactoferrin (Carlsson et al., 1977), glycoprotein (Lebreton et al. 1977, 1978,
1979; Corradini et al., 1988; Gmeiner et al., 1995; Wojczyk et al., 1996; Herve et al.,
1996; Sedzik et al., 1999), recombinant protein (Ford et al., 1991), and fusion protein
(Wizemann and von Brunn, 1999). For other proteins, reviews (Sulkowski, 1989; Enfors
et al., 1990; Porath, 1990, 1992; Jones et al., 1995; Sawadogo et al., 1995; Turkova,
1999; Hage, 1999) should be consulted.
Since IMAC separation of protein is based on the interactions of histidine,
cysteine and tryptophan residues with metal ions, IMAC is very useful in topological
studies aimed at the determination of the number and location of amino acid (histidine)
residues exposed on the surface of proteins (Hemdan et al., 1989). A variety of proteins
were characterized with this method, such as, an enzymatically active immobilized
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derivative of myosin (Elgart et al., 1975), cell-cycle-regulated protein calcyclin (Filipek et
al., 1991), chimeric rDNA proteins (Evans et al., 1991), Zn (II)-transport protein (Yip
and Hutchens, 1991; Vosters et al., 1992), recombinant human interferon gamma (Zhang
et al., 1992), a monomeric HIV-1 reverse transcriptase (Sharma et al., 1994), lymphocyte
chymase I (Woodard et al., 1998), and a β-peptide of Alzheimer's disease (Liu et al.,
1999) etc. There is a special method to apply IMAC in protein purification: reversed
IMAC (Nishino and Powers, 1979). A blank gel without metal ion was used instead of
regular IMAC. It is a very effective method to purify metalloproteins. Metal Ion Transfer
(MIT) based on the IMAC principle, may offer an efficient way to deplete metal ions
from a metalloprotein or, conversely, to charge it with metal ions (Sulkowski, 1989).
The most widely used commercially available matrices for IMAC are Chelating
Sepharose CL-6B, Chelating Sepharose Fast Flow and Chelating Superose from
Pharmacia LKB, IDA or TED gels from Pierce, IDA agarose and IDA Sepharose 6B from
Sigma and TSK Chelating-5PW (silica based) from Toyo Soda.
2.2.3 Protein-metal Chelate Interactions
As mentioned in Section 2.1, the binding of proteins to IMAC stationary phase is due to
the substitution of weakly bonded small molecule such as water or mobile phase ions on
the surface of metal chelate stationary phase, with electron-rich groups (ligands) on the
surface of proteins as the electron donor. The metal ions are acting as the electron
acceptor in this process.
The interaction strength between protein and immobilized metal ions is mainly
determined by the number of histidine residues exposed on the surface of the protein. It
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is also on that of cysteine or tryptophan (Porath et al., 1975; Sulkowski, 1985) in some
extent. The chromatographic behavior of selected model proteins on IMAC with
different metal ions was evaluated. The affinity of protein with immobilized metal ions
mainly depends on the histidyl side chain distribution on the proteins: (i) either interior
or surface; (ii) if localized on the surface, accessible or inaccessible for coordination; (iii)
single or multiple; (iv) if multiple, either distant or vicinal (Hemdan et al., 1989).
Proteins displaying single histidyl side chain on their surfaces may, in some instances, be
resolved by IMAC (Hemdan et al., 1989). Affinity retention of proteins by immobilized
metal ions increased with their number of His residue (Scully and Kakkar, 1982;
Hutchens and Yip, 1990). The accessibility of the residue to IMAC interaction is very
important (Berna et al., 1997). In some cases, contribution of other amino-acid side
chains such as cysteine (Hutchens et al., 1989; Kipriyanov et al., 1994, 1995), trytophan
(Sulkowski, 1985; Hansen et al., 1992), and occasionally, terminal amino group (tyrosine,
serine, threonine and perhaps arginine) (Bianchi et al., 1994) should be considered as the
source of interactions, or enhance or reduce protein-metal interactions. When ferric ion is
used, phosphate groups on the surface of protein enhance the strength of IMAC affinity
(Andersson and Porath, 1986). Contribution of net charge and hydrophobic properties of
protein should be investigated (Belew and Porath, 1990; Turkova, 1999).
2.2.4 Stationary Phases in IMAC
2.2.4.1 Solid matrix or choice of chelating
Like the matrix of affinity chromatography, the solid matrix for IMAC must possess
several properties, such as a macroporous structure, which provides a large surface area,
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limited mass transfer resistance, high mechanical strength and chemical resistance. The
chemical inertness is required to ensure that nonspecific adsorption does not happen
during the separation. The matrix must be chemically stable and possess sidechains that
can easily be modified for ligand or spacer arm attachment (Phillips, 1992). The
generally used matrix for IMAC (Porath, 1990) is agarose (Porath and Olin, 1983;
Andersson and Porath, 1986; Muszynska et al., 1986), dextran, and TSK gel (Porath et
al., 1983; Belew et al., 1987). The regular soft agarose gel can not withstand high
pressure, while highly cross-linked Sepharose beads or silica based gel can be used in
high-pressure conditions.
2.2.4.2 Nature of chelating groups
Chelating groups are used to hold metal ions onto the matrix. To ensure that there is no
metal ion leaching during the separation process, the binding between the chelating group
and metal ions should be very strong. However, too strong binding will make the
interactions between metal and protein weak. The resulting low adsorption capacity is
not suitable for practical IMAC process.
Various chelating groups have been used in IMAC. The most commonly used
chelating group has been iminodiacetic acid (IDA). The dissociation constant between
the IDA and metal ion is very small. The dissociation constant is 10 -1" 7 M for IDA-Cu2+
and 10 072 M for IDA-Fe3+ (Martell and Smith, 1974). The strong binding of metal ions
to IDA minimizes the bleeding of metal ions from the column in IMAC processes. Tris
(carboxymethyl) ethylenediamine (TED) has found some applications (Chaga et al., 1996;
Yip and Hutchens, 1991; Porath et al., 1983; Porath and Olin, 1983) with Ni (II) used as
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the chelating ion. Nitriloacetic acid (NTA) was also tried (Ramadan and Porath, 1985;
Pos et al., 1994).
2.2.4.3 Nature of chelated metal ions/choice of metal ions
Another key issue in IMAC is to choose metal ions for immobilization. The chosen metal
should form a stable complex with the chelating ligand and thus maintain high affinity to
protein to be separated.
Metal ions were divided into three categories: hard, soft and intermediate
(Pearson, 1973). Hard metal ions such as Mg(II), Ca(II), Fe(II), Al(III), and Ga(III) and
In(III) have a strong preference for oxygen-containing compounds. Soft metal ions such
as Cd(II), Hg(II) and TWIT) have a tendency to coordinate sulfur-containing compounds.
The ions Cu(II), Zn(II), Ni(II) and Co(II), which belong to intermediate category,
preferentially coordinate with nitrogen. The application of transition metals (Co, Ni, Cu,
and Zn) was reviewed by Sulkowski (1989). Adsorption of proteins on these metal ions
can be rationalized in terms of the coordination of histidine residues. Various metal ions
were investigated by researchers (Andersson and Porath, 1986).
According to the classification of Pearson (1973), Fe (III) is a hard metal ion and
can be considered as a Lewis acid or electron-pair acceptor. It has a very strong tendency
to bind oxygen-containing compounds. IMAC-Fe(III) was used by several researchers to
purify proteins, such as lysozyme, cytochrome c, avidin, bovine pancreatic RNase,
myoglobin, ovalbumin and human serum albumin (Ramadan et al ., 1985; Kastner an
Neubert, 1991; Zachariou and Hearn, 1995). In most cases IMAC-Fe (III) was used to
separate or purify phosphoproteins, phosphoamino acids (Andersson and Porath, 1986),
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and phosphopeptides (Scanff et al., 1991). Because of very low dissociation constant
between Fe(III) and phosphate group, IMAC—Fe(III) has very strong binding to phosphate
group containing proteins. This may be very useful in the adsorption of endotoxins.
2.2.5 Elution Process of IMAC
In ion exchange chromatography, a gradient of increasing salt concentration is used to
elute target product, while in hydrophobic interaction chromatography, a decreasing salt
concentration is used in most cases. For reversed phase chromatography, a gradient of
increasing organic eluent concentration is widely employed (Scope, 1994). In IMAC, the
adsorption mechanism is possibly a combination of interactions of metal chelate,
electrostatic, hydrophobic and special groups, such as phosphate group. Of course the
metal chelate affinity contributes most. The development of elution procedure is
complex and time consuming compared with other chromatographic processes.
In affinity chromatography, elution of the adsorbed solutes (in author's case,
protein or protein mixture) can be accomplished by differentially modifying the affinity of
protein for the stationary phase (Scope, 1994). The same principle was applied to IMAC.
Elution in IMAC process is done either by lowering pH to protonate the donor groups on
the adsorbed protein, or by use of a stronger complexing agent such as imidazole, glycine
(Scope, 1987). Since use of pH elution has some limitations (Vunnum and Cramer,
1997), the effective elution can be obtained by inclusion of a competing solute in the
elution buffer. However, the choice of an appropriate competing agent is very difficult.
The biggest problem is metal ion leakage caused by the competing displacer (Belew et al.,
1987).
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2.3 Rational Significance and Scope of Study
2.3.1 Previous Studies and Problems
As mentioned in Chapter 1, endotoxin removal depends on its origin, structure, molecular
weight, as well as the nature and molecular weight of biomolecules to be purified. The
endotoxin removal from water, buffer solutions and dialysate solutions has been solved.
However, endotoxin removal from biological solutions such as protein solutions and
plasma, has proved to be very difficult due to several reasons. The endotoxin exists in
different aggregation states with molecular weight ranging from 10,000 to 1,000,000,
which varies greatly as a function of solution conditions. Many proteins form complexes
with endotoxins, which are extremely difficult to break down. Finally, the interaction
mechanism between the endotoxin and protein is not well understood.
Ideal affinity chromatography ligands in endotoxin removal from protein solutions
should a) dissociate the ET-protein complex; b) capture the ET/protein molecule with
high affinity, high capacity, and high selectivity; c) either not capture or allow differential
elution of protein/ET; d) allow controlled release of the ET/protein under conditions that
preserve (i.e., do not degrade or denature) the protein; e) permit cleaning and reuse of the
chromatography matrix. Currently available endotoxin removal affinity resins or gels
such as Acticlean Etox gel from Sterogene Bioseparation Inc., have many problems,
which will be described in detail in Chapter 4:
• Low capacity, even at low ionic strength the ET adsorption capacity is about 100
EU/ml gel.
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• Removal mechanism is affinity and ion exchange or mainly ion exchange mechanism,
which is problematic. When the ionic strength is low both the protein and ET are
adsorbed. As the ionic strength increases both protein and ET are eluted.
• Affinity resin may dissociate the ET-protein complex. However the dissociation
effects are not notable. It is very difficult to get endotoxin concentration less than 0.5
EU/ml in HbAo solution.
• Regeneration problems. For regeneration, the column must be treated with 1 M
NaOH solution for 24 hrs, which is very time consuming and inconvenient.
• Low flow rate: 0.3 ml/min and therefore time consuming procedure.
• Very expensive.
Therefore highly efficient and cost effective ligands for removing endotoxins from
protein solutions need to be developed.
Conventionally, Cu2+ , Zn2+ , Ni2+ , Ca2+
 are used in IMAC. Fe3+
 was chosen in this
work, based on dissociation constant between Fe 3+
 and different groups, which is one of
the most important parameters in affinity chromatography. Lipid A is a very important
part in endotoxin, in which the phosphate group is vital to the structure and functionality
of endotoxins. Ferric ion and the phosphate group form a complex which has a
dissociation constant Kd = 10 —13
 M (Andersson and Porath, 1986). For the complex
between ferric ion and histidine group in the proteins, the Kd is about 10-6 to 10 -8 M
(Scopes, 1987), depending on how many histidine residues in the protein are exposed to
the metal ion. The dissociation constant of complex between endotoxin and protein is
around 10 -8
 M (Kaca, 1994). Theoretically, the Fe3+
 ion may break down the endotoxin-
protein complex and separate endotoxin from protein.
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2.3.2 Main Objectives
The main objective of present study was to develop an IMAC method to remove the
endotoxin from protein solutions. Optimization of the chromatography process will be
the second step. The effects of different solution conditions, such as pH, ionic strength,
and protein types on endotoxin removal from the protein solutions should be investigated.
The following contributions will be made:
I)	 ET removal from protein solutions by IDA-Fe3+
 column with model proteins:
bovine serum albumin (BSA), human hemoglobin Ao (HbAo) and
immunoglobulin G (IgG).
• The effects of mobile phase conditions such as ionic strength and pH on
endotoxin removal from protein solutions will be evaluated;
• The effects of feed concentration and volume on the endotoxin removal from
protein solutions will be investigated to determine the column capacity;
• The effects of flow rate on the endotoxin removal from protein solutions will be
investigated to determine the process throughput.
II)	 For comparison, ET removal from protein solutions will be conducted by a current
commercially available affinity column.
III) Leaching study of the IDA-Fe 3+
 IMAC column will be conducted.
CHAPTER 3
ANALYTICAL METHOD DEVELOPMENT
3.1 Historical Background and LAL Test
Bacterial endotoxins have been recognized by industry as a major cause of pyrogenic
reactions that can be encountered during the administration of biotherapeutics. It is
crucial to accurately detect and monitor endotoxin contents in biomolecule-based parental
therapeutics. Limulus Amebocyte Lysate (LAL) test is a widely used method to detect
endotoxin level in solutions.
LAL was based on the discovery that bacterial endotoxins activate a clotting
cascade in a lysate of horseshoe crab (Limulus polyphemus) amoebocytes reported by
Bang (1956) and Levin and Bang (1964, 1968). Stanley Watson, working at Woods Hole
Oceanographic Institution, developed the LAL test (Novisky, 1985, 1994). In December
1987, the United States Food and Drug Administration (FDA) published the "Guideline
on validation and use of the Limulus Amebocyte Lysate test as an end-product endotoxin
test for human and animal parenteral drugs, biological products, and medical devices". In
early 1990s the switch was complete when the USP monographs were changed to specify
the bacterial endotoxin (LAL) test in place of the pyrogen (rabbit) test.
There are three different methods (Sharma, 1986; Cross, 1993; Guo, 1997) of
endotoxin determination utilizing LAL assay. They are gel-clot, kinetic turbimetric and
chromogenic substrate assays.
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3.1.1 Gel-clot LAL test
In gel-clot test (Karprus, 1987; Aida et al., 1990; Lahiri et al., 1994; Liu et al., 1997)
lyophilized LAL is reconstituted by adding it to the test solution and incubating for 1 hr
at 37°C. If a solid gel-clot is formed and is able to withstand a 180° inversion of the tube,
the test is considered positive. This method is qualitative or semiquantitative. The
detection limit of gel-clot is about 0.025 EU/ml (Guo, 1997) or 0.03 EU/ml (Cross,
1993). This test process is very tedious.
3.1.2 The Kinetic Turbidimetric LAL Assay
The kinetic turbidimetric LAL assay (Chapman et al., 1992; Brown and Fuller, 1993;
Hirayama et al., 1994; Evans-Strikfaden et al., 1996; Refiee-Tehrani, 1997) is a sensitive
and quantitative technique comparing with gel-clot assay. It measures the increases of
turbidity during the development of a gel-clot. The rate of turbidity increase is
proportional to the endotoxin concentration. Hence turbidimetric method determines
endotoxin levels in solutions based on the time needed to reach a specific degree of
turbidity. The detection limit for kinetic turbidimetric assay is 0.001 EU/ml.
The following kinetic turbidimetric assay equipment and kits are provided by the
several manufacturers: Wako Toxinometer ET-201 (Hirayama et al., 1994; Morimoto et
al., 1995), LAL 500 series 1 from Atlas Bioscan (Associates of Cape Cod) as well as
LAL 500 series 2 automatic endotoxin detection system (Associates of Cape Cod). For
LAL 500 series 2, test sensitivity of the assay was 0.0031 EU/ml.
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3.1.3 Chromogenic Substrate Assay
In a chromogenic substrate test, a synthetic chromogenic substrate is used. This substrate
is a short synthetic polypeptide with an amino acid sequence that mimics a nature
cleavage site on the coagulogen. The chromogenic p-nitroaniline (pNA) moiety is
attached to the end of the peptide as Ac-Ile-Glu-Gly-Arg-pNA. In the chromogenic LAL
test, the proenzyme is activated by the endotoxin in a water bath at 37°C for 10 min.
Chromogenic substrate is then added, and the active enzyme causes the release of pNA
from the substrate, producing a yellow color. The reaction is stopped with acetic acid.
The intensity of the color change produced by the substrate cleavage is measured
spectophotometrically at 405 nm. The correlation between the absorbance and endotoxin
concentration is linear in certain range. This method is widely used in the determination
of endotoxin concentration because of its high sensitivity and easy operation (Burger et
al., 1989; Hou, and Zaniewski, 1990; Vanholder et al., 1992; Mitzner et al., 1993; Roth,
and Kaca, 1994; Longerman et al., 1994; Rafiee-Tehrani et al., 1996).
Main manufacturers of chromogenic kits are BioWhittaker, Seikagku (Japan),
Chromogenix (Sweden).
3.1.4 The effects of LPS on protein assays
Protein concentration is determined with the method of Stanford with BSA or lysozyme
as a standard (reference), or measured at 280 nm for its absorbance. The latter causes a
problem. The LPS has absorbance at 280 nm, which interferes with the protein assay.
The protein concentration determined by this method is higher than its actual value.
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3.2 Accurate Chromogenic Measurement of Endotoxin Concentration in A
Hemoglobin-Lipopolysaccharide Complex Solution
Chromogenic LAL assay is widely used in the determination of endotoxin concentration
because of its high sensitivity and easy operation (Hou, Zaniewski, 1990; Cliff et al.,
1995; Refiee-Tehrani et al., 1996). Problems arise when chromogenic LAL test is used
to determine endotoxin contents in some protein solutions with color. It is known that
hemoglobin forms a complex with endotoxin (Kaca et al., 1994; Li and Luo, 1997) and
has a strong absorbance at 405 nm, which causes interference with the reading of the
color intensity generated by the LAL reaction. Although previous studies reported by
Cliff et al. (1995), Roth and Levin (1994) mentioned that the chromogenic LAL test
required a deduction of HbAo absorbance from the total absorbance of the mixture, no
detailed descriptions have been provided about the compensation. More importantly, the
compensation approach has not been verified experimentally. This approach was
described in details theoretically by considering both color sources introduced by the
hemoglobin and the LPS activation reaction in this Section.	 It was verified
experimentally by comparing the compensation curve to an endotoxin standard curve.
3.2.1 Materials and Methods
Reagents
Endotoxin standard from QCL-1000 LAL test kit (BioWhittaker, Inc., Walkersville, MD,
USA) was used in all studies. All solutions were prepared with endotoxin free water
(LAL reagent water, BioWhittaker Inc., Walkersville, MD, USA). Hemoglobin Ao
(HbAo, ferrous) was purchased from Sigma.
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Labware
All glassware used was autoclaved at 15 psig for 30 minutes with an electric pressure
steam sterilizer (Model No. 25X, Wisconsin Aluminum Foundry Co., Inc., WI, USA) and
followed with heating in an oven (Model 16, Precision Scientific Co., IL, USA) at 210°C
for 3 hours. All solution transfers were performed by endotoxin free devices. Sterile,
disposable plastic ware was used at all times to prevent endotoxin contamination.
Protein Assay
The absorbance scanning from 250 nm to 750 nm in our laboratory shows that the
endotoxin sample has a small absorbance peak at around 280 nm (absorbance spectrum
not shown). Therefore HbAo concentration was measured with a spectrophotometer (U-
2000, Hitachi, Japan) at 415 nm to avoid the effect of endotoxin absorbance interference.
Endotoxin Standard Curve of Chromogenic LAL Assay
The endotoxin standard curve was generated following the procedure of BioWhittaker
(1998). After LAL incubation, the absorbance (ABS) of endotoxin standard solutions at
a series of endotoxin concentrations, i.e., 0.05, 0.1, 0.25, 0.5 EU /ml was measured by
spectrophotometer individually. Using endotoxin free water as the blank, standard
endotoxin curves were obtained by plotting each ABS versus the corresponding
concentration, i. e., 0.05, 0.1, 0.25 and 0.5 EU/ml.
The two performance characteristics of standard curve were used as suggested by
BioWhittaker (1998): linearity and reproducibility. The linearity of the standard curve
within the concentration range used to predict endotoxin values was verified based on the
least squares method. The reproducibility can be verified by comparing the different
curves.
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Interference of HbAo on Chromogenic LAL Assay: Shifted Curves
Two sets of endotoxin standard solutions with a series of endotoxin concentrations as
mentioned above, i.e., 0.05, 0.l, 0.25, 0.5 EU/ml, were used. Each solution of the first
set was spiked with HbAo to 10 µg/ml (Case 1) and each solution of the second set was
spiked with HbAo to 20 µg/ml (Case 2). Therefore eight HbAo spiked endotoxin
solutions were prepared. After the LAL incubation the ABS of each HbAo spiked
endotoxin solution was measured by the spectrophotometer. At each endotoxin
concentration, the experiment was conducted in duplicate and total absorbance, ABS mix ,
was obtained using endotoxin free water as the blank. The blank was also incubated with
LAL following the same steps for the samples. The experimental curves (the shifted
curves) were constructed by plotting each ABSmix
 versus the corresponding endotoxin
concentration for samples spiked to 10 µg/m1 and 20 µg/ml HbAo, respectively.
Compensation of HbAo Interference on Chromogenic LAL Assay: Theory
In this study three kinds of solutions were used: endotoxin standard solution (pure
endotoxin solution), the HbAo solution and the mixture of endotoxin standard solution
and the HbAo solution. The mixture was prepared so that the HbAo concentration in it
was the same as that in the HbAo solution. In the endotoxin standard solution, the
endotoxin concentration is C LPs and the absorbance after LAL incubation is ABS LpsSTAN .
The interference of HbAo on the chromogenic LAL assay can be compensated by
considering both the absorbance caused by HbAo and the absorbance caused by the LPS
in the HbAo solution. The method of compensation can be mathematically described as
follows.
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In the HbAo solution, which contains small amount of LPS, the endotoxin
concentration is GHbAoLPS. The total abs rbance of the HbAo solution after LAL incubation,
ABSHbAo , has two contributions:
Where ABSHbAois the absorbance of the HbAo solution contributed by the color of HbAo
itself, which is the same before and after the LAL incubation. ABSHbAoLPSis the absorbance
of the HbAo solution contributed by the small amount of LPS that generated the color
after the LAL incubation. For the mixture of the HbAo solution and endotoxin standard
solution, we have
Where CMixLPS
 is the total endotoxin concentration of the mixture.CMixLPS,Stan
 
is the
endotoxin concentration of the endotoxin standard solution in the mixture. CMixLPS,HbAo
 is
the endotoxin concentration of the HbAo solution in the mixture. ABS A4" is the total
absorbance of the mixture. ABS
,STAN is the absorbance of endotoxin standard solution
in the mixture. ABSMixLPS,HbAois the endotoxin absorbance in the original HbAo solution in
the mixture. ABSMixHbAo,HbAo is the absorbance of HbAo in the mixture. The experiments
were designed so that the last two terms of Eq. (3.3) should have the following
relationship with the ABSHbAo in Eq. (3.1):
47
Therefore, the absorbance of the endotoxin standard solution in the mixture after the
compensation for HbAo interference is
The values of ABSMixLPS,STANand their corresponding endotoxin concentrations can be
plotted as the curve of compensation, i.e., the corrected curve. The position of this curve
is expected to be very close to that of the original endotoxin standard curve. Eq. (3.5) can
also be rearranged as
Where ABSMixLPSis the absorbance of the total endotoxin in the mixture, which corresponds
to the total endotoxin concentration of the mixture, CMixLPS, in Eq. (3.2). For a mixture of
HbAo and endotoxin, Eq. (3.7) can be used to calculate the total endotoxin concentration
of the mixture. Since ABSHbAocan be measured from the mixture before the LAL
incubation and ABSMiX can be measured from the mixture after the LAL incubation,
ABSMixLPScan be calculated using Eq. (3.7). The corresponding Cixthen be obtained
from the endotoxin standard curve.
Compensation of HbAo Interference on Chromogenic LAL Assay: Corrected Curves
Two series of endotoxin standard solutions as above were spiked to 10 µg/m1 and 20
µg/m1 HbAo, respectively. This time during the chromogenic LAL assay, instead of
endotoxin free water, HbAo solutions were used as the blanks to compensate the effect of
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HbAo in the mixtures being assayed. The HbAo solution of a concentration of 10 µg/ml
was used as the blank for the assay of the series of endotoxin standard solutions spiked to
10 µg/ml, and a HbAo solution with a concentration of 20 µg/ml was used as the blank
for assay of the series of endotoxin standard solutions spiked to 20 µg/ml. The blanks
were also incubated with LAL following the same steps for the samples. It is expected
that the experimental curves (corrected curves) for both Case 1 and Case 2 should be very
close to the original endotoxin standard curve.
3.2.2 Results
Endotoxin Standard Curve of Chromogenic LAL Assay
The endotoxin standard curve was shown in Figure 3.1 which was the average of thirteen
groups of experimental data considering standard deviation. R is much higher than the
BioWhittaker's requirement, which is R 0.98. This indicates that the data points for
both curves are highly linear. The line above the standard curve gives the up end (+
standard deviation) of the standard curve while the line below it is the low end (-standard
deviation).
Interference of HbAo on Chromogenic LAL Assay: Shifted Curves
Figure 3.2 shows the interference of HbAo on the chromogenic assay. In Case 1, where
endotoxin standards were spiked to 10 µg/ml HbAo, although the linearity of the curve is
high (R=0.986), the curve has shifted away from the position of the standard curve due to
the interference of HbAo.	 In Case 2, the linearity of the curve is also high (R=0.984),
Figure 3.1 Endotoxin standard curves generated using endotoxin standard
solutions. Blank: endotoxin free water.
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Figure 3.2 Shifted curves when the endotoxin standard solutions were
spiked to 10µg/ml HbAo (Case 1) and 20 µg/ml HbAo (Case 2). Blank:
endotoxin free water.
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but the curve has shifted even further away compared to Case l. This is expected due to
the higher spiking HbAo concentration in Case 2.
Compensation of HbAo Interference on Chromogenic LAL Assay: Corrected Curves
As discussed before, the interference of HbAo on the chromogenic LAL assay can be
compensated using HbAo solutions at corresponding concentrations as the blanks. Figure
3.3 shows the results of the compensation, i.e., the corrected curves for Case 1 (10 µg/ml
HbAo spike) and Case 2 (20 µg/ml HbAo spike). It can be seen that both the corrected
curves are very close to the standard curve. The linearity for both curves is high
(R.0.98). In Figure 3.4, the corrected curve and the shifted curve, both for Case 2, are
plotted together for comparison. The figure shows that the position of corrected curve is
much closer to the standard curve than that of the shifted curve.
3.2.3 Summary
In this study, a simple method was demonstrated to compensate the interference of
hemoglobin on the chromogenic LAL assay using a series of mixtures of the endotoxin
standard solutions and human hemoglobin Ao (HbAo) solutions. This approach has been
described mathematically by considering both the color sources introduced by the
hemoglobin and the endotoxin activated reaction. The approach has also been verified
experimentally by comparing the compensated curve to an endotoxin standard curve.
Further, it is expected that both the theoretical and experimental approaches can be
applied to the mixtures of endotoxin and other proteins with color that interfere the
chromogenic LAL assay. It is noticed that the concentrations (10 µg/ml and 20 µg/ml) of
Figure 3.3 Corrected curves using the method of compensation. Case l:
endotoxin standard solutions spiked to 10 µg/ml HbAo; Blank: 10 µg/ml
HbAo solution. Case 2: endotoxin standard solutions spiked to 20 µg/m]
HbAo; Blank: 20 µg/ml HbAo solution
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Figure 3.4 Comparison of shifted curve (before compensation) and the
corrected curve (after compensation) of Case 2 (endotoxin solutions
spiked to 20 µg/ml HbAo).
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HbAo spikes used in this work were not very high. If hemoglobin concentration is
higher, a proper sample dilution before the compensation process is required.
3.1 Inhibitions of phosphate ion on the detection of LAL test
Limulus Amebocyte Lysate (LAL) assay is widely used to determine the endotoxin
content in all kinds of samples such as water, buffers, and protein solutions. Some types
of samples inhibit the LAL assay. Sample inhibition occurs when substances in the
sample interfere with the LAL test results. In the chromogenic assay, this inhibition
results in a lower final absorbance, indicating lower level of endotoxin than what exists in
the test sample. The lack of sample inhibition should be determined for each specific
sample, either undiluted or at an appropriate dilution (BioWhittaker, Inc., QCL-1000
Quantitative Chromogenic LAL manual). In this research, sodium phosphate buffer was
found to have some inhibition effect on LAL assay. Hence if the lipopolysaccharides
(LPS) solution was prepared with phosphate buffer, proper methods are required to
remove the inhibition: these are described below.
3.3.1 Materials and Methods
Reagents
Endotoxin standard from QCL-1000 LAL test kit (BioWhittaker, Inc., Walkersville, MD,
USA) was used in all studies. All solutions were prepared with endotoxin free water
(LAL reagent water, BioWhittaker Inc., Walkersville, MD, USA).
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Labware
All glassware used was autoclaved at 15 psig for 30 minutes with an electric pressure
steam sterilizer (Model No. 25X, Wisconsin Aluminum Foundry Co., Inc., WI, USA) and
followed with heating in an oven (Model 16, Precision Scientific Co., IL, USA) at 210°C
for 3 hours. All solution transfers were performed using endotoxin free devices Sterile,
disposable plastic ware was used at all times to prevent endotoxin contamination.
Endotoxin Assay
QCL-1000 Chromogenic LAL test kit (BioWhittaker, Inc., Walkersville, MD, USA) was
used to determine the LPS content in the solutions.
Experimental Methods
To determine the phosphate buffer inhibition to LPS LAL test, an equal volume of
phosphate buffer with different concentrations was spiked with a known amount of
standard endotoxin. The spiked solution was assayed with the control, which is
endotoxin free water spiked with the same amount of standard endotoxin. Then
endotoxin concentrations in both sample and control were determined. The difference
between these two calculated endotoxin concentrations should be lower than ± 25% of
the known LPS spike concentration. The endotoxin recovery is defined as (LPS detected
in sample/ LPS in the control) x 100%. LPS concentration in the sample solution by
LAL test should be in the range of 75% to 125% of control solution. Otherwise the
inhibition has strong effect on the LAL test, and LAL test results are not acceptable.
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3.3.2 Results and Discussions
Inhibition of phosphate buffer on the LAL assay
The experimental results of LAL assay with different concentration of sodium phosphate
at fixed endotoxin spike are shown in Figure 3.5. From the figure, the strong inhibition
of sodium phosphate on the LAL test is observed when the sodium phosphate
concentration is higher than 10 mM. However, as the phosphate solution was diluted to
lower than 8.33 mM, 90% recovery of LAL assay was obtained. Therefore, proper
dilution is a good way to overcome the inhibition of sodium phosphate on LAL test.
Thus, this inhibition is reversible. When the sample is properly diluted, the pyrogenicity
of LPS is measurable.
Figure 3.5 Phosphate concentration on the endotoxin concentration
determination: Endotoxin concentration recovery
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CHPATER 4
EFFECT OF SOLUTION CONDITIONS ON ENDOTOXIN REMOVAL AND
PROTEIN RECOVERY BY ACTICLEAN ETOX COLUMN
4.1. Introduction
Lipopolysaccharide (LPS) or endotoxin is known to have potent biological effects in
human. Serious endotoxin infection can cause sepsis and septic shock, leading to severe
hypertension, cardiovascular collapse, multiple organ failure and death (Billiau and
Vandekerckhove, 1991). In biotechnology industry, Gram-negative bacteria are widely
used to produce recombinant DNA products such as peptides and proteins. Bacterial
endotoxins have been recognized by the industry as a major cause of the pyrogenic
reactions that can be encountered during the administration of biotherapeutics (Hou and
Zaniewski, 1990). The removal of these physiologically active agents from final
bioproducts has always been a challenge, especially in the situations where endotoxins
bind product proteins. Significant product loss and low product yield can result from the
separation steps employed to remove endotoxins. It is known that some proteins can
disaggregate endotoxins and form complexes with LPS in biological solutions, which
makes the removal of endotoxin from protein-based biopharmaceutical products more
complicated. It was reported that hemoglobin not only can bind but also disaggregate
LPS, and enhance LPS activation of limulus amebocyte lysate (LAL) in a concentration
dependent manner (Kaca et al., 1994; Roth et al., 1994). In previous studies, researchers
in Luo's research group investigated the concentration effects of hemoglobin and albumin
on protein-LPS binding and endotoxin removal (Li and Luo, 1997). It was found that the
proteins interacted with LPS and formed protein-LPS complexes, resulting in the
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disaggregation of LPS vesicles. Researchers in this group also reported the use of Ca +2
 to
re-aggregate lipopolysaccharide (LPS) in hemoglobin solutions and the subsequent
removal of endotoxin in a two-stage ultrafiltration process (Li and Luo, 1998, 1999).
Although numerous methods such as ion exchange adsorption (Weber et al.,
1995), ion exchange membrane (Belanich et al., 1996), ion-exchange filter (Hou and
Zaniewski, 1990), ultrafiltration (Li and Luo, 1998, 1999), and extraction (Aida and
Pabst, 1990) have been studied for endotoxin removal from protein solutions, affinity
adsorption has proven to be the most effective technique. Polymyxin B has been
investigated intensively as an endotoxin binding ligand since Issekutz (1983) reported its
ability to remove endotoxin from solutions. In subsequent studies, polymyxin B has been
immobilized on chromatographic supports such as Sepharose (Karprus et al., 1987) to
remove endotoxin from protein solutions. Membranes (Petsch et al., 1997) or fibers
(Tani et al., 1992) have been used as the support as well. Immobilized histidine has also
been employed to remove endotoxin from protein solutions. Sepharose resin (Matsumae
et al., 1990), filter-paper (Guo et al., 1997), and hollow fiber membranes (Legallais et al.,
1997) have been used as the support. Hirayama et al. (1994) studied the use of cross-
linked N, N-dimethylaminopropylacrylamide (DMAPAA) spherical particles for selective
removal of endotoxin from protein solutions. They found that ionic strength had less
effect on the endotoxin removal efficiency with DMAPAA than with immobilized
histidine. In another study, investigators from the above group (Morimoto et al., 1995)
studied the application of polyethyleneimine (PEI)-immobilized cellulose fibers for
endotoxin removal from protein solutions. Matsumae et al (1990) applied immobilized
histidine to remove endotoxin from protein solutions. The effects of pH and ionic
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strength on the removal of endotoxin were investigated. Although the influences of ionic
strength on endotoxin removal were reported in the above articles, the effects of divalent
cations on endotoxin removal and protein recovery were not studied. At the same ionic
strength, divalent cations have much stronger influences on endotoxin aggregation state
due to the bridging effect (Li and Luo, 1998).
The use of Acticlean Etox affinity column from Sterogene Bioseparations
(Carlsbad, CA) to remove endotoxin from hemoglobin preparations where the protein
formed complex with LPS subunits (Kang and Luo, 1998) was reported. The effects of
various solutions such as endotoxin-free water, NaCl and CaCl2 on the endotoxin removal
efficiency and protein recovery in the chromatographic process were investigated.
However, the study was carried out with a fixed ionic strength at neutral pH. Further
experiments were needed to see how the column would behave at various ionic strength
and pH conditions.
In this study, endotoxin was removed from hemoglobin preparations using an
Acticlean Etox affinity column. The effects of ionic strength and pH on endotoxin
removal efficiency and protein recovery have been investigated. The LPS-resin and
protein-resin adsorption mechanisms have been discussed. The effects of protein-LPS
complexation on protein recovery in the chromatographic column had also been studied.
4.2. Experimental
4.2.1 Materials
4.2.l.l Reagents
Endotoxin from Escherichia coli 026:B6 (Sigma, St. Louis, MO, USA) was used in all
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studies. All solutions were prepared with endotoxin free water (LAL reagent water,
BioWhittaker Inc., Walkersville, MD, USA). Hemoglobin Ao (HbAo, ferrous), NaCl
(>99%) and CaCl2 (>99%) were purchased from Sigma.
4.2.l.2 Column and Experimental Setup
The experiments were conducted on an Acticlean Etox column (Product No. 4AA04),
which was kindly provided by Sterogene Bioseparations, Inc. (Carlsbad, CA, USA). The
column dimensions were 3.5x0.7 cm. The column was packed with an Acticlean Etox
affinity resin, which had a Actigel ALD support matrix (4% agarose) linked to a
proprietary ligand through a secondary amine. The experimental setup was shown in
Figure 4.l. Before each use the column was cleaned by perfusion with 30 ml of l.0 M
NaOH, allowed to stand at 4°C overnight and washed with endotoxin free water until
neutrality. Samples were applied to the column at an approximate flow rate of 0.3 ml/
min. Elution was carried out at above flow rate with endotoxin-free water as the mobile
phase.
4.2.1.3 Labware
All glassware used was autoclaved at 15 psig for 30 minutes with an electric pressure
steam sterilizer (Model No. 25X, Wisconsin Aluminum Foundry Co., Inc., WI, USA) and
followed with heating in an oven (Model 16, Precision Scientific Co., IL, USA) at 210°C
for 3 hours. All solution transfers were performed by endotoxin free devices. Sterile,
disposable plasticware was used at all times to prevent endotoxin contamination.
Figure 4.1 Experimental Setup
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4.2.2 Protein Assay
The absorption scanning from 250 nm to 700 nm by author shows that the endotoxin
sample only has the absorbance peak at around 280 nm (The absorption spectrum is not
shown here). Therefore HbAo concentration was measured with a model U-2000 UV-
Vis spectrophotometer (Hitachi Instruments Inc., Danbury, CT, USA) at 415 nm to avoid
interference by the endotoxin absorbance.
4.2.3 Endotoxin Assay
To determine endotoxin concentration, a chromogenic limulus amebocyte lysate (LAL)
test kit QCL-1000 from BioWhittaker (BioWhittaker Inc., Walkersville, MD) with a
modified procedure was used. The sensitivity of this test is 0.01 EU/ml. The reaction
mixtures were measured at 405 nm using the Hitachi U-2000 spectrophotometer and the
results were compared to a standard curve to obtain endotoxin concentrations. However,
HbAo also has a strong absorbance at 405 nm and subtraction of HbAo absorbance is
necessary. The correction was done by subtracting the HbAo absorbance from total
absorbance of the reaction mixture (Kang and Luo, 1999).
The endotoxin removal ability of the process was quantitatively evaluated using
Endotoxin Removal Efficiency, ERE, which was determined by the following equation,
Where r I feeus is the amount of endotoxin (in endotoxin unit, EU) in the feed loaded on
fracthe column. n Lps is the amount of endotoxin (EU) in all the elution fractions.
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4.2.4 Endotoxin Removal from HbAo-LPS Feeds Prepared
with Endotoxin Free Water
HbAo solutions were mixed with endotoxin to reach about 2.00 EU/ml final endotoxin
concentration and 90 to 100.00 µg /ml HbAo and incubated for 30 minutes at 37°C in
water bath in order to form HbAo-LPS complex (Li and Luo, 1998). 10 ml feed of such
HbAo solution was perfused through the column at 0.3 ml /min. The eluents were
collected at 3 ml (Fraction I), 13 ml (Fraction II), and 23 ml (Fraction III). Fraction II is
the main fraction, or product. Proper dilutions of samples taken from the fractions were
needed in order to obtain the maximum endotoxin assay sensitivity.
4.2.5 Endotoxin Removal from HbAo-LPS Feeds Prepared with NaCl Solutions
at Various Ionic Strength
HbAo solutions prepared with NaCl solutions at different ionic strength, 0.05, 0.10, 0.15
and 0.25 M, were mixed with endotoxin to reach about 2.00 EU/ml final endotoxin
concentration and 90 to 100.00 µg /ml HbAo concentration. The mixtures were
incubated for 30 minutes at 37°C. The ionic strength of the solution was calculated
according to Debye-Huckel theory (Pimmetel and Spratley, 1971). 10 ml feed was
applied to the column. Three fractions were collected in the same way as described in
Section 4.2.4.
4.2.6 Endotoxin Removal from HbAo-LPS Feeds Prepared with CaC12 Solutions
at Various Ionic Strengths
HbAo solutions prepared with CaCl2 solutions of different ionic strengths, 0.05, 0.10,
0.15, 0.25 M, were mixed with endotoxin to reach about 2.00 EU/ml final endotoxin
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concentration and 90.00 to 100.00 µg /ml HbAo concentration. The mixtures were
incubated for 30 minutes at 37°C. 10 ml feed was applied to the column. Three fractions
were collected in the same way as described in Section 4.2.4.
4.2.7 Elution of Pure HbAo Feed Prepared with Endotoxin Free Water
In the second part of the study on ionic strength effect on protein recovery in the affinity
process, pure protein solutions were employed as feeds, which served as controls to those
involving HbAo-LPS mixtures as feeds. HbAo solutions without an endotoxin spike
were prepared with endotoxin free water to reach final HbAo concentrations from 90 to
100 µg /ml. After incubation at 37°C for 30min., 10 ml feed was applied to the column.
Three fractions were collected in the same way as described in Section 4.2.4.
4.2.8 Elution of Pure HbAo Feeds Prepared with NaC1 Solutions
at Various Ionic Strength
HbAo solutions without endotoxin spike were prepared with NaCl solutions at 0.05,
0.10, 0.15, 0.25 M ionic strength to reach final HbAo concentration from 90 to 100 µg
/ml. The solutions were incubated for 30 minutes at 37°C. 10 ml feed was applied to the
column. Three fractions were collected in the same way as described in Section 4.2.4.
4.2.9 Elution of Pure HbAo Feeds Prepared with CaC12 Solutions
at Various Ionic Strength
HbAo solutions without endotoxin spike were prepared with CaCl2 solutions at 0.05,
0.10,0.15, 0.25 M ionic strength to reach final HbAo concentration from 90 to 100 µg
/ml. The solutions were incubated for 30 minutes at 37°C. 10 ml feed was applied to the
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column. Three fractions were collected in the same way as described in Section 4.2.4.
All feeds applied to the Acticlean Etox column in the study of ionic strength effect were
summarized in Table 4.l.
4.2.10 Endotoxin Removal from HbAo-LPS Mixtures Prepared with Buffers
at Various pH
In order to study the effect of pH on the endotoxin removal efficiency and protein yield,
HbAo-LPS feeds were prepared with buffers at various pH: 4.5, 6.0, 7.0, 8.0 and 9.0.
The buffers used were acetate buffer (pH 4.5, Cases 4.l), phosphate buffer (pH 6.0, Case
4.2; pH 7.0, Case 4.3; and pH 8.0, Case 4.4), and This-HCl buffer (pH 9.0, Case 4.5).
The concentration was 0.05 M for all buffer solutions. First, the stock solutions of HbAo
and endotoxin were prepared separately with the same buffer at a specific pH. A certain
volume of the HbAo stock was then mixed with a certain volume of endotoxin stock to
reach final endotoxin concentration at about 2.00 EU/ml and HbAo at 90 to 100 /ml.
The HbAo-LPS mixtures at pH 4.5, 6.0, 7.0, 8.0 and 9.0 were incubated at 37°C for 30
min., respectively, to form HbAo-LPS complex. 10 ml feed from each mixture was
applied to the column at a flow rate of 0.3 ml/min in individual runs. Three fractions
were collected in the same way as described in Section 4.2.4.
4.2.11 Elution of Pure HbAo Feeds Prepared with Buffers at Various pH
In the second part of the study on pH effect on the protein recovery in the affinity
process, pure protein solutions at various pH were employed as feeds, which served as
controls to those involving HbAo-LPS mixtures as feeds. The buffers used were acetate
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buffer (pH 4.5, Case P-4.1), phosphate buffer (pH 6.0, Case P-4.2; pH 7.0, Case P-4.3;
and pH 8.0, Case P-4.4) and Tris-HCl buffer (pH 9.0, Case P-4.5). The concentration
was 0.05 M for all buffers. Five pure HbAo solutions were prepared with above buffers
at pH 4.5, 6.0, 7.0, 8.0 and 9.0, respectively. In the control experiments, 10 ml of the
pure HbAo feed from each solution were applied to the column at a flow rate of 0.3
ml/min in individual runs. Three fractions were collected in the same way as described
in Section 4.2.4.
4.3. Results and Discussion
4.3.1 Endotoxin Removal Efficiency of HbAo-LPS Feeds Prepared with NaC1
Solutions at Various Ionic Strength
The endotoxin concentrations in the feeds and the products of the chromatography
process are shown in Table 4.l for Cases 2.l, 2.2, 2.3 and 2.4 in which feeds were
prepared with NaCl solutions at various ionic strengths. The endotoxin removal
efficiency, ERE, as a function of ionic strength, IA, for all these cases is shown in Figure
4.2. It can be seen from Figure 4.2 that ERE was around 71% as the ionic strength was
increased from 0 to 0.05 M. When the ionic strength was increased from 0.05 to 0.15 M,
ERE dropped significantly from 72% to 43%, which indicates the mechanism of ion
exchange in this range of ionic strength. When ionic strength was increased from 0.15 to
0.25 M, ERE was kept almost constant at a level of 40%. This indicates affinity
interactions other than ionic exchange had taken place.
Table 4.1 Effect of solution ionic strength on LPS concentration in feed and product,
HbAo recovery, and endotoxin removal efficiency, ERE
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Cases
Ionic Strength
I (M)
HbAo recovery
R (%)
LPS Concentration
(EU/ml) ERE
(%)
NaCl CaCl2 Without LPS With LPS Feed Product
Case 1 0 0 94.0 90.0 2.19 0.64 71.8
Case 2.1 0.05 0 100.0 99.7 2.27 0.69 69.6
Case 2.2 0.10 0 100.0 100.0 2.31 0.99 56.4
Case 2.3 0.15 0 99.0 96.0 2.44 l.30 42.7
Case 2.4 0.25 0 99.0 92.9 2.12 l.37 39.6
Case 3.1 0 0.05 97.0 97.6 2.85 l.19 54.0
Case 3.2 0 0.10 100.0 99.0 2.43 1.56 39.7
Case 3.3 0 0.15 99.0 99.0 2.75 l.60 38.2
Case 3.4 0 0.25 96.0 96.9 2.67 l.61 37.8
4.3.2 Endotoxin Removal Efficiency of HbAo-LPS Feeds Prepared with CaC12
Solutions at Various Ionic Strength Conditions
The endotoxin concentrations in the feeds and the products of the chromatography
process are shown in Table 4.1 for Cases 3.l, 3.2, 3.3 and 3.4 in which feeds were
prepared with CaCl2 solutions at various ionic strengths. The endotoxin removal
efficiency, ERE, as a function of ionic strength, I, for all above cases was shown in
Figure 4.2. It can be seen from Figure 4.2 that ERE dropped significantly from 71% to
around 38%, as the ionic strength was increased from 0 to 0.10 M, which indicates the
mechanism of ion exchange in the range of ionic strength. When ionic strength was
increased from 0.10 to 0.25 M, ERE was kept almost constant at a level of 38%. This
indicates affinity interactions other than ionic exchange had taken place.
Figure 4.2 Effect of solution ionic strength on endotoxin removal
efficiency, ERE, of HbAo-LPS feeds prepared with NaCl and CaCl2
solutions at various ionic strength, respectively
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4.3.3 Protein Recovery of HbAo-LPS Feeds Prepared with NaC1
at Various Ionic Strength Conditions
The HbAo recovery, R, of the chromatography process is shown in Table 4.1 for Cases
2.l, 2.2, 2.3 and 2.4 in which HbAo-LPS feeds were prepared with endotoxin free water
(Case l) and NaCl solutions (other cases) at various ionic strength. It can be seen that
HbAo recovery was around 90% when the feed was prepared with endotoxin free water.
When ionic strength was increased from 0 to 0.10 M, HbAo recovery was also increased
to 100%, which indicates a very weak ion exchange interaction in this range of ionic
strength. When ionic strength was increased from 0.10 to 0.25 M, HbAo recovery was
decreased slightly and then kept almost constant at a level of 94%. This indicates that
possible hydrophobic interactions might have taken place. Within the ionic strength
range studied, i.e., 0 to 0.25 M, R was always above 90% and it reached the maximum
point, 100% at I = 0.l M. The largest discrepancy of HbAo recovery at different ionic
strength was less than 10%. There was a very limited HbAo adsorption to the column in
the cases reported.
4.3.4 Protein Recovery of HbAo-LPS Feeds Prepared with CaC12
at Various Ionic Strength Conditions
The HbAo recovery in the chromatography process is shown in Table 4.1 for Cases 3.l,
3.2, 3.3 and 3.4 in which HbAo-LPS feeds were prepared with endotoxin free water
(Case l) and CaCl2 solutions (other cases) at various ionic strength. It can be seen that
HbAo recovery was increased from 90% to around 99%, as the ionic strength was
increased from 0 to 0.10 M, which indicates the mechanism of ion exchange in this range
of ionic strength. When ionic strength was increased from 0.10 to 0.25 M, R was
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decreased slightly and retained constant at a level of 97%. Similar to the situations in
Section 4.3.3, this indicates possible hydrophobic interactions between the HbAo and the
resin. Within the ionic strength range from 0 to 0.25 M, R was always above 90% and it
reached the maximum point, 99%, at I = 0.1 M. The largest discrepancy of HbAo
recovery at different ionic strength was less than 9%, which represents a very limited
HbAo-resin interaction in the whole range of ionic strength studied in the experiments.
By comparing the HbAo recovery of above two situations, i.e., feeds prepared
with NaC1 solutions and feeds prepared with CaCl 2 solutions, the changes of R versus
ionic strength followed a similar pattern. When the ionic strength was increased from 0
to 0.25 M, R was first increased to a maximum value at I = 0.1 M, then decreased slightly
and kept at a constant level thereafter. The largest difference of R values between the
two situations was about 3% at I = 0.25 M.
4.3.5 Protein Recovery of Pure HbAo Feeds Prepared with NaCI
at Various Ionic Strength Conditions
Table 4.l shows the HbAo recovery in the chromatographic process in which pure HbAo
feeds were prepared with endotoxin free water (Case P-l) and NaCl solution (Cases P-
2.l to P-2.4). Here pure HbAo feeds were used as controls for the HbAo-LPS feeds
described in Section 4.3.3. From the table, HbAo recovery was 94% when the feed was
prepared with endotoxin free water (I = 0). When the ionic strength was increased from
0 to 0.05 M and further to 0.15 M, HbAo recovery was close to 100% and stayed there.
This indicates a weak ionic interaction between the protein and resin. When the ionic
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strength was increased to 0. 25 M, HbAo recovery dropped slightly to 99%, which
implies a minimum affinity interaction between HbAo and the resin.
4.3.6 Protein Recovery of Pure HbAo Feeds Prepared with CaCl2
at Various Ionic Strength Conditions
Table 4.l also shows the HbAo recovery in the chromatographic process in which pure
HbAo feeds were prepared with endotoxin free water (Case P-l) and CaCl2 (Cases P-3.l
to P-3.4). Here pure HbAo feeds were used as controls for the HbAo-LPS feeds
described in Section 4.3.4. From table, HbAo recovery was 94% when the feed was
prepared with endotoxin free water (I = 0). When the ionic strength was increased from
0 to 0.05 M and further to 0.15 M, HbAo recovery was close to 98% and stayed there.
This indicates a weak ionic interaction between the protein and resin. When the ionic
strength was increased to 0. 25 M, HbAo recovery dropped slightly to 96%, which
implies a minimum affinity interaction between HbAo and the resin.
4.3.7 Effect of pH on Endotoxin Removal Efficiency of HbAo-LPS Feeds
In this part of the study (Sections 4.3.7 and 4.3.8), HbAo-LPS mixtures prepared with
buffers at various pH were applied to the column, as described in Section 4.2.10. Figure
4.3 shows how the change of pH effected the endotoxin removal efficiency, ERE. When
pH = 4.5, ERE was 92%. As pH was increased from 4.5 to 8.0, ERE decreased gradually
from 92% to 83%. As pH was increased further from 8.0 to 9.0, ERE dropped drastically
from 83% to 43%. The results indicate that ion exchange and other interactions had
occurred between the endotoxin molecules and the resin.
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4.3.8 Effect of pH on Protein Recovery of HbAo-LPS Feeds
Figure 4.3 shows how the change of pH affected the HbAo recovery, R. When pH = 4.5,
R was 97%. As pH was increased from 4.5 to 7.0, R increased to 100%. As pH was
increased further from 7.0 to 9.0, R decreased slightly to 97%. Therefore, there was only
less than 3% of HbAo being retained in the column across the pH range in the study.
4.3.9 Effect of pH on Protein Recovery of Pure HbAo Feeds
As described in Section 4.2.11, pure HbAo solutions prepared with buffers at various pH
were employed as the feeds to the column. These pure HbAo feeds served as controls to
the HbAo-LPS mixtures mentioned in Section 4.3.8. When pure HbAo feeds were
applied to the column, HbAo recovery, R, was 100% for all of the pH values.
4.3.10 Discussion
The results in Section 4.3.l and 4.3.2 have revealed several aspects of endotoxin removal
from HbAo-LPS mixture in this affinity column. First, endotoxin removal efficiency,
ERE, was a strong function of ionic strength in both situations (feeds prepared with NaCl
solutions and CaCl 2 solutions). ERE had a general decreasing trend when ionic strength
was increased. Second, cations in the feeds have significant influences on ERE of the
column. Moreover, CaCl2 solutions affected endotoxin binding to the column much more
than NaCl solutions at all ionic strengths (except I = 0 M). Third, the results indicate that
the adsorption mechanism between endotoxin molecules and the resin includes ion
exchange as well as other interactions such as hydrophobic interaction.
Figure 4.3 Effect of pH on endotoxin removal efficiency, ERE, and
protein recovery, R, of HbAo-LPS feeds prepared with buffers at various
pH, m=0.05 M
74
75
Ionic strength also affects protein recovery, R, in both situations of HbAo-LPS
feeds and pure HbAo feeds as presented in Sections 4.3.3, 4.3.4, 4.3.5 and 4.3.6.
However, the effects of ionic strength on protein recovery are very limited. When HbAo-
LPS mixtures were used as the feeds, R was always above 94% within the ionic strength
range studied. The results indicate that the column has very weak affinity to HbAo.
Further, it was also shown that the protein-LPS interactions affected protein recovery. By
comparing HbAo recovery of HbAo-LPS mixtures to the HbAo recovery of pure HbAo
solutions, the presence of endotoxin in protein solutions decreased the protein recovery.
The decrease of R is apparently due to the complexation between HbAo and LPS. Since
LPS was adsorbed by the resin in the column, the HbAo molecules in the HbAo-LPS
complex were also retained in the column.
The results in Section 4.3.7 show a strong influence of pH on endotoxin removal
efficiency. The adsorption mechanism may be explained as follows. Since the pI of
endotoxin is about 2 (Pearson, 1985), endotoxins are always negatively charged within
the pH range in this study. According to the manufacturer, the resin has a pKa around
8.0. Therefore the resin was positively charged when pH was less than 8.0, neutral when
pH was equal to 8.0, and negatively charged when pH was greater than 8.0. At pH = 4.5,
the resin had a strong positive charge and adsorbed majority of the endotoxin in the
HbAo-LPS mixture, resulting in a very high ERE = 92%. As pH was increased from 4.5
to 8.0, the resin gradually became less positively charged and eventually neutral. As a
result, the resin adsorbed less endotoxin than before, and ERE slowly decreased to 83%.
However, other affinity interactions were still at play, which contributed to the 83% ERE
even though the resin was not charged at this point. As the pH was increased further
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from 8.0 to 9.0, the resin was negatively charged, which created a repulsion between
endotoxin molecules and the resin. Consequently, there was a sharp 40% drop of ERE.
At pH 9.0, only 43% of the endotoxin was adsorbed by the column. The adsorption was
likely due to other affinity interactions such as hydrophobic interactions between the
endotoxin and the resin.
The pH has a very limited effect on protein recovery in both situations of HbAo-
LPS feeds and pure HbAo feeds, as presented in Sections 4.3.8 and 4.3.9. The influence
of pH on R was even smaller than that of ionic strength. Further, from the results of both
ionic strength study and pH study, it can be seen that the resin has almost no affinity to
HbAo. When pure HbAo feeds were applied to the column, R was 100 % at all pH
values. When HbAo-LPS feeds were applied to the column, R was above 97% at all pH
values. The fact that applying HbAo-LPS mixture had reduced the protein recovery once
again demonstrated the effect of protein—LPS complex on protein recovery as discussed
earlier in this section.
4. 4 Summary
In this study, an affinity chromatographic column Acticlean Etox was used to remove
endotoxin from HbAo preparations. It was found that ionic strength and pH conditions
of the feed solutions had significant effects on endotoxin removal from HbAo solutions.
For HbAo-LPS feeds prepared with NaCl solutions, endotoxin removal efficiency
decreased from 71% to 38% when ionic strength increased from 0 to 0.25 M. For HbAo-
LPS feeds prepared with CaCl 2 solutions, endotoxin removal efficiency decreased from
71% to 37% when ionic strength increased from 0 to 0.25 M. When pH was varied from
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4.5 to 9.0, endotoxin removal efficiency of the column was significantly reduced from
92% to 43%. The adsorption mechanism has been discussed for both situations. Protein
recovery of the endotoxin removal process was also investigated. Contrary to the finding
on endotoxin removal efficiency, both ionic strength and pH had only very limited effects
on protein recovery in the process, for HbAo-LPS feeds as well as pure HbAo feeds. The
column adsorbed less than 6% of HbAo in all cases while removing significant amounts
of endotoxin. Finally, it was found that the presence of endotoxin in protein solutions
could reduce the protein recovery of this affinity process, due to the complexation of
HbAo and LPS.
Current available endotoxin removal affinity resins or gels such as Acticlean Etox
gel from Sterogene Bioseparation Inc., have following problems.
1) Low capacity. Even at low ionic strength the ET adsorption capacity is about
100EU/ml gel, which is very low.
2) Removal mechanism is affinity and ion exchange or mainly ion exchange mechanism,
which is problematic. When the ionic strength is low both the protein and ET are
adsorbed. As the ionic strength increases both protein and ET are eluted out.
3) Affinity resin may dissociate the ET-protein complex. However the dissociation
effects are not notable. It is very difficult to reduce endotoxin concentration below 0.5
EU/ml in HbAo solution.
4) Regeneration problems. The column must be treated with 1 M NaOH solution for 24
hrs, which is very time consuming and inconvenient.
5) Low flow rate: 0.3 ml/min and therefore time consuming procedure.
6) Very expensive.
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Therefore highly efficient and cost effective ligands for removing endotoxin from protein
solutions need to be developed.
CHAPTER 5
ADSORPTION ISOTHERM OF ENDOTOXIN IN IDA-Fe 3+ IMMOBILIZED
METAL AFFINITY CHROMATOGRAPHY COLUMN
5.1 Introduction
Immobilized metal ion affinity chromatography (IMAC) is a special affinity
chromatographic method based on the interactions between biomolecules (mainly
proteins) and metal ions. It was first introduced in 1975 by Porath et al. In IMAC, the
interactions are due to coordination between immobilized metal ions and electron donors
on the surface of adsorbates such as surface-located histidine, tryptophan and cysteine
residues. IMAC has been applied in the purification of many proteins, which was
reviewed by Sulkowski in 1985 and Porath in 1992.
The removal of bacterial endotoxins from final bioproducts such as proteins and
peptides has always been a challenge, especially in the situation where endotoxins bind
product proteins.
IMAC has found a wide application in protein purification process. However,
there is no report applying IMAC to remove endotoxin from protein solutions, and here a
novel IMAC method is developed to removal endotoxin from protein. Fe 3+ was charged
to a chelating gel that contains iminodiacetic acid (IDA). The IDA-Fe 3+
 IMAC column
was exploited to remove endotoxin from the mixtures of proteins and endotoxin. In most
cases more than 90% protein yield and higher than 99% endotoxin removal efficiency
were obtained. It is an efficient, cost effective, user friendly method to selectively
remove endotoxin from protein solutions as compared with traditional endotoxin
removal methods (Issekutz, 1983; Karprus et al., 1987; Aida and Pabst, 1990; Hou and
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Zaniewski, 1990; Matsumae et al., 1990; Tani et al., 1992; Webber et al., 1995; Belanich
et al., 1996; Petsch et al., 1997; Legallais et al., 1997; Guo et al., 1997; Kang and Luo,
1998; Li and Luo, 1998, 1999).
To improve the efficiency of IDA-Fe3+
 IMAC in endotoxin removal from protein
solutions, the endotoxin adsorption isotherms were investigated under different solution
conditions. Isotherm models were tested and the adsorption mechanism was discussed.
Good agreement between the experimental data and model predictions was achieved.
5.2 Model
In order to allow quantitative analysis of the effect of buffer conditions such as ionic
strength and pH on the endotoxin adsorption, equilibrium isotherm models were
considered. The frequently used equilibrium models are illustrated as follows. More
sophisticated models can be found in the literature (Ruthven, 1984; Valenzuella and
Myers, 1989).
5.2.1 Linear Isotherm
Where q* is the average solute concentration in the adsorbent at equilibrium and C* is the
equilibrium concentration of the solute in bulk liquid. K is the equilibrium constant.
This linear isotherm is a very ideal situation. Generally, adsorption follows linear
isotherm when the solution concentration is very low.
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5.2.2 Langmuir Isotherm
The most widely used model is the Langmuir isotherm, shown in equation 5.2.
Where q* is the average solute concentration in the adsorbent at equilibrium and C* is
the equilibrium concentration of the solute in bulk liquid. This model contains two
isotherm parameters: q,,,, which is the maximum binding capacity of the adsorbent, and
KD, which is the apparent dissociation constant of the adsorbate-adsorbent complex.
Langmuir model is applicable when following conditions are satisfied: (l) the
solution is ideal; (2) the solute gives monolayer coverage; (3) the adsorption layer is
ideal; (4) no solute-solute interactions in the monolayer; (5) there are no solvent-solute
interactions. These conditions cannot be valid in liquid-solid adsorption at high
concentrations. However, the Langmuir isotherm was in excellent approximation for
single-component adsorption equilibrium in liquid-solid adsorption.
One method for testing the validity of Langmuir isotherm is by Scatchard analysis,
which simply involves linearization of the isotherm model to the form as shown in
Equation 5.3.
As indicated in this equation, a linear relation between q*/C* and q* would
indicate Langmuir adsorption. If the Langmuir isotherm does not fit the experimental data
adequately, the consideration of alternative approaches is required.
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5.2.3 Freundlich Isotherm
As shown in equation 5.4, the Freundlich isotherm model employs two isotherm
parameters.
The parameter k' is very similar to the capacity parameter in Langmuir isotherm, and is
numerically equal to the adsorbed solute concentration in equilibrium with a solution
having a concentration of l.0 mg/ml. It is more difficult to assign a physical meaning to
the exponential parameter n'. Perhaps the best interpretation is that 1/n' indicates the
affinity of the adsorbate-adsorbent interaction, similarly to the dissociation constant in the
Langmuir model. In this regard, a high value of l/n' indicates a strong interaction while a
low value represents a weak interaction.
5.3 Determination of Endotoxin Adsorption Isotherm
5.3.1 Frontal Analysis
Frontal analysis was first independently developed by James and Philips (1954) and by
Schay and Szekely (1954) for determination of adsorption isotherm. Successive abrupt
step changes of increasing concentration are performed at the column inlet and the
breakthrough curves are determined. The preparation of the series of solutions of known
concentrations needed is labor intensive. As an alternate, it is possible to use a liquid
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chromatograph with a gradient system that can deliver step gradients of known
concentrations, which are not only precise but also accurate.
The area from the dead time to the inflection point of the breakthrough curve gives
the amount adsorbed:
Where Q i
 and Qi+1 are the amounts of compound adsorbed by the column packing after
the ith and the (i+l)th step, when in equilibrium with the concentrations Ci and Ci+1,
respectively, VF,i+1
 
is the retention volume of the inflection point of the (i+l)th
breakthrough curve, V o is the column void volume, and V a is the volume of adsorbent in
the column, which is 1 ml for 1 ml IMAC column and Vo is 0.75 ml. For the case of one
feed concentration, equation 5.5 can be modified to
5.3.2 Frontal Analysis by Characteristic Point (FRCP)
Measurement of a single-component isotherm can be performed from the rear boundary
recorded in FA. This is frontal analysis by characteristic points (Glueckauf, 1955). One
large concentration solution is pumped into the column. After a long enough plateau has
been formed in the column, pure mobile phase is again pumped into the column. The
diffusion profile is recorded and the isotherm is derived from this profile using Equation
5.5 to 5.6. Contrary to conventional practice, it is not necessary to wait until the steady
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response of the detector indicates that the eluate concentration is the same as the
concentration in the stream of mobile phase pumped into the column to return to a pure
mobile phase system.
A mass balance can be established for each point on the rear part of the elution profile
of this rectangular injection pulse. The amount adsorbed is calculated by integration of
the area under the peak, starting from the tail end (C = 0). Following equation might be
written:
Where Qc is the amount of compound adsorbed by the column packing when in
equilibrium with the concentration C, Va is the volume of adsorbent in the column, and V
is the retention volume of the point of the diffusion profile at concentration C, or the
characteristic point. Thus, each point of the rear profile gives one point of the isotherm.
With the data acquisition system, several hundred points of an elution profile can be
conveniently recorded and stored, providing as many data points for the isotherm as
needed.
5.3.3 Static Method
This method consists of immersing a known weight of adsorbent in a solution of known
concentration in a closed vessel and waiting until equilibrium is reached. After the
equilibrium is reached, the solution concentration is determined. In many aspects the
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static methods is comparable to frontal analysis. However, it has disadvantages such as
being time consuming and requiring a large amount of materials.
5.4 Materials and Methods
5.4.1 Materials
Endotoxin from Escherichia coli 026: B6 (Sigma Chemical Co., St. Louis, MO) was
used in all experiments. FeCl3, NaCl, NH4C1 and EDTA were also purchased from
Sigma. All solution transfers were performed with endotoxin free devices. Sterile,
disposable plasticware was used at all times to prevent endotoxin contamination. All
solutions were prepared with Milli-Q water generated by a Biocel water purification
system (Millipore Corporation, Bedford, MA). The endotoxin concentration in the
Milli-Q water was below 0.05 EU/ml based on the results of LAL tests in this research.
5.4.2 Experimental Apparatus
A GradiFrac chromatographic system (Amersham Pharmacia Biotech, Piscataway, NJ)
was used in all the experiments. The experimental setup was shown in Figure 5.l. Feed
and mobile phase solutions were transferred by an adjustable peristaltic P-l pump. The
ultraviolet absorbance of the eluent from the column was measured by UV-l monitor at
280nm. The flow cell used in the monitor was a standard cell with an optical path length
of l.00 cm. The UV absorbance was recorded by two means. The first one was a REC
102 2-channel recorder, which was used to show chromatograms directly during the
experiments. The second one was a data acquisition system Mll01 (Keithley Metrabyte,
Figure 5.1 IMAC experimental setup
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Cleveland, OH) connected with a computer, which was used to record the chromatograms
in digital forms so that they could be transferred later for data processing and analysis.
5.4.3 IMAC Column and Adsorbent Resin
A HiTrap Chelating column with dimensions of 0.7 x 2.5 cm was purchased from
Amersham Pharmacia Biotech. The column was packed with Pharmacia Chelating
Sepharose High Performance resin consisting of highly cross-linked agarose beads to
which iminodiacetic acid (IDA) was coupled by stable ether bounds via a seven atom
spacer arm. From the manufacturer, the mean diameter of the adsorbent particle is
approximately 34 pm. The average pore size is around 100 nm.
5.4.4 Buffers
Three kinds of buffer solutions were used in the experiments. All LPS feeds were
prepared with buffer A - 0.5 M NaCl in 0.02 M acetate buffer at pH 5.5. The starting
buffer was buffer A. The elution buffer, buffer B, was 0.5 M NH 4Cl in 0.02 M acetate
buffer at pH 5.5. The stripping buffer, buffer D, was 0.05 M EDTA
(ethylenediaminetetraacetic acid) in buffer A. All buffers were filtered through a 0.22
pm filter and degassed under vacuum for at least 25 min prior to being applied to the
column.
5.4.5 Column Preparation and Operation
The HiTrap Chelating column was stored in 20% ethanol when purchased. The column
was first washed with 5 ml Milli-Q water at a flow rate of 1 ml/min to remove the
88
ethanol. Then the column was loaded with 0.5 ml of 0.1 M FeCl 3 solution at 1 ml/min to
charge Fe3+
 to the resin. Finally, the column was washed with 5 ml Milli-Q water at 1
ml/min to remove the unbound Fe3+ from the column. The column was now charged
with metal ion and ready for use. Before applying the feed, a blank run was performed
to elute nonspecifically bound metal ions that might otherwise be eluted during
desorption. The column was washed with 2.5 ml of buffer A at 2 ml /min followed by
5ml of buffer B at 1 ml/min. The column was then equilibrated with 2.5 ml of buffer A
at 1 ml/min. The feed (LPS solution) was applied to the column at 1 ml /min until
inflection point was reached in elution profile. The column was then washed with the
starting buffer (buffer A) at 1 ml/min for 10 min. The column was regenerated by
washing with buffer D to strip all the metal ions, followed by washing with 5 ml of
Milli-Q water, both at a flow rate of 1 ml/min.
5.4.6 Endotoxin Assay
To determine endotoxin concentration, a chromogenic Limulus Amebocyte Lysate
(LAL) test kit QCL-l000 from BioWhittaker (BioWhittaker Inc., Walkersville, MD)
with a modified procedure was used. The sensitivity of this test is 0.01 EU/ml. The
reaction mixtures were measured at 405 nm by a Hitachi U-2000 spectrophotometer
(Hitachi Instruments Inc., Danbury, CT) and the results were compared to a standard
curve to obtain endotoxin concentrations.
A series of solutions of known endotoxin concentrations were prepared as the
endotoxin has strong absorption at 280 nm on UV detector. Endotoxin standard curve
could be also obtained by drawing the endotoxin concentration (EU/ml or µg/ml) vs.
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absorbance (ABS) at 280 nm. Endotoxin ABS in the whole process can be obtained
from a data acquisition system M1l01 (Keithley Metrabyte, Cleveland, OH) incorporated
with a computer, which was used to record the chromatograms in digital forms so that they
could be transferred later for data processing and analysis. By comparing with the standard
curve, the endotoxin concentration was easily obtained. Both methods were used in this
research.
5.5 Results
The experimental results of endotoxin adsorption at different solution conditions by
frontal analysis are depicted in Figure 5.2. In order to allow quantitative analysis of the
effects of buffer conditions such as ionic strength and pH on the endotoxin adsorption,
different equilibrium isotherm models were investigated.
5.5.1 Langmuir Isotherm
The most widely used model, Langmuir isotherm, was investigated in this study. The
derivation of Langmuir isotherm includes the assumption of monovalent and
homogeneous adsorption on the adsorbent. The assumption of monovalent adsorption is
valid only when each adsorbate molecule is bound by interaction with single immobilized
ligand. Homogeneous adsorption implies that each adsorbate molecule is bound by an
identical interaction. Consequently, the binding energy and dissociation constant must be
the same for each adsorbed molecule. Furthermore, Langmuir isotherm requires that the
adsorbed molecules do not interact with other unbound molecules. Thus it is obvious that
Langmuir isotherm is truly valid only when the adsorption is simple and well behaved.
Figure 5.2 Isotherms of endotoxin on IDA-Fe3+
 IMAC column, acetate
buffer at different ionic strength and pH conditions at room temperature,
flow rate 0.5 ml/min
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Regardless of these limitations, Langmuir isotherm has been widely used for protein
adsorption processes and quite often has been found to fit equilibrium data adequately.
Other factors, which contribute to the popularity of Langmuir isotherm, are simplicity, the
physical significance of the parameters, and the ability to use this model in conjunction
with complex rate models. One possibility of the Langmuir isotherm used in the
characterization of the endotoxin adsorption process is that the immobilized ligand, Fe3+ ,
is homogenous in the IMAC matrix.
A typical Langmuir isotherm model which best fits the experimental equilibrium
data was determined by non-linear regression analysis. The result was shown in Figure
5.3. Solid points represent the experimental data. The dash line is the result predicted by
Langmuir model. The q m  is l.43 x 104 EU/ml while Kd is 6.66x 10 -3 EU/ml, about
6.66xl0 -6
 M. The Langmuir isotherm did not fit the experimental data very well.
Disagreement between experimental data and the modeling prediction was found
especially at high endotoxin concentration. In most cases, predictions for maximum
endotoxin binding capacity were well below measured values of adsorbed endotoxin
concentration. The Scatchard analysis was used to test the adequacy of Langmuir
isotherm as mentioned before. The Scatchard analysis corresponding to the experimental
data in Figure 5.3 was repeated in Figure 5.4, which indicates that Langmuir isotherm
yielded an inadequate fit to the experimental data. All the Scatchard analyses of
experimental data at different buffer ionic strength and pH conditions are shown in Figure
5.5. All the curves are not linear and have same trends. At same q*, as the ionic strength
increases, q*/c* increases. This means that higher q* can be achieved with higher ionic
strength at same C*. The Langmuir isotherm is truly valid only when the adsorption is
Figure 5.3 Langmuir isotherm yielded an inadequate fit to the
experimental data
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Figure 5.4 Scatchard analysis of LPS adsorption on IDA-Ferric IMAC
column
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Figure 5.5 Scatchard analysis, adsorption of endotoxin on IDA-Fe 3+
IMAC column from acetate buffer with different ionic strength and pH
conditions at room temperature, flow rate: 0.5 ml/min
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simple and well behaved. It is obvious that this is not the case with the adsorption of
endotoxins, due to their large and labile size, a wide variety of existing forms and a wide
variety of surface sites on endotoxin for interactions with the ligands.
From the analysis of Langmuir isotherm, several conclusions were obtained.
First, endotoxin adsorption capacity on the IMAC-Fe 3+
 is more than 14,000 EU/ml gel,
which is very high. Second, the non-linear Scatchard plots can be interpreted as an
indication of heterogeneous adsorption (Sada et al., 1986). Heterogeneous adsorption of
endotoxin by IDA-Fe 3+
 IMAC is not surprising when a variety of LPS existing states and
correspondingly various LPS-ligand interactions contributing to adsorption. Third, the
interactions among the endotoxin molecules could be possible in the experimental
conditions.
5.5.2 Freundlich Isotherm
Freundlich isotherm model is an empirical model and can be derived from the case of
heterogeneous adsorption. It has been used extensively in liquid adsorption systems
where the assumptions of non-interactive solutes and homogeneous binding energies are
often not valid (Maron and Lando, 1974). The Freundlich isotherm parameters which
best fit experimental data for LPS adsorption on IMAC-Fe 3+
 were determined by non-
linear regression analysis similar to that used in the Langmuir analysis. These parameters
are presented in Table 5.l. At pH 3.3, the endotoxin adsorption capacity of IMAC-Fe 3+ is
very high. In the experiments it is impractical to get endotoxin breakthrough the column
because the process takes such a long time.
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Table 5.1 Variation of Freundlich parameters for LPS adsorption with buffer and ionic
strength
pH I (M)
0.02
k'
4.924
n'
1.203369
R2
0.9646
0.02 4.030 1.183432 0.9725
5.5 0.25 3.457 1.090513 0.9701
0.25 2.668 1.027855 0.9629
0.5 2.256 1.078749 0.9817
1.0 11.233 1.194743 0.964
5.5 2.256 1.078749 0.9817
7.0 0.5 10.381 1.212415 0.9495
In Table 5.1, duplicate experiments were conducted for ionic strength 0.02 M, pH
5.5 and 0.25 M, pH 5.5, respectively. The Freundlich analyses for each duplicate of data
gave similar k' and n', which indicated that frontal analysis of endotoxin was
reproducible. The dependence of k' and n' on buffer pH and ionic strength provides the
basis for endotoxin adsorption and removal. As shown in Table 5.1, the capacity
parameter k' and exponential parameter n' both show weak dependence on ionic strength
and pH.
The isotherm determined by these analyses was found to give fair agreement with
the experimental data, as typically shown in Figure 5.6, where the dash line represents
Freundlich model prediction. The Freundlich modeling gave a fair match to the
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experimental data at different ionic strengths and pH, especially in the low endotoxin
concentration range. The isotherm predictions of endotoxin adsorption behavior at a high
endotoxin concentration are very poor. Other isotherm models should be considered.
Fortunately, in practical applications, the endotoxin concentration is in the range where
Freundlich isotherm is acceptable.
5.5.3 The Interaction between Endotoxin and IDA—Fe3+
The effects of buffer conditions on the endotoxin adsorption, as discussed previously,
may indicate the type of the interaction, which is responsible for the endotoxin
adsorption. All the model predicted results under different ionic strength conditions are
shown in Figure 5.7, compared with one group of experimental data. The circles are the
experimental data at ionic strength of 0.02M, pH 5.5. The main trend of the effect of the
ionic strength is that as the ionic strength increases q* increases except when ionic
strength is changed from 0.25 to 0.5 M at the same C*. The result indicates that
electrostatic interactions might be involved in endotoxin adsorption. The effect of pH on
endotoxin adsorption to IDA-Fe3+
 IMAC column was shown in Table 5.l, which is more
complex than that of ionic strength on endotoxin adsorption.
The interactions described above are quite surprising as physical properties of
endotoxins are considered. Endotoxin has an isoelectric point of l.3 and consequently
carries a net negative charge in the studied pH range (Petsch et al., 1997). Ligand, Fe 3+ ,
is positive charged. Ion exchanger exploits different net charges on biomolecules at a
given pH, and interacts with the biomolecules principally by electrostatic attraction.
Figure 5.6 The comparison of experimental data and Freundlich
modeling, pH 5.5, IS = 0.5 M, buffer flow rate, 0.5 ml/min.
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Figure 5.7 The effects of ionic strength on the model of endotoxin
adsorption
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There are two main classes of ion exchangers: anion exchanger with positively charged
adsorbents and cation exchanger with negatively charged adsorbents. Therefore, anion
exchange might be one part of the mechanism for endotoxin adsorption to IDA-Fe 3± .
However, as shown above, as buffer ionic strength is increased from 0 to 0.5 M, the
adsorption capacity increases. Therefore the ion exchange mechanism above can not
provide satisfactory explanation to endotoxin adsorption.
The endotoxin is usually described as both hydrophobic and hydrophilic
molecule. In aqueous solvents, hydrophobic patches on adsorbates seek out other
hydrophobic surfaces (on adsorbents) preferentially. Hydrophobic interaction
chromatography (HIC) exploits this hydrophobic interaction between the adsorbate and
adsorbent. Obviously HIC mechanism can be excluded in the adsorption process of
endotoxin to IMAC-Fe 3+ column, except for nonspecific binding.
In protein purification with IMAC, the underlying principles of the binding of
proteins to the metal chelate stationary phase is believed to be the result of the ability of
electron-rich ligands on the surfaces of proteins to substitute weakly bonded ligands such
as water or mobile phase ions in the metal complexes on the surface. In this process, the
chelating metal plays the role of accepting unshared pair of electrons from the side chains
of amino acids at the surface of the protein molecule. Phosphate groups have been shown
to strengthen protein interactions with immobilized metal (Sulkowski, 1988). The
contribution of phosphate groups to the overall binding strength was also reported
(Andersson, 1986). For the endotoxin adsorption on IMAC-Fe3+, it is believed in this
research that the mechanism is similar to the latter.
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The adsorption mechanism can be analyzed as follows. At the beginning, the
endotoxin was adsorbed on the IMAC gel as a monolayer. In this step the adsorption
follows Langmuir isotherm. The endotoxin concentration is low and the interaction
between adsorbed endotoxin molecules is very weak. Also as explained above, the ligand,
Fe3+
 is very homogeneous. Therefore Langmuir isotherm can predict the adsorption
behaviors of endotoxin, as long as endotoxin concentration is low. As the adsorption
continues, the monolayer condition is not satisfied any more. Then the adsorption breaks
the conditions indicated by Langmuir isotherm. Since the interaction among endotoxin
molecules are very strong at this time, the endotoxin adsorption continues. Therefore
adsorption of endotoxin to the column includes two periods. First, endotoxin is adsorbed
to Fe3+ , which is due to the interaction between the Fe 3+ and the phosphate group in the
endotoxin. Second, additional endotoxin in solution is adsorbed on the already adsorbed
endotoxin because of the strong interactions among the endotoxin molecules. In the first
step it is reasonable to assume Langmuir adsorption mechanism. The saturation
adsorption capacity is l.43 x 10 4 EU/ml gel. In second step the adsorption continues, and
more endotoxin will be adsorbed. Therefore endotoxin adsorption capacity of IDA-Ferric
is very high.
5.5.4 Discussion —Implications in Adsorption Process Design
The work in this chapter was to determine the isotherm of endotoxin adsorption on the
IDA-Fe3+ IMAC column. The results provided more reliable and efficient theoretical
basis for buffer selection and adsorption process design, optimization, simulation and
process scale-up. Isotherm model provides deep insights into the character of the
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endotoxin and IDA-Fe 3+
 interactions. If the isotherm is known, the process development
and optimization have a theoretical basis and can be completed in a more rational way.
In this study, the endotoxin exhibited heterogeneous interactions with immobilized IDA-
Fe3+
 IMAC column. Variation of ionic strength and pH in the study was to identify the
adsorption mechanism, types of the forces involved in the adsorption. As described
above, adsorption of endotoxin on the IDA-Fe 3+
 IMAC column was mainly due to the
phosphate group in the endotoxin and the interaction mechanism was essentially metal
chelating. Hydrophobic interactions might also be involved as nonspecific binding.
5.6 Summary
Frontal analysis studies have been shown to be an effective way of characterizing the
effects of buffer conditions on the endotoxin adsorption process as well as the Fe 3+-
endotoxin interactions. By comparison of experimental data with different isotherm
models, endotoxin adsorption mechanism was put forward. Then isotherm parameters
were calculated. The developed isotherm models are in good agreement with
experimental results.
The adsorption isotherm of endotoxin provides a theoretical basis for endotoxin
removal. In this chapter, the adsorption of endotoxin, LPS, by IDA-Fe 3+
 IMAC column
has been investigated. It was found that endotoxin was bound mainly by interactions
between the phosphate group in endotoxin and ligand Fe 3+
 on the beads. The interaction
mechanism is believed to be the metal chelating. The adsorption of endotoxin to the
IDA-Fe3+
 IMAC column may be also due to the hydrophobic property of the lipid A, a
key part of endotoxin, and maybe net negative charge of the endotoxin. The properties
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of the endotoxin are important in discussing the mechanism of its adsorption on IDA-
Fe3+ . Interactions among endotoxin molecules are very important in discussing the
adsorption of the endotoxin to IMAC-column. The interactions result in multi-layer
adsorption of endotoxin on IDA-Fe 3+ IMAC column.
CHAPTER 6
ADSORPTION CAPACITY OF ENDOTOXIN IN IDA-Fe 3+ IMMOBILIZED
METAL ION AFFINITY CHROMATOGRAPHY COLUMN
6.1 Introduction
The removal of bacterial endotoxins from final bioproducts has always been a challenge,
especially in the situations where endotoxins bind product. IMAC was widely used for
protein purification (Porath, 1985, 1992; Sulkowski, 1985). However, there is no
reported application of IMAC to remove endotoxin from protein solutions except that a
novel IMAC method was developed to removal endotoxin from protein by the author.
Fe3+
 was charged to a chelating gel that contains iminodiacetic acid (IDA). It is an
efficient, cost effective method to selectively remove endotoxin from protein solutions
compared to traditional endotoxin removal methods (Issekutz, 1983; Karprus et al., 1987;
Aida and Pabst, 1990; Hou and Zaniewski, 1990; Matsumae et al., 1990; Tani et al.,
1992; Webber et al., 1995; Belanich et al., 1996; Petsch et al., 1997; Guo et al., 1997;
Legallais et al., 1997; Li and Luo, 1998, 1999).
To the author's knowledge, there is no report concerning the quantitative aspect
of interactions between endotoxin and IMAC adsorbent. In this chapter the investigation
of quantitative interactions was reported. The frontal analysis was used as a reliable
method to obtain the column capacity under different solution conditions such as the
ionic strength and pH.
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6.2 Materials and Methods
6.2.1 Reagents
Endotoxin from Escherichia coli 026:B6 (Sigma, St. Louis, MO, USA) was used in all
studies. All solutions were prepared with water from Milli-Q system (BioWhittaker Inc.,
Walkersville, MD, USA). All other chemicals were purchased from Sigma.
6.2.2 Experimental Apparatus
The experimental apparatus was used as Chapter 5.
6.2.3 IMAC Column and Adsorbent Resin
IMAC column and adsorbent resin was described in Chapter 5.
6.2.4 Buffers
Three kinds of buffer solutions were used in the experiments as Chapter 5.
6.2.5 Column Preparation and Operation
Column preparation and operation follow the same procedure outlined in Chapter 5.
6.2.6 Frontal Analysis
Frontal analysis in this research was performed according to the standard procedure.
Each equilibrated column, loaded with Fe 3+, was fed continuously with a endotoxin
solution at a constant concentration and the absorbance of the effluent at 280 nm was
continuously monitored and recorded on a chart paper and in computer data acquisition
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system. The sample was fed until the absorbance of the effluent reached a constant
plateau level equaling to the absorbance of the feed solution. The elution volume of the
each test endotoxin feed was then determined from inflection point of the front of the
elution profile, taking into account each column's void volume as below.
Figure 6.l shows the principle of frontal analysis. The column capacity is
calculated according to following equation:
Where Ve is frontal retention volume of the endotoxin solution, Vo is the void volume of
the column, i.e., retention volume of unretained solutes, and C is the concentration of
endotoxin in the feed solution. Ve was determined from the breakthrough curve at the
median bisector of the frontal curve (inflection point) as shown in Figure 6.l. As will be
demonstrated below, this method yielded accurate data. If the chromatogram was
described as the endotoxin response vs. elution time. The equation 5.5 to 5.7 should be
used.
6.2.7 Endotoxin Assay
To determine endotoxin concentration, a chromogenic Limulus Amebocyte Lysate (LAL)
test kit QCL-1000 from BioWhittaker (BioWhittaker Inc., Walkersville, MD) with a
modified procedure was used. The procedure was described in Chapter 5.
6.2.8 Determination of the Amount of Immobilized Ligand (Fe3+)
The amount of immobilized Fe 3+ was calculated as the difference between the total
amount of Fe3+ applied to the column and the amount washed out as the excess during
Figure 6.1 The principle of frontal analysis
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washing process. The Fe 3+ concentration is determined by Sigma Ferrozine total iron ion
kit. The leaching of the column can be investigated by determination of the ferric ion
concentration in all elution fractions.
6.2.9 Data Analysis
The results obtained from chromatographic experiments were used as a basis to calculate
the dissociation constants for endotoxin to IMAC-Fe3+. Kasai et al. equation (1986) was
used:
Where Kd = dissociation constant of endotoxin-ferric, [A 0] = initial concentration of
endotoxin applied to the column, B t = total amount of immobilized ligand, ferric, V =
variable volume, Vo = elution volume of endotoxin under the conditions where its
interaction with the immobilized ligand ferric is abolished. Kd can be obtained by
plotting l/(V-Vo) vs. [Ao].
The experimental data were also treated according to a modified form of Nichol
equation:
Where V = variable volume, Vo = elution volume of endotoxin under the condition where
its interaction with the immobilized ligand X is abolished, Vm = elution volume of
neutral, completely excluded molecule, [Ao] = concentration of endotoxin in the applied
solution, [X] =concentration of adsorption sites, Kax = associate constant for the
adsorption of endotoxin with the immobilized ligand ferric.
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6.3 Results and Discussions
6.3.1 Concentration of Immobilized Ligand
Using the procedure outlined above, the total amount of immobilized Fe 3+ on the IDA
IMAC column was determined to be 34 µmol/ml of adsorbent. As provided by the
manufacturer, the total Cu2+ amount immobilized is about 23 µmol/ml of adsorbent for
IDA-Cu2+
 IMAC column. The results obtained in this research are within the range
stated by the manufacturer.
6.3.2 Frontal Analysis
Figure 6.2 shows the frontal analysis profile for endotoxin after the chromatographic
process on the IDA-Fe 3+ column when mobile phase flow rate is 0.3 ml/min with the feed
concentration of 6054 EU/ml. This profile is a representative of endotoxin elution for all
different feeds under different solution conditions. From the experimental result, the
reproducibility is very good if the Fe 3+ was stripped and recharged every time after use.
The shape of the elution front is sigmoidal. This is generally caused as a consequence of
imperfection in the column packing as well as a lack of local distribution equilibrium
mainly due to large variations in the size of gel beads. The technical and operational
advantages of adsorbents packed with small and uniform sized beads are thus obvious.
The HiTrap chelating beads are adsorbents with big pores. However, large pores are
easily accessed by the endotoxins, which is a big advantage over small pore adsorbents.
Figure 6.2 Breakthrough curve of ET with IDA-FERRIC IMAC column,
mobile phase: 0.5M NaCI, 0.02 M acetate buffer, pH 5.5, flow rate: 0.3
ml/min
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6.3.3 The Effects of Mobile Phase Flow Rate on the Column Capacity of Endotoxin
Adsorption to IDA- Fe3+ IMAC Column
The adsorption capacity of the IDA-Fe 3+
 IMAC column at different feed flow rates are
shown in Figure 6.3 and Table 6.l. Four flow rates, 0.2, 0.3, 0.5 and l.0 ml/min were
investigated to discuss the effect of flow rate on the column adsorption capacity to
endotoxin. At a flow rate of 0.3 ml /min, the highest capacity was obtained: 6054 EU/ml.
Considering the productivity of the IMAC column, 0.5 ml/min flow rate was used in
following experiments.
Table 6.1 Column endotoxin adsorption capacity at different feed conditions
Flow rate
(ml/min)
Feed Concentration Column Capacity
(EU/ml)(µg/ml) (EU/ml)
0.2
100
2797 5801
0.3 2883 6054
0.5 3080 4876
l.0 2877 4074
0.5
1 27 51
10 172 343
25 456 950
50 1146 2482
200 5344 8909
300 7339 11009
400 9853 13082
Figure 6.3 Endotoxin adsorption capacity on IDA-Fe 3+ IMAC column
vs. mobile phase flow rate, feed concentration : 100 µg/ml, buffer: 0.5 M
NaCI, 0.02 M acetate buffer, pH 5.5
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6.3.4 The Effects of Ionic Strength on the Column Capacity of Endotoxin
Adsorption to IDA-Fe3+ IMAC Column
The effect of ionic strength on the column capacity was shown in Figure 6.4 at the same
buffer pH and same level of endotoxin feed concentration. Four different ionic strength
conditions were tried. Some of them were duplicated, and experimental reproducibility
was very good. At lowest ionic strength, 0.02 M, the column capacity was lowest. As
the ionic strength increased the column capacity increased as well. At an ionic strength
of l.0 M, the column capacity is l.l x 10 4
 EU/ml, which is the 10 times of that at ionic
strength of 0.02 M.
6.3.5 The Effects of pH on the Column Capacity of Endotoxin Adsorption
to IDA-Fe3+ Column
The effect of pH on the column adsorption capacity of endotoxin was shown in Figure
6.5 with the same ionic strength and same level of endotoxin concentration in feed
solution. At pH 3.3, the column capacity was highest. As solution pH increased the
column capacity decreased sharply. At pH 7.0, the column capacity is 6656.7 EU/ml,
which is the l/5 of that at pH 3.3. This result was very useful in applying IMAC in
protein-LPS separation. The elution of the protein should be implemented in low pH (<
4.0) to prevent the LPS from being eluted from the column. However, during the
adsorption period, a higher pH can be applied to keep the adsorption amount of LPS as
small as possible. Therefore, the selective removal of LPS from protein solutions can be
conducted by choosing appropriate ionic strength and pH conditions.
Figure 6.4 Endotoxin adsorption capacity on IDA -Fe 3+
 IMAC column
vs. mobile phase ionic strength, pH 5.4
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Figure 6.5 Endotoxin adsorption capacity on IDA-Fe 3+ IMAC column
vs. mobile phase pH, ionic strength 0.5 M
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6.3.6 Quantitative Affinity Data
The plot of the experimental data according to Kasai equation is shown in Figure 6.6.
From the plot, the total concentration of ligand that has interacted with endotoxin, B t, is
obtained directly from the intercept on the ordinate. Kd can be calculated from the slope
and B t. If the molecular weight of endotoxin is assumed to be 1,000,000, Kd = 4.47xl0 -7
M and B t = 9.7x10 -4
 µmol. If the molecular weight of endotoxin is 100,000, K d
 =
4.47xl0 -8
 M. Further if the molecular weight of endotoxin is 10,000, Kd = 4.47xl0 -9 M.
If the equation of Nichol et al. is used, the results are shown in Figure 6.7. In the
figure, l/(V-V0) is plotted against endotoxin concentration in the feed solution. Kax,
which is 1/Kd, is calculated by slope/intercept. (V 0-Vm )[X], which is similar to B t in
Kasai equation is reciprocal of the slope. Finally parameters were obtained: Kd = 5.6
xl0-7
 M and (Vo-Vm)[X] =l.286 x 10 -3
 µmol as MW of endotoxin is l,000,000.
Therefore the calculations from Kasai and Nichol equations gave similar results.
Kd shows stability of the complex of endotoxin (adsorbate) and Fe3+
 (ligand). Kd
is very low in the case, which means the complex is very stable. B t
 is obviously too low
compared to the total Fe 3+
 amount which is immobilized in the column as the adsorption
ligands. This means that most of the active sites were not used.
As well known, the interaction of proteins with IMAC adsorbents is governed by
the number or density of exposed histidine, cysteine or tryptophan residues. Unlike
proteins, endotoxin has no amino residues. However, Kd of endotoxin to IDA-Fe3+ is
higher than that to ordinary proteins. As discussed in previous chapters, the endotoxin
adsorption to the IMAC column is due to interactions of phosphate group in lipid A
potion of endotoxin with the ligand, Fe 3+ . This can explain its adsorption behavior.
Figure 6.6 Determination of quantitative affinity parameters for the
interaction between the endotoxin and IDA-Fe 3+, MW of ET: 1000K
(Kassai eq.)
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Figure 6.7 Determination of quantitative affinity parameters for the
interaction between the endotoxin and IDA-Fe 3+, MW of ET: 1000K (
Nichol eq.)
118
119
At low ionic strength, the endotoxin exists as vesicle or micelle. Its molecular
weight is very high, i.e., around l,000,000. Many lipid A groups were encased in the
vesicles or micelles and have no chance to interact with Fe 3+ . The adsorption capacity to
IMAC column is very low. However, as ionic strength is increased, e.g. lM, the situation
is quite different. The endotoxin exists in small subunits with molecular weight around
10,000 to 20,000, which bring many lipid A groups to active sites on adsorbents. Thus,
the adsorption capacity of the column for endotoxin at higher ionic strength condition is
much larger that at low ionic strength. It might be argued that the low capacity of IMAC
IDA-Fe3+
 adsorbents for endotoxin at low ionic strength is a consequence of steric
effects. This may be caused by an efficient shielding of the adsorption sites by the bulk
of endotoxin molecules since endotoxin molecules are too big to get into the pores of the
adsorbents. It seems that the author's results also show some support for this argument.
As reported in the literature (Sweadner, 1977), the size of endotoxin aggregates is around
10 to 70 nm while the endotoxin subunit (existing in high ionic strength solution) is much
smaller. Pores of the adsorbents should be large enough that free diffusion is not
hindered significantly. This normally can be met with pores that are 10 to 20 times larger
than the size of the adsorbate molecule (Satterfield et al., 1973). For the case of
endotoxin, pore should be larger than l.4 lam. From manufacturer, the pore size of IDA
adsorbent is around 100 nm. Therefore, the steric effect is one of the reasons for low
endotoxin adsorption capacity at low ionic strength.
Figure 6.8 shows the column capacity and capacity/Fe 3+ used at different feed
concentration. At low feed concentration, ET/Fe 3+ = 0.02. This suggests the presence of
many extra binding sites in IMAC- Fe 3+
 gel. At high feed concentration, five endotoxin
Figure 6.8 Column capacity at different initial endotoxin concentrations
and ratio of ET to Fe 3+ in the complex
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molecules interact with one molecule of ferric ligand. This means that ferric ion can
interact with multi-molecules. There are two possibilities. First, one endotoxin binding
site interactions with an endotoxin complex, which is composed of several endotoxin
molecules. Another possibility is one site can bind several endotoxin molecules at the
same time. The first mechanism is more convincing.
6.4 Summary
The work in this chapter was to determine the capacity of endotoxin adsorption on the
IDA-Fe3+
 IMAC column under different solution conditions. The results provided more
reliable and efficient theoretical basis for buffer selection and adsorption process design,
optimization, simulation and process scale-up. It also provided deep insight into the
character of the endotoxin and IMAC-Fe 3+
 interactions. In this study, the endotoxin
exhibited heterogeneous interactions with immobilized IMAC-Fe 3+ . Variation of ionic
strength and pH in the study was to identify the adsorption mechanism, types of the
forces involved in the adsorption. As described above, adsorption of endotoxin on the
IMAC-Fe 3+
 is mainly due to the phosphate group in the endotoxin and the interaction
mechanism is essentially metal chelation. Hydrophobic interactions might also be
involved as nonspecific binding. The very small dissociation constant indicates that
affinity between ET and Fe 3+
 is very strong. Steric effect should be considered in process
development of endotoxin removal, as ET aggregate is a big molecule. The interactions
among the ET molecules are very important in ET adsorption process.
As adsorption capacity under different conditions is known, the process
development and optimization have a theoretical basis and can be completed in a more
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rational way. In the loading period of endotoxin removal process, in order to get low
endotoxin adsorption and higher protein adsorption, a higher pH buffer condition should
be chosen. During elution period lower pH will be used to prevent the endotoxin from
eluting together with protein targets.
CHAPTER 7
ADSORPTION ISOTHERM OF BSA IN IDA-Fe 3+ IMMOBILIZED METAL
AFFINITY CHROMATOGRAPHY COLUMN
7.1 Introduction
To more efficiently apply of IMAC-Ferric in removal of endotoxin from protein
solutions, protein adsorption isotherm was investigated at different solution conditions in
this chapter. Different isotherm models were tried and adsorption isotherm was
obtained. Good matches between the experimental data and model predictions were
reached.
7.2 Models
Different models were summarized in Chapter 5.
7.3 Determination of the Isotherm
Different methods to determine the endotoxin adsorption isotherm were described in
Chapter 5.
7.4 Materials and Methods
7.4.1 Materials
Bovine Serum Albumin (BSA) (Sigma Chemical Co., St. Louis, MO) with very low
endotoxin content was used in all experiments. FeCl 3 , NaCl, NH4Cl and EDTA were
also purchased from Sigma. All solution transfers were performed with endotoxin free
devices. Sterile, disposable plasticware was used at all times to prevent endotoxin
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contamination. All solutions were prepared with Milli-Q water generated by a Biocel
water purification system (Millipore Corporation, Bedford, MA). The endotoxin
concentration in the Milli-Q water was below 0.05 EU/ml based on the author's test
results.
7.4.2 Experimental Apparatus
The same experimental apparatus as described were used.
7.4.3 IMAC Column and Adsorbent Resin
IMAC column and adsorbent resin was described in Chapter 5.
7.4.4 Buffers
Three kinds of buffer solutions were used in the experiments as chapter 5.
7.4.5. Column Preparation and Operation
Column preparation and operation follow same procedure outlined in Chapter 5 except
one difference. BSA was used as the feed in stead of LPS in Chapter 5.
7.4.6 Protein Assay
To determine protein concentration, an UV monitor was used. A series of solutions of
known BSA concentrations were prepared. BSA standard curve was plotted by drawing
absorbance (ABS) vs. BSA concentration (µg/ml) at 280 nm. ABS of BSA in the whole
process was also obtained from a data acquisition system Mll01 (Keithley Metrabyte,
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Cleveland, OH) incorporated with a computer, which was used to record the
chromatograms in digital form so that they could be transferred later for data processing
and analysis. By comparing with standard curve, protein concentration was easily
obtained.
7.5 Results
Adsorption isotherms of BSA under different solution conditions were obtained
experimentally with frontal analysis and depicted in Figure 7.l. For all the solution
conditions except pH 3.4 and pH 7.0, the adsorption isotherms are very similar. This
indicates that BSA adsorption under different solution conditions on IDA-Ferric IMAC
column follows the same isotherm model. In order to allow quantitative analysis of the
effect of buffer conditions on the BSA adsorption, different equilibrium isotherm models
were investigated as follows.
7.5.1 Langmuir Isotherm
The most widely used isotherm model, Langmuir isotherm, was used for adsorption of
BSA on the IMAC-Fe 3+ column. It is obvious that the Langmuir isotherm is truly valid
only when the adsorption is simple and well behaved. One concern is that Langmuir
isotherm may be too simple for the adsorption of the protein, due to interactions among
the protein molecules. Regardless of these limitations, the Langmuir isotherm has been
widely used for the protein adsorption processes and quite often has been found to fit the
equilibrium data adequately. As mentioned before one reason that the Langmuir isotherm
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might be used in the characterization of the protein adsorption process is that the
immobilized ligand, Fe 3+, is homogeneously distributed in the matrix.
The adsorption isotherm under different solution conditions was determined by
experiments as shown in Figure 7.l. The Scatchard analysis was used to test the
adequacy of the Langmuir isotherm as mentioned before. The typical Scatchard analysis
corresponding to the experimental data at pH 5.5, 0.5 M solution condition was
conducted as seen in Figure 7.2, which indicated that Langmuir isotherm yielded an
inadequate fit to experimental data. All Scatchard analyses of experimental data at
different buffer ionic strength (0 to l.0 M) and pH (3.4 to 7.0) are not linear and have the
same trends (not shown here) as Figure 7.2.
The non-linear Scatchard plots can be interpreted as an indication of
heterogeneous adsorption (Sada et al., 1986). As heterogeneous adsorption by IMAC-
Ferric ligand is identified, Freundlich isotherm might be a model to describe the
adsorption of protein on IMAC column.
7.5.2 Freundlich Isotherm Model
Freundlich isotherm model is an empirical model and can be derived from the case of
heterogeneous adsorption. The Freundlich isotherm parameters which best fit the
experimental data for protein adsorption in IDA-Fe 3+
 IMAC column were determined by
non-linear regression analysis similar to that used in Langmuir analysis. These
parameters were presented in Table 7.l. The isotherms determined by these analyses
were found to give fair agreement with the experimental data, as typically seen in Figure
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7.3. In Figure 7.3 the isotherm model with Freundlich at different ionic strength was
shown.
Table 7.1 Variation of Freundlich parameters for BSA adsorption with buffer pH and
ionic strength conditions
pH I.S. (M) k' n' R2
3.4
0.5
2.7475 0.796876 0.9875
4.4 3.5353 0.788706 0.9826
5.5 3.6943 0.799808 0.9749
7.0 3.0858 0.755173 0.9854
5.5
0.02 5.9044 0.869338 0.9813
0.25 7.5511 0.913159 0.9873
0.5 3.6943 0.799808 0.9749
l.0 7.7106 0.902039 0.9886
As shown in Table 7.l and Figure 7.3, the capacity parameter k' and exponential
parameter n' both showed very weak dependence on ionic strength. As the ionic strength
increased from 0.25 M to l.0 M, fluctuation of the k' and n' was observed. However, all
the models derived from the experimental data at different ionic strength conditions gave
very similar predictions. If the same BSA concentration at different ionic strength is used
in the feed, almost the same BSA concentration on the IMAC beads could be obtained.
Figure 7.1 Isotherms of BSA on IDA-Fe3+ IMAC column, acetate buffer
under different ionic strength and pH conditions at room temperature, flow
rate 0.5 ml/min
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Figure 7.2 Scatchard analysis for experimental data at buffer condition of
pH 5.5, I.S. 0.5 M
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Figure 7.3 The effect of buffer ionic strength on the isotherm model of
BSA adsorption to IDA-Fe3+ IMAC column
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Therefore the prediction of BSA adsorption on IMAC by Freundlich model is not ionic
strength sensitive.
More dependence of k' and n' on pH was observed as compared with that of ionic
strength. The dependence of k' and n' on buffer pH and ionic strength provided the basis
for BSA adsorption process.
7.5.3 The Interaction between BSA and IMAC—Fe 3+
The effect of buffer conditions on the BSA adsorption, as discussed previously, may
indicate the type of interactions, which are responsible for the BSA adsorption. The
behavior of BSA adsorption presents an interesting picture. The effect of ionic strength
on the BSA adsorption is shown in Figure 7.3. As the solution ionic strength increases
from 0.02 M to 1.0 M, the adsorption isotherm of BSA changes very little. Thus, the
results indicate that electrostatic interactions might be involved in BSA adsorption on the
IMAC-Fe3+. However, it does not play a major role. The effect of pH on BSA
adsorption is shown in Table 7.1, which is more complex than that of ionic strength on
BSA adsorption. In whole pH range, the IMAC-Fe 3+ has a very high BSA concentration
on the beads. This indicates that there are strong interactions between the IMAC-Fe 3+
and BSA.
The interactions described above are quite surprising when the physical properties
of the BSA are considered. BSA has an isoelectric point of 4.6 and consequently carries a
net negative charge at pH > 4.6 and a positive charge at pH < 4.6. Ligand, Fe 3+, is
positive charged. Ion exchanger exploits the different net charges on the proteins at a
given pH, and interaction with the proteins principally by electrostatic attraction. At pH <
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4.6, both Fe3+ and BSA have net positive charge. The corresponding adsorption capacity
of BSA on IMAC-Fe 3+ should be low. On the other hand, as buffer pH > 4.6, BSA is
negatively charged. Due the electrostatic attraction of Fe 3+ and BSA, the BSA adsorption
capacity on the column could be higher than that at pH < 4.6. Furthermore as the buffer
pH increases, the BSA adsorption capacity should increase. Therefore ion exchange
might explain BSA adsorption to IDA-Fe 3+ beads. However, as shown above, as buffer
ionic strength was increased from 0.02 M to 1.0 M, the adsorption behavior has little
change. Therefore the ion exchange mechanism can not provide satisfactory explanation
for the BSA adsorption behavior. Obviously HIC mechanism can be excluded in the
adsorption process of BSA to IMAC-Fe 3+ column except the situation of nonspecific
binding.
In IMAC, the underlying principles of the binding of proteins to the metal chelate
stationary phase is believed to be the result of the ability of electron-rich ligands on the
surfaces of proteins to substitute weakly bonded ligands such as water or mobile phase
ions in the metal complexes on the surface. In this process, the chelating metal plays the
roles of accepting unshared pair of electrons from the side chains of the amino acids at
the surface of the protein molecule.
7.5.4 Discussion: Implications in Adsorption Process Design
The work in this chapter was to determine the isotherm of BSA adsorption on the
IMAC-Fe3+ column. The results provided more reliable and efficient theoretical basis
for buffer selection and adsorption process design, optimization, simulation and process
scale-up. Isotherm model provides deep insights into the character of the BSA and IDA-
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Fe3+
 interactions. In this study, the BSA exhibited heterogeneous interactions with
immobilized IDA-Fe3+ . Variation of ionic strength and pH in the study was to identify
the adsorption mechanism, types of the forces involved in the adsorption. As described
above, adsorption of BSA on the IDA-Fe3+ IMAC beads was mainly due to metal
chelating affinity between the metal ion Ferric and BSA. Since at higher pH, adsorption
capacity is higher, adsorption process can be executed at higher pH and elution process
at lower pH. To prevent possible ion exchange interactions, higher ionic strength should
be maintained.
As isotherm is known, the process development and optimization has the
theoretical basis and can be completed in a more rational way. It also provides the basic
data for process simulation, which is a very important step in process scale-up. The
isotherm studies comprise the first step in the process model evaluation.
7.6 Summary
Frontal adsorption studies have been shown to be an effective way of characterizing the
effects of buffer conditions on an adsorption process as well as the Fe 3+-BSA
interactions. The adsorption isotherm of BSA also provides theoretical basis for the
purification of the BSA. In this chapter, the adsorption of BSA by IMAC-Fe3+ was
investigated.
The Langmuir isotherm cannot predict adsorption behaviors of BSA, even at low
BSA concentration as the adsorption does not follow the conditions assumed by
Langmuir isotherm. The Freundlich isotherm model provides very good predictions of
the BSA adsorption behavior in IDA-Fe 3+ IMAC column.
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It was found that BSA was bound mainly by metal chelating interactions between
BSA and ligand Fe3+ . The effects of buffer ionic strength and pH conditions on the BSA
adsorption behaviors indicate that ion exchange mechanism might be involved in
process. However, it doesn't play a major role. To prevent possible ion exchange
interactions, the higher ionic strength should be maintained.
CHAPTER 8
ADSORPTION CAPACITY OF BSA IN IDA-Fe 3+
 IMMOBILIZED METAL
AFFINITY CHROMATOGRAPHY COLUMN
8.1 Introduction
To the author's knowledge, there is no report concerning the quantitative aspects of
interactions between protein and IMAC-Ferric adsorbents. In this chapter, BSA was
used as a model protein. The frontal analysis was used as a reliable method to obtain the
endotoxin adsorption capacity on IMAC column under different solution conditions.
The effects of solution ionic strength and pH on BSA adsorption capacity of IMAC-
Ferric were obtained. The adsorption mechanism was investigated quantitatively by
adapting previously reported equation to IMAC-Ferric system. Then interaction
mechanism between proteins and IMAC-Ferric was discussed.
8.2 Materials and Methods
8.2.1 Reagents
Bovine Serum Albumin (BSA) (Sigma, St. Louis, MO, USA) with low endotoxin
content was used in all studies. All solutions were prepared with Mill-Q water
(BioWhittaker Inc., Walkersville, MD, USA). All the other chemicals were purchased
from Sigma.
8.2.2 Experimental Apparatus
Experimental apparatus was described in Chapter 5.
135
136
8.2.3 IMAC Column and Adsorbent Resin
A HiTrap Chelating column with dimensions of 0.7 x 2.5 cm was purchased from
Amersham Pharmacia Biotech. The resin was described in Chapter 5 in details.
8.2.4 Buffers
The same buffers were used as Chapter 5.
8.2.5 Column Preparation and Operation
The column preparation and operation procedure was described in Chapter 7.
8.2.6 Frontal Analysis
The frontal analysis method was described in Chapter 5.
8.2.7 BSA Assay
The optical density of BSA was monitored by UV-1 in Pharmacia GradiFrac System,
which was collected by a data acquisition system M1101 (Keithley Metrabyte, Cleveland,
OH) incorporated with a computer. This system was used to record the chromatograms in
digital forms so that they could be transferred later for data processing and analysis. By
comparing with standard curve, BSA concentration was easily obtained.
8.2.8 Determination of the Amount of Immobilized Ligand (Fe3±)
The Fe3+ concentration is determined by Sigma total iron kit. First, the concentration of
feed FeC1 3 solution was determined and total amount of Fe 3+ applied to column was
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calculated. Second, the Fe 3+
 amount eluted in loading and washing process was
determined. The amount of immobilized Fe 3+ was calculated as the difference between
the total amount of Fe 3+
 applied to the column and the amount washed out during
washing process. The leaching of the column can be investigated by determination of the
ferric ion concentration in all elution fractions
8.2.9 Data analysis
The same equations described in Chapter 5 were used.
8.3 Results and Discussions
8.3.1 Concentration of Immobilized Ligand, Fe3+
Using the procedure outlined above, the total concentration of immobilized Fe3+ on the
IDA IMAC column was determined to be 34 µmol/m1 of adsorbent. As provided by the
manufacturer, the total Cu2+
 concentration is about 23 µmol/m1 of adsorbent for IDA-
Cu2+
 IMAC column. Author's measured results are within the range stated by the
manufacturer.
8.3.2 Frontal Analysis
The shape of the elution front is also sigmoidal as the elution front of endotoxin. This is
generally caused as a consequence of imperfection in the column packing as well as a
lack of local distribution equilibrium mainly due to large variations in the size of the gel
beads. The technical and operational advantages of adsorbents packed with small and
uniform sized beads are obvious. The HiTrap chelating beads are adsorbents with big
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pores, which is easily accessed by BSA molecules, which is a big advantage over the
small pore adsorbents. The separation of BSA and endotoxin might be achieved using
their size difference.
8.3.3 The Effects of Ionic Strength on the Column Capacity of BSA Adsorption
to IDA-Fe3+ Column
The effect of ionic strength on the column capacity was shown in Figure 8.1 and Table
8.1 at the same buffer pH and BSA feed concentration (ca. 550 µg/m1). Four different
buffer ionic strength conditions, 0.02, 0.25, 0.5 and 1.0 M, were used in the experiments.
At the lowest ionic strength condition, 0.02 M, the column capacity was highest. As the
ionic strength was increased from 0.02 to 0.25 M, the column capacity decreased from
71.4 mg/ml gel to 53.4 mg/ml. This indicates that electrostatic interaction might partly
contribute to BSA adsorption to the IMAC-Fe3+
 beads at low ionic strength buffer
condition. This seems reasonable considering that BSA is negatively charged at pH 5.5.
However, as ionic strength increased further from 0.25 to 1.0 M, the column capacity
remains constant, 52 to 53 mg/ml gel. This result indicated that the IMAC-Fe 3+ was
quite different from regular ion exchange chromatography. Electrostatic interactions can
not satisfactorily explain the adsorption behavior of BSA on IDA-Fe 3+ IMAC column.
8.3.4 The Effects of pH on the Column Capacity of BSA Adsorption
to IDA-Fe3+ Column
The effect of buffer pH on the column capacity was shown in Figure 8.2 and Table 8.1.
Four different pH conditions were tried with the same ionic strength (0.5 M) and same
level of BSA concentration in feed solution (ca. 550 µg/ml). At lowest pH 3.4, the
Figure 8.1 The effect of mobile phase ionic strength on BSA adsorption
capacity on IDA-Fe3+ IMAC beads, pH 5.5
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column capacity was highest. As the pH was increased from 3.4 to 4.3, the column
capacity decreased slightly from 69.8 to 67.5 mg/ml gel. As the pH increased further to
5.5, the column capacity decreased to 53.5 mg/ ml gel. Finally as buffer pH was
increased to 7.0, the column capacity is lowest, 18.2 mg/ml. As the properties of BSA
were considered, the experimental results are very interesting. pI of BSA is about 4.6.
At pH< 4.6, BSA is positively charged while negatively charged at pH > 4.6. Since Fe 3+
is positively charged, ion exchange mechanism cannot explain the adsorption behavior
of BSA on IMAC-Fe ThisThis research was very useful in applying IMAC in protein-
LPS separation. To keep the protein adsorption capacity at very high level the buffer pH
for adsorption process should be less than 7.0.
Table 8.1 Column capacity for BSA adsorption with buffer pH and ionic strength
conditions
pH I.S. (M) Capacity(mg/ml)
3.4 69.8
4.4 67.5
5.5 0.5 53.5
7.0 18.2
0.02 71.4
0.25 53.4
5.5 0.5 53.5
1.0 52.0
Figure 8.2 The effect of mobile phase pH on the adsorption to IDA-Fe 3+
IMAC column, Ionic Strength 0.5 M
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Figure 8.3 Determination of quantitative affinity parameter for the
interaction between BSA and IDA-Fe 3+, MW of BSA: 64.5K, Kassai eq.
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8.3.5 Quantitative Affinity Data
The plot of experimental data fitting to the equation of Kasai et al. is shown in Figure 8.3.
From the plot, the total concentration of ligand that has interacted with BSA, B t, is
obtained directly from the intercept on the ordinate. Kd can be calculated from the slope
of the plot and the B t. As the molecular weight of BSA is 64,500, Kd = 4.6x10 -5 M and B t
= 6567.7 µmol.
Kd shows stability of the complex of BSA, the adsorbate and Fe3+, the ligand. If
Kd is very low, the complex is very stable. B t is obviously very large compared to the
total Fe3+
 amount, which was immobilized in the column as the adsorption ligands. This
means that many BSA molecules were bound to one single adsorption site
As well known, the interaction of proteins with IMAC adsorbents is governed by
the number or density of exposed histidine, cysteine or tryptophan residues. This can
explain protein's adsorption behaviors. As reported in the literature, the size of BSA
molecule is around 5 nm (Creighton, 1984). Pores of the adsorbents should be large
enough so that free diffusion is not hindered significantly. This normally can be met with
pores that are 10 to 20 times larger than the sizes of the adsorbate molecule (Satterfield et
al., 1973). For the case of BSA, pore should be larger than 50nm. The pore size of IDA
adsorbent is around 100 nm. Therefore, the steric effect is not a problem for BSA
adsorption.
8.4 Summary
The work in this article was to determine the capacity of BSA adsorption on the IMAC-
Fe3+
 column under different solution conditions. The results provided more reliable and
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efficient theoretical basis for buffer selection and adsorption process design,
optimization, simulation and process scale-up. It also provided deep insight into the
character of the BSA and IMAC- Fe 3+ interactions. In this study, the BSA exhibited
heterogeneous interactions with immobilized IMAC- Fe 3+ . Variation of ionic strength
and pH in the study was used to identify the adsorption mechanism, types of the forces
involved in the adsorption. As described above, adsorption of BSA on the IMAC- Fe 3+
was mainly due to histidine group in the BSA and the interaction mechanism was
essentially metal chelating. Electrostatic forces might also be involved at the low
solution ionic strength.
As adsorption capacity under different conditions is known, the process
development and optimization has the theoretical basis and can be completed in a more
rational way. It also provides the basic data for process simulation, which is a very
important step in process scale-up. In the loading period of BSA removal process, in
order to get high BSA adsorption capacity, buffer with a very high pH should be
avoided.
BSA is a typical model protein, its adsorption on IMAC- Fe 3+ is due to metal
chelating interaction between BSA and Fe 3+ . As the bead pore size is very big, steric
effect on BSA adsorption can be eliminated. Other proteins, such as HbAo (neutral
protein) and IgG (alkaline protein) were known for strong endotoxin binding. It is very
difficult to remove endotoxin from these protein solutions. Like BSA, these proteins
have many common properties. First, the protein size is smaller than 10 nm. In other
words, there is no steric effect on mass transfer in the pores of IMAC-Fe 3+ beads.
Second, all these proteins have histidine group(s) on the surface, which could contribute
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the metal chelating interactions. This indicates that IMAC-Fe3+ can be used to purify
proteins and at same time remove endotoxins.
CHAPTER 9
ELUTION PROCESS DEVELOPMENT AND OPTIMIZATION IN
IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY FOR ENDOTOXIN
REMOVAL FROM PROTEIN SOLUTIONS
9.1 Introduction
Bacterial endotoxins are lipopolysaccharides (LPS) derived from the outer cell
membranes of Gram-negative bacteria (Vaara and Nikaido, 1984). In biotechnology
industry, Gram-negative bacteria are widely used to produce recombinant DNA products
such as peptides and proteins. Bacterial endotoxins have been recognized by the industry
as a major cause of the pyrogenic reactions that can be encountered during the
administration of biotherapeutics (Hou and Zaniewski, 1990). The removal of these
physiologically active agents from final protein products has always been a challenge,
especially in the situations where endotoxins bind proteins.
Although numerous methods such as ion exchange adsorption (Webber et al.,
1995), ion exchange membrane (Belanich et al., 1996), ion-exchange filter (Hou and
Zaniewski, 1990), ultrafiltration (Li and Luo, 1998, 1999), extraction (Aida and Pabst,
1990) have been studied for endotoxin removal from protein solutions, affinity
adsorption has proven to be the most effective technique. As to the endotoxin binding
affinity ligands, immobilized Polymyxin B (Issekutz, 1983; Karprus et al., 1987; Tani et
al., 1992; Petsch et al., 1997) and Immobilized histidine (Matsumae et al., 1990; Guo et
al., 1997; Legallais et al., 1997) have been investigated intensively with variety of
supports. Both adsorbents have high capacities for adsorbing endotoxin in solutions
with low ionic strength. However, it is difficult to selectively remove endotoxin from the
protein solutions. The nephrotoxicity and neurotoxic reaction of polymyxin B
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(Physicians' Desk Reference, 1993; Kodama et al., 1997) further prevent its application
in endotoxin removal from bioproducts. The author (Kang and Luo, 1998) has reported
the use of Acticlean Etox affinity column from Sterogene Bioseparations (Carlsbad, CA)
to remove endotoxin from hemoglobin preparations where the protein formed a complex
with LPS subunits. The effects of various solutions such as endotoxin-free water, NaC1
and CaC12 on the endotoxin removal efficiency and protein recovery in the
chromatographic process were investigated. All the above study indicates that an
effective and economic adsorbent, which can give both high endotoxin removal
efficiency and high protein recovery, is yet to be developed.
Since its introduction by Porath et al. in 1975, immobilized metal ion affinity
chromatography (IMAC, also know "metal chelate chromatography") has gained wide
acceptance in purification of proteins and peptides (Sulkowski, 1985; Yip and Hutchens,
1994; Scopes, 1994). Much of the earlier work concentrated on using Cu 2+
 or Zn2+ as the
chelating metal ion (Sulkowski, 1985; Scopes, 1987). Later Fe 3+ was found to be a very
effective chelating ion for isolation of phosphorylated amino acids, peptides and proteins
based on the preferential affinity between the immobilized iron (III) ion and the
phosphate groups in the biomolecules (Andersson, 1986; Muszynsha, 1992). It was
proposed by author and coworkers that LPS also had phosphate groups in its structure,
which might interact strongly with immobilized Fe3+ . However, to the best of author's
knowledge, there are no reported studies on the specific use of IMAC for endotoxin
removal. In this chapter a novel IMAC method or process for endotoxin removal from
protein solutions (acidic protein, BSA, neutral protein, HbAo and basic protein, IgG) was
developed. Fe 3+
 was charged to a chelating gel that contains iminodiacetic acid (IDA).
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The IDA-Fe3+
 IMAC column was exploited to remove endotoxin from the mixtures of
bovine serum albumin and endotoxin (BSA-LPS), and from the mixtures of human
hemoglobin Ao and endotoxin (HbAo-LPS), as well as from the mixture of IgG and
endotoxin (IgG-LPS). Endotoxin removal efficiency and protein yield were investigated
(Kang and Luo, 1999).
The selectivity and retention of biomolecules in IMAC could be altered in several
ways (Anspach, 1994; Vunnum and Cramer, 1997). First, the different type of stationary
phase and chelating function between the ligand and the spacer arm can be used when the
methods are first developed. Second, changing pH is regularly used to selectively elute
the adsorbed molecules from IMAC column. Third, changing the nature and
concentration of the salts is frequently used in the research. Fourth, with different nature
and concentration of competing agent in elution buffer, the selectivity and retention of
the adsorbed molecules can be modulated or adjusted. In this chapter the elution process
development and optimization were reported to obtain high endotoxin removal efficiency
and high protein yield. Different elution strategies were tried. Phosphate ion is a very
efficient modulator in the elution of protein from the IDA-Fe 3+ column. The
experimental results were used to confirm the theory which was put forward in Chapter 5
to 8. Adsorption mechanism was further discussed.
9.2 Materials and Methods
9.2.1 Materials
Endotoxin from Escherichia coli 026: B6 (Sigma Chemical Co., St. Louis, MO) was
used in all experiments. Human Hemoglobin Ao (HbAo, ferrous), bovine serum albumin
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(BSA), Goat immunoglobulin (IgG), FeCl3, NaC1, NaH2PO4, Na2HPO4, Na3PO4, NH4C1
and EDTA (ethylenediaminetetraacetic acid, sodium) were also purchased from Sigma.
N-octyl-β-D-glucopyranoside (OBDG) was purchased from CALBIOCHEM
(Calbiochem-Novabiochem International, San Diego, CA). All solution transfers were
performed with endotoxin free devices. Sterile, disposable plasticware was used at all
time to prevent endotoxin contamination. All solutions were prepared with Milli-Q
water generated by a Biocel water purification system (Millipore Corporation, Bedford,
MA). The endotoxin concentration in the Milli-Q water was below 0.05 EU/ml based on
author's test.
9.2.2 Experimental Apparatus
A GradiFrac chromatographic system (Amersham Pharmacia Biotech, Piscataway, NJ) was
used in all experiments. Feed and mobile phase solutions were transferred by an adjustable
peristaltic P-1 pump. The ultraviolet absorbance of the eluent from the column was
measured by an UV-1 monitor at 280 nm. The flow cell used in the monitor was a standard
cell with an optical path length of 1.00 cm. The UV absorbance was recorded by two
means. The first one was a REC 102 2-channel recorder, which was used to show
chromatograms directly during the experiments. The second one was a data acquisition
system M1101 (Keithley Metrabyte, Cleveland, OH) incorporated with a computer, which
was used to record the chromatograms in digital forms so that they could be transferred
later for data processing and analysis. A GradiFrac fraction collector was used to collect
fractions for protein and endotoxin assay.
150
9.2.3 IMAC Column and Adsorbent Resin
A HiTrap chelating column with dimensions of 0.7 x 2.5 cm was purchased from
Amersham Pharmacia Biotech. The column was packed with Pharmacia chelating
Sepharose High Performance resin consisting of highly cross-linked agarose beads to
which iminodiacetic acid (IDA) was coupled by a stable spacer arm. The mean diameter
of the adsorbent is approximately 34 p.m. The average pore size is around 100 nm.
9.2.4 Buffers
Buffers A, B, C and D were used in the experiments, which were listed in Table 9.1. All
feed solutions were prepared with buffer A — 0.5 or 1.0 M NaC1 in 0.02 M acetate buffer at
pH 5.5. The starting buffer was buffer A. To develop an effective chromatographic process,
which keeps endotoxin in the column, four elution buffers were used individually or in
combination for protein elution study. The first elution buffer, buffer B, was 0.5 M NH 4C1
in 0.02 M acetate buffer at pH 5.5. The second elution buffer, buffer Co, was OBDG in
buffer B. The third elution buffer, buffer C1 , was sodium phosphate in buffer A. The fourth
elution buffer, buffer C2 was sodium phosphate buffer. The stripping buffer, buffer D, was
0.05 M EDTA in buffer A. All buffers were filtered through a 0.22 filter (Nalgene,
MA) and degassed under vacuum for at least 25 min prior to being applied to the column.
9.2.5 Column Preparation and Operation
The HiTrap chelating column was stored in 20% ethanol when purchased. The column
was first washed with 5 ml Milli-Q water at a flow rate of 1 ml/min to remove the
ethanol. Then the column was loaded with 0.5 ml of 0.1 M FeC13 solution at 1 ml/min to
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Table 9.1 Summary of buffers used in the IMAC process
Buffer Composition pH
A (starting buffer) 0.5 M or 1.0M NaC1 in 0.02 M acetate buffer 5.5
B (elution buffer) 0.5 M NH4C1 in 0.02 M acetate buffer 3.3-5.5
Co (elution buffer) OBDG in buffer B 5.5
Col 0.17 mM OBDG
CO2 0.34 mM OBDG
CO3 0.69 mM OBDG
C04 1.03 mM OBDG
CO5 8.60 mM OBDG
CI (elution buffer) 0.06 M Sodium phosphate in buffer A 3.5
5.0
5.4, 5.5
8.0
C2 (elution buffer) 0.06 M Sodium phosphate buffer 5.5
D (stripping buffer) 0.05 M EDTA in buffer A
charge Fe3+
 to the resin. Finally, the column was washed with 5 ml Milli-Q water at 1
ml/min to replace the unbound Fe 3+
 from solution. The column was now charged with
metal ion and ready for use. Before applying the feed, a blank run was performed to
elute nonspecifically bound metal ions that might otherwise be eluted during desorption.
In the blank run, the column was washed with 2.5 ml of buffer A at 2 ml/min followed by
5m1 of buffer B at 1 ml/min. The column was then equilibrated with 2.5 ml of buffer A
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at 1 ml/min. The feed (10 ml of pure protein, pure LPS or protein-LPS mixture) was
applied to the column at 1 ml /min. The column was then washed with the starting buffer
(buffer A) at 2 ml/min for 10min. Finally, the column was eluted by elution buffers
(buffer B, C or combination of B and C) at 1 ml/min using step gradients. The column
was regenerated by washing with buffer D to strip all the metal ions, followed by
washing with 5 ml of Milli-Q water, both at a flow rate of 1 ml/min.
9.2.6 Protein Assay and Protein Yield of Protein-LPS Mixtures by the Column
Protein concentrations in all eluents from the IMAC column were measured by two
means. First, the ultraviolet absorbance of the eluent was monitored continuously at 280
nm for protein peaks. Second, fractions were collected and protein concentrations in all
fractions or fraction pools were assayed using Bradford method (Bradford, 1976).
Protein yield, Y, of the IMAC process was determined by the following equation:
Where m feedpro is the amount of protein (µg) in the feed loaded to the column. mpeakpro is the
amount of protein (1g) in the protein peak collected.
9.2.7 Endotoxin Assay and Endotoxin Removal Efficiency of Protein-LPS Mixtures
by IMAC Column
To determine endotoxin concentration, a chromogenic limulus amebocyte lysate (LAL)
test kit QCL-1000 from BioWhittaker (BioWhittaker Inc., Walkersville, MD) with a
modified procedure was used. The reaction mixtures were measured at 405 nm with a
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results were compared to a standard curve to obtain endotoxin concentrations. However,
HbAo has a strong absorbance at 405 nm and subtraction of its absorbance is necessary.
The correction was done by deducting the HbAo absorbance from total absorbance of the
reaction mixture (Kang and Luo, 1999).
The endotoxin removal performance of this IMAC process was quantitatively
evaluated using two parameters: Local Endotoxin Removal Efficiency, LERE, and Global
Endotoxin Removal Efficiency, GERE. LERE was determined by the following
equation (Li and Luo, 1999):
Where feed is the amount of endotoxin (in endotoxin unit, EU) in the feed loaded to theM LPS
column. M uspeak is the amount of endotoxin (EU) in the protein peak collected.
GERE was determined by the following equation:
Where mbufferLPS is the amount of endotoxin (EU) in buffer solutions used to wash and elute
the column. mfracLSP is the amount of endotoxin (EU) in all elution fractions collected.
LERE and GERE were calculated based on endotoxin concentrations in the feeds, buffers
and elution fractions of chromatographic runs for BSA-LPS, HbAo-LPS or IgG-LPS.
9.2.8 Assay of Ferric Ions in the Eluents
To check if there is any leaching of ferric ions during the elution process, a total iron test
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kit based on a ferrozine colorimetric principle (Sigma Chemical Company, St. Louis,
MO) with a modified procedure was used. The detection limit is 0.05µg/ml. Milli-Q
water, iron standard and test sample were placed in three cuvets individually and then
mixed with iron buffer reagent and color reagent respectively. After 10 minutes the
mixtures were measured at 560 nm with a Hitachi U-2000 spectrophotometer. The total
iron concentration in the sample was obtained by comparing the absorbance of sample to
that of the iron standard.
9.2.9 Elution with Buffer B (NH4C1 in 0.02 M Acetate Buffer)
In this section, the elution of protein and endotoxin from IMAC with buffer B was
investigated. Five different feeds were used: pure BSA, pure HbAo, pure LPS, BSA-LPS
mixture and HbAo-LPS mixture. Protein concentrations were determined by Bradford
assay while endotoxin contents were obtained by LAL test. 10 ml feed solution was
loaded to the column at 1 ml/min and fraction collection started at the beginning of the
loading. The subsequent washing and elution steps were described in Section 9.2.5. The
fraction collection program was set in the following fashion. Both features of "fraction
collection" and "peak collection" of the Gradifrac system were used. The fractions were
collected at every 5 min before the last "peak collection" was activated. The fractions
were collected at every one-minute after the last "peak collection" was finished. All
fractions or fraction pools were assayed for protein and endotoxin contents. To check the
effect of NH4C1 concentration on the elution of protein or endotoxin, gradient elution
runs were also conducted with 0 to 1.0 M NH4C1 in buffer A.
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9.2.10 Elution with Buffer Co (OBDG in Buffer B)
It was reported that OBDG could dissociate protein-LPS complex (Karplus, 1987), a
feature that might be used to improve the endotoxin removal efficiency and protein
recovery in a process of endotoxin removal from protein solutions. In this work, OBDG
was added into buffer B to form buffer Co. Buffer Co solutions with various OBDG
concentrations were applied to IMAC column. BSA-LPS mixtures and HbAo-LPS
mixtures were used as feeds. The chromatographic process was carried out in the same
way as mentioned in Section 9.2.9.
9.2.11 Elution with Buffer C1 (Sodium Phosphate in Buffer A)
As mentioned before, phosphate might be an efficient modulator for protein elution from
IDA-Fe3+
 IMAC. Sodium phosphate in buffer A under different solution conditions was
tried. Buffer CI with different pH, i.e., pH 3.5, 5.0, 5.5 and 8.0 were prepared to
investigate the effect of buffer pH on the elution of protein. In another set of experiments,
Buffer B or Co was used followed by buffer CI in the elution process of IMAC for a
comparison.
9.2.12 Elution with Buffer C2 (Phosphate Buffer)
BSA-LPS feed was prepared as the same procedure in Section 9.2.9. 10 ml feed solution
was loaded to the column at 1 ml/min and the fraction collection started at the beginning
of the loading. The subsequent washing and elution steps were described in Section 9.2.5.
0.06 M phosphate buffer was used instead of sodium phosphate in the buffer A to
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selectively elute protein and endotoxin from the column. The protein and endotoxin
contents were determined in all fractions or fraction pools. This experiment is used to
show which component in Buffer C 1 , modulator or acetate buffer, is more important to
elute the protein from the IMAC column.
9.2.13 Phosphate Buffer (Buffer C2) as both the Starting Buffer
and the Elution Buffer
The feed, the mixture of BSA and LPS, was prepared as same procedure in Section 9.2.9
except that phosphate buffer was used in stead of acetate buffer. 10 ml feed solution was
loaded to the column at 1 ml/min and the fraction collection started at the beginning of
the loading. The subsequent washing and elution steps were described in Section 9.2.5
except this time the phosphate buffer was used for washing and elution. All fractions or
fraction pools were assayed for protein and endotoxin contents.
9.3 Results and Discussions
9.3.1 Effect of NH4C1 on the Elution Process
NH4C1 is routinely used as an eluting agent in IMAC for protein purification. However,
buffer B (containing NH4C1) was not able to elute proteins in the experimental runs for
both pure feeds (pure BSA, HbAo and LPS) and mixture feeds (BSA-LPS and HbAo-
LPS). Neither stepwise elution (0.5 M or 1.0 M NH4C1) nor linear gradient elution from
0 to 1.0 M could elute proteins or endotoxin. Hence, NH4C1 is not an effective agent to
elute proteins out of the IMAC-Fe 3+ column. The reason might be that affinity between
IMAC-Fe3+ and protein/LPS is very high compared with affinity between IMAC-Fe 3+
and NH4+.
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9.3.2 Effect of OBDG in Elution Buffer on the Elution Process
Buffer Co solutions containing OBDG at different concentrations were prepared as shown
in Table 9.1. They were tested to see if any of them could selectively elute the protein
from the column after binding of protein-LPS mixture on the IDA-Fe 3+ resin. The
experiments were summarized in Table 9.2. The OBDG concentration in elution buffer
B ranges from 0.17 mM to 8.6 mM. An example of elution profiles was shown in Figure
9.1 in which OBDG concentration is 0.17 mM. The major peak, i.e., first peak, is
elution buffer front. The corresponding elution time equals time for buffer Co to displace
the column. Other small changes in the chromatogram were caused by buffer changes or
changes of operating flow rate. Bradford assay and LAL test confirmed that there was no
protein and endotoxin eluted in all fractions. As OBDG concentration in elution buffer B
is 0.34, 0.69, and 1.03 mM, and similar results were obtained. No protein or endotoxin
was eluted. Further from Table 9.2, when acetate buffer pH ranges from 3.5 (Case 1.2,
OBDG 0.34 mM) to 5.0 (Case 1.3, OBDG 0.34 mM), the similar results were obtained as
Figure 9.1.
As OBDG concentration in buffer B was increased to 8.5 mM, a different elution
profile was obtained (not shown here). Two major peaks were found in the profile. The
first was the peak corresponding to the dead volume. The second peak indicated that
there was ferric ion leaching from the column. This was confirmed by a blank run (with
the starting buffer as the feed instead of the protein or endotoxin feed) with same elution
buffer. Nearly the same elution profile was obtained (not shown here).
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Tables 9.2 Removal of endotoxin from protein solutions using buffer Co (OBDG in
buffer B) as the elution buffer
Feed Elution buffer pH
Case 1.1 BSA-LPS Col 3.5
Case 1.2 BSA-LPS CO2 3.5
Case 1.3 BSA-LPS CO2 5.0
Case 1.4 BSA-LPS CO3 5.5
Case 1.5 BSA-LPS C04 5.5
Case 1.6 BSA-LPS Cos 5.5
9.3.3 Effect of Phosphate on the Elution Process
The use of phosphate as an eluting agent to selectively elute proteins from the column
was studied. Buffer C at various pH conditions was used as shown in Table 9.3. In all
experiments, phosphate was dissolved in buffer A.
Three strategies were used in elution of protein or endotoxin from IMAC column.
First, only one elution buffer, C1, was used. Second, buffer C 1 was used after buffer B.
Third, buffer CI was used after buffer Co. The experimental results were summarized in
Table 9.3. HbAo-LPS feed was applied in Case 2.1. BSA-LPS feed was used in Case
Figure 9.1 The chromatogram of BSA-LPS mixture eluted with
buffer Col (Case 1.1). Loading period: feed, 10 ml mixture containing
16.14 µg/m1 BSA and 18.26 EU/ml LPS at 1 ml/min, 10 min.
Washing period: 20 ml buffer A at 2 ml/min, 10 min. Elution period,
15 ml buffer Col at 1 ml/min, 15 min.
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2.2. IgG-LPS was used in Case 2.3. Two elution buffers, buffer B or buffer CO and
buffer C1 in series or only one buffer C 1
 were used in the experiments, respectively. Table
9.3 shows that over 97% of endotoxin was removed from the protein solutions and
protein yield was more than 90% in all the cases.
Table 9.3 Removal of endotoxin from protein solutions using phosphate as elution buffer
Case Feed Elution Buffer LERE
(%)
GERE
(%)
Y
(%)
Case 2.1
2.1.1 HbAo-LPS C1 (pH5.0) 99.9 97.7 95.9
2.1.2 HbAo-LPS B (pH5.3)+C1 (pH5.0) 99.3 86.4 96.5
Case 2.2 BSA-LPS
2.2.1 BSA-LPS B (pH5.3)+C1 (pH5.0) 99.7 97.5 90.0
2.2.2 BSA-LPS
2.2.2.1 BSA-LPS C1 (pH5.0) 99.5 86.6 94.5
2.2.2.2 BSA-LPS C1 (pH5.4) 99.9 84.8 98.0
2.2.2.3 BSA-LPS C 1
 (pH5.5) 99.8 88.5 100.0
2.2.2.4 BSA-LPS C1 (pH8.0) 97.3 82.1 100.0
2.2.3 BSA-LPS
2.2.3.1 BSA-LPS CO2+C1 (pH3.5) 99.7 97.5 93.6
2.2.3.2 BSA-LPS Co2+C1 (pH5.0) 99.8 94.7 90.0
2.2.4 BSA-LPS C2 (pH5.5) 99.8 90.2 100.0
Case 2.3 IgG-LPS C2 (pH5.5) 99.9 92.3 92.1
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9.3.3.1 Endotoxin Removal from HbAo Solution
Figure 9.2A shows elution profile of endotoxin of HbAo-LPS mixture separated by the
IMAC column (Case 2.1.1). It can be seen that endotoxin concentrations in all eluted
fractions were very low. During the loading period (0 to 10 min) and the washing period
(10 to 20 min), the output endotoxin concentration was between 0.6 and 0.7 EU/ml. This
indicated that in loading and washing periods some endotoxin was not adsorbed to the
column and washed out. During the first elution period (20-30 min) with buffer B, some
endotoxin was also found in the eluants. However, in the second elution period (after 35
min), in which buffer CI was used, the eluted endotoxin was less than 0.1 EU/ml. This is
low enough to satisfy all the endotoxin limit requirements (Held et al., 1997; Williams,
1996). Figure 9.2B shows that the elution profile of HbAo of the HbAo-LPS mixture
separated by the IMAC column (Case 2.1.1). The chromatogram in Figure 9.2B (up) was
recorded directly by the data acquisition system and the elution profile in Figure 9.2B
(down) was obtained by Bradford assay of fractions and fraction pools. It can be seen
that the HbAo peak came out at around 36 min. The peak was sharp with protein
concentration of 95.69 µg/m1 (35-40 min), 48.33 pg/m1 (40-44 min) 5.62 µg/m1 (44-49).
During the loading (0 to 10 min), washing (10 to 20 min) and early elution (20 to 36 min)
periods, the baseline of the chromatogram was very stable. This indicated that there was
no protein content in this period. Total protein yield is 96.5%.
Figure 9.3A also shows elution profile of endotoxin of HbAo-LPS mixture
separated by the IMAC column (Case 2.1.2). Similar to the situation in Figure 9.2A,
endotoxin concentrations were low during the loading period (0-10 min), the washing
period (10-20 min) and the elution period (20-42 min).
Figure 9.2A Endotoxin elution profile of HbAo-LPS mixture (Case
2.1.1). Loading period: feed, 10 ml mixture containing 76.72 µg/ml
HbAo and 7.4 EU/ml LPS at 1 ml/min, 10 min. Washing period: 20 ml
buffer A at 2 ml/min, 10 min. Elution period, 10 ml buffer B at 1
ml/min, 10min. Elution period: 20 ml buffer Ci at 1 ml/min, 20min.
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Figure 9.2B Protein elution profile of HbAo-LPS mixture (Case 2.1.1). Up:
chromatogram of UV response at 280 nm, recorded by the data acquisition
system. Down: chromatogram of Bradford assay results of fractions and fraction
pools. Loading period: feed, 10 ml mixture containing 76.72 µg/m1 HbAo and
7.4 EU/rnl LPS at 1 ml/min, 10 min. Washing period: 20 ml buffer A at 2
ml/min, 10 min. Elution period: 10 ml buffer B at 1 ml/min, 10min. Elution period:
20 ml buffer C1
 at 1 min/ml, 20 min.
Figure 9.3A Endotoxin elution profile of HbAo-LPS mixture from the IMAC
column (Case 2.1.2). Loading period: feed, 10 ml mixture containing 19.06
µg/m1HbAo and 21.26 EU/m1LPS; flow rate, 1 ml/min. Washing period: 20
ml buffer A at 2 ml/min. Elution period: 22 ml buffer CI at 1 ml/min.
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Figure 9.3B shows that the elution profile of HbAo in the HbAo-LPS mixture
separated by the IMAC. A sharp HbAo peak came out at around 24 min with a
concentration of 36.56 µg/ml. The baseline of the HbAo chromatogram was also very
stable during the loading (0 to 10 min), washing (10 to 20 min) and the early elution (20
to 24 min) periods.
9.3.3.2 Endotoxin Removal from BSA Solution
Figure 9.4A shows the elution profile of endotoxin in BSA-LPS mixture separated by the
IMAC column (Case 2.2.1). It can be seen that endotoxin concentrations in all fractions
were very low. During the loading period (0 to 10 min) and the washing period (10 to 20
min), the output endotoxin concentration was 0.15 EU/ml. During the elution period (20
to 52 min) while the protein was eluted out, the output endotoxin concentration was 0.05
EU/ml before 36 min and 0.03 EU/ml from 36 to 38 min. After 38 min, the endotoxin
contents were below the detection limit of the LAL test. Figure 9.4B shows the elution
profile of BSA in the BSA-LPS mixture separated by the IMAC column. The
chromatogram in Figure 9.4B (up) was recorded directly by the data acquisition system,
and the elution profile in Figure 9.4B (down) was obtained by Bradford assay of fractions
and fraction pools. It can be seen that the BSA peak came out at around 36 min. The
peak was sharp with a BSA concentration of 75.31 µg/ml. During the loading (0 to 10
min), washing (10 to 20 min) and early elution (20 to 36 min) periods, the baseline of the
chromatogram was very stable except a small peak at 24 min. The Bradford assay result
of the corresponding fraction of this peak showed no protein content.
Figure 9.3B Protein elution profile of HbAo-LPS mixture from the
IMAC column. Up: chromatogram of UV response at 280 nm,
recorded by the data acquisition system. Down: chromatogram of
Bradford assay results of fractions and fraction pools. Loading period:
feed, 10 ml mixture containing 19.06 µg/m1 HbAo and 21.26 EU/ml
LPS; flow rate, 1 ml/min. Washing period: 20 ml buffer A at 2 ml/min.
Elution period: 22 ml buffer C 1 at 1 ml/min.
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Figure 9.4A Endotoxin elution profile of BSA-LPS mixture from the IMAC
column (Case 2.2.1). Loading period: feed, 10 ml mixture containing 16.14
µg/ml BSA and 18.26 EU/m1LPS; flow rate, 1 ml/min. Washing period: 20
ml buffer A at 2 ml/min. Elution period: 10 ml buffer B at 1 ml/min. Elution
period: 22 ml buffer C 1 at 1 ml/min.
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Figure 9.4B Protein elution profile of BSA-LPS mixture from the
IMAC column. Up: chromatogram of UV response at 280 nm,
recorded by the data acquisition system. Down: chromatogram of
Bradford assay results of fractions and fraction pools. Loading
period: feed, 10 ml mixture containing 16.14 µg/ml BSA and 18.26
EU/ml LPS; flow rate, 1 rnl/min. Washing period: 20 ml buffer A at 2
ml/min. Elution period: 10 ml buffer B at 1 ml/min. Elution period: 22
ml buffer C1 at 1 min/mL
168
169
Figure 9.5A shows the elution profile of endotoxin of BSA-LPS mixture separated
by the IMAC column (Case 2.2.2.1). Similar to the situation in Figure 9.2A, there was
some endotoxin washed out in the loading period (0-10 min), the washing period (10-20
min) with starting buffer A, and first several minutes in elution period (20-24 min) with
buffer B. After 24 minutes the endotoxin concentration in eluant is very low. Figure
9.5B shows the elution profile of BSA in the BSA-LPS mixture separated by the IMAC.
A sharp BSA peak came out at 24 min with a concentration of 141.5 µg/ml. Similar to
the situation of HbAo-LPS experiment, the baseline of the BSA chromatogram was also
very stable during the loading (0 to 10 min), washing (10 to 20 min) and the early elution
(20 to 24 min) periods. The difference is that elution peak is narrower than that in the
case of HbAo. The protein yield was 94.5%. It was also noticed that in Case 2.2.2.1
BSA concentration in the product fraction pool was 141.5 µg/ml, which was 2.0 times of
the BSA concentration in the feed (71.89 µg/ml). Therefore protein concentration was
increased after IMAC processes.
As described previously, three strategies were used in elution of protein or
endotoxin from IMAC column. As shown in Table 9.3, for HbAo-LPS feed, nearly the
same LERE and protein yield were obtained in first two strategies. Using combination of
two buffers, GERE was 86.4%, which is less than 97.7% with one buffer C 1 . This means
that in the process with two elution buffers, some endotoxin was washed out in loading or
washing periods. Two strategies have similar good separate results. For BSA-LPS feed,
high protein yield was obtained for three elution strategies. In all the cases (Cases 2.2.1,
2.2.2, 2.2.3 and 2.2.4), more than 99% LERE and above 90% protein yield was obtained.
Figure 9.5A Endotoxin elution profile of BSA-LPS mixture (Case
2.2.2.1). Loading period: feed, 10 ml mixture containing 71.89 µg/m1BSA
and 19.06 EU/m1LPS at 1 ml/min, 10min. Washing period: 20 ml buffer A
at 2 ml/min, 10 min. Elution period: 28 ml buffer C 1 at 1 ml/min, 28min.
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Figure 9.5B Protein elution profile of BSA-LPS mixture. Up:
chromatogram of UV response at 280 nm, recorded by the data
acquisition system. Down: chromatogram of Bradford assay results of
fractions and fraction pools. Loading period: feed, 10 ml mixture
containing 71.89µg/m1 BSA and 19.06 EU/ml LPS at 1 ml/min, 10min.
Washing period: 20 ml buffer A at 2 ml/min, 10 min. Elution period: 28
ml buffer C1 at 1 ml/min, 28 min.
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The endotoxin elution profiles for Cases 2.2.2.3, 2.2.2.2 and 2.2.4 were shown in
Figure 9.6A, 9.7A and 9.8A, respectively. For all the cases, in the loading (0-10 min) and
washing with buffer A (10 to 20 min), endotoxin concentration in eluant was less than 1
EU/ml, which indicates that some endotoxin was washed out in the process of loading
and washing. The endotoxin concentration in the product fractions (after 20 min) was
getting lower. These were eluted by elution buffer C l , Cl and C2, respectively. The
protein elution profiles were provided in Figure 9.6B, 9.7B and 9.8B, separately. The
figures indicated that most of the protein was eluted in a very short time. This means the
IMAC process not only removes the endotoxin from the protein solution but also
concentrates the protein solutions as well.
9.3.3.3 Endotoxin Removal from IgG Solution
Figure 9.9A shows elution profile of endotoxin of IgG-LPS mixture separated by the
IMAC column (Case 2.3). Similar to the cases of BSA and HbAo solutions, some of
endotoxins were eluted during the loading period (0-10 min), the washing period (10-20
min). Figure 9.9B the elution profile of IgG in the IgG-LPS mixture separated by the
IMAC. A sharp IgG peak came out at around 25 min with a concentration of 115.3
µg/ml. Similar to the situations in the BSA-LPS and IgG-LPS experiments, the baseline
of the IgG chromatogram was also very stable during the loading (0 to 10 min), washing
(10 to 20 min) and the early elution (20 to 24 min) periods. 92.1% protein yield and
99.9 % LERE were obtained in this research.
Figure 9.6A Endotoxin elution profile of BSA-LPS mixture (Case
2.2.2.3). Loading period: feed, 10 ml mixture containing 78.87 µg/ml
BSA and 9.92 EU/m1 LPS at 1 ml/min. Washing period: 20 ml buffer
A at 2 ml/min. Elution period, 28 ml buffer C1 at 1 ml/min.
173
Figure 9.6B Protein elution profile of BSA-LPS mixture (Case
2.2.2.3). Up: chromatogram of UV response at 280 nm, recorded by
the data acquisition system. Down: chromatogram of Bradford assay
results of fractions and fraction pools. Loading period: feed, 10 ml
mixture containing 78.87µg/m1 BSA and 9.92 EU/ml LPS at 1 ml/min.
Washing period: 20 ml buffer A at 2 ml/min. Elution period: 28m1
buffer C1 at 1 ml/min.
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Figure 9.7A Endotoxin elution profile of BSA-LPS mixture (Case 2.2.2.2).
Loading period: feed, 10 ml mixture containing 78.87 BSA and 7.08
EU/m1 LPS; flow rate at 1 ml/min. Washing period: 20 ml buffer A at 2
ml/min. Elution period: 28 ml buffer C 1at 1 ml/min.
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Figure 9.7B Protein elution profile of BSA-LPS mixture (Case 2.2.2.2).
Up:chromatogram of UV response at 280 nm, recorded by the data
acquisition system. Down:chromatogram of Bradford assay results of
fractions and fraction pools. Loading period: feed, 10 ml mixture
containing 78.87 µg/m1 BSA and 7.08 EU/ml LPS at 1 ml/min. Washing
period: 20 ml buffer A at 2 ml/min. Elution period: 28 ml buffer C 1 at 1
ml/min.
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Figure 9.8A Endotoxin elution profile of BSA-LPS mixture
(Case 2.2.4). Loading period: feed, 10 ml mixture containing
74.44 BSA and 20.90 EU/ml LPS at 1 ml/min. Washing
period: 20 ml buffer A at 2 ml/min. Elution period: 28m1 buffer
C2 at 1 ml/min.
177
Figure 9.8B Protein elution profile of BSA-LPS mixture (Case 2.2.4).
Up:chromatogram of UV response at 280 nm, recorded by the data
acquisition system. Down: chromatogram of Bradford assay results of
fractions and fraction pools. Loading period: feed, 10 ml mixture containing
74.44 µg/m1 BSA and 20.90 EU/m1 LPS at 1 ml/min. Washing period: 20 ml
buffer A at 2 ml/min. Elution period: 28 ml buffer C2 at 1 ml/min.
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Figure 9.9A Endotoxin elution profile of IgG-LPS mixture from the IMAC
column (Case 2.3). Loading period: feed, 10 ml mixture containing 93 µg/m1
IgG and 31.42 EU/ml LPS; flow rate, 1 ml/min. Washing period: 20 ml
buffer A at 2 ml/min. Elution period: 22 ml buffer C2 at 1 ml/min.
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Figure 9.9B Protein elution profile of IgG-LPS mixture from the IMAC column.
Up: chromatogram of UV response at 280 nm, recorded by the data acquisition
system. Down: chromatogram of Bradford assay results of fractions and fraction
pools. Loading period: feed, 10 ml mixture containing 75.1 µg/ml IgG and 31.42
EU/ml LPS; flow rate, 1 ml/min. Washing period: 20 ml buffer A at 2 ml/min.
Elution period: 22 ml buffer C2 at 1 min/ml.
181
9.3.4 Effect of Elution Buffer pH and Ionic Strength on the Protein Yield
and Endotoxin Removal Efficiency
In this part of study, BSA-LPS mixtures prepared with buffer A were applied to the
column as the feeds as shown in Table 9.3. Elution buffers with different pH (3.5, 5.0,
5.5 and 8.0) were investigated. The effect of elution buffer pH on the endotoxin removal
efficiency and protein recovery was shown in Figure 9.10. As pH was increased from 3.5
to 5.5, LERE was nearly constant. As pH was further increased from pH 5.5 to 8.0,
LERE decreased slightly from 99.8% to 97.3%. In the whole pH range, BSA recovery is
more than 93%. Protein elution profiles were shown in Figure 9.11 (pH3.5, Case
2.2.3.1), Figure 9.12 (pH 5.0, Case 2.2.3.2), Figure 9.6B (pH5.5, Case 2.2.2.3) and Figure
9.13 (pH8.0, Case 2.2.2.4). At low pH range (pH3.5), high protein yield and endotoxin
removal efficiency were obtained. Protein was eluted in a very narrow period (5 min)
and its concentration is higher than corresponding concentration in the feed. At pH 8.0,
ferric ions were detected in the eluents after main protein peak. This indicated that high
pH could cause the leaching of ferric ions. In all experiments, the ionic strength in the
starting buffer and elution buffer was 0.5 M or 1.0 M, which is very high. In all cases,
endotoxin concentrations in the product fractions were very low and protein
concentrations were high. The endotoxin removal efficiency from the protein solution is
more than 99%, and protein yield is above 90%. The results indicate that the interactions
between the adsorbed biomolecules, protein or LPS and the resin are typical for an IMAC
column, which matches conclusions from Chapter 5 to Chapter 8.
9.3.5 Phosphate Buffer as both the Starting Buffer and the Elution Buffer
In order to optimize the process, experiments were carried out using buffer C2 as both the
Figure 9.10 The effect of pH on the behavior of IMAC column.
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Figure 9.11 Protein elution profile of BSA-LPS mixture (Case 2.2.3.1).
Up: chromatogram of UV response at 280 nm, recorded by the data
acquisition system. Down: chromatogram of Bradford assay results of
fractions and fraction pools. Loading period: feed, 10 ml mixture containing
19.23 µg/ml BSA and 41.23 EU/m1LPS at 1 ml/min. Washing period: 20
ml buffer A at 2 ml/min. Elution period: 10 ml buffer CO2 at 1 ml/min.
Elution period: 10 ml buffer C I at 1 min/mL
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Figure 9.12 Protein elution profile of BSA-LPS mixture (Case 2.1.3.2).
Chromatogram of Bradford assay results of fractions and fraction pools.
Loading period: feed, 10 ml mixture containing 19.69 µg/ml BSA and 19.40
EU/ml LPS at 1 ml/min. Washing period: 20 ml buffer A at 2 ml/min. Elution
period: 10 ml buffer CO2 at 1 ml/min. Elution period: 20 ml buffer C1 at 1
min/ml.
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Figure 9.13 Chromatogram of BSA-LPS mixture eluted at pH 8.0 (Case
2.2.2.4). Loading period: feed, 10 ml mixture containing 83.33 µg/m1 BSA
and 19.16 EU/ml LPS at 1 ml/min. Washing period: 20 ml buffer A at 2
ml/min. Elution period: 10 ml buffer B at 1 ml/min. Elution period: 18 ml buffer
C 1 at 1 min/mL
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starting buffer and the eluting buffer. However, this method was not successful. It is
reasonable. As mentioned before, the phosphate ion in this process was used as a
modulator. Phosphate ion competed with protein or endotoxin for adsorption sites on
IMAC beads. Phosphate ion has higher affinity with ferric ion than protein and
endotoxin. Therefore protein or endotoxin was not adsorbed to the column and washed
out during loading and washing periods as detected by UV absorbance, Bradford assay
and LAL test (not shown here).
9.4. Discussions
Using a novel method / process with an IMAC column, the removal of at least 99%
endotoxin from HbAo, BSA and IgG solutions was achieved. During the elution process,
the proteins were selectively eluted from the column by phosphate ions. The interaction
mechanism between IDA-Fe 3+ and LPS or protein was explained by authors (Kang and
Luo). In this chapter different elution strategies were optimized the elution process.
NaCl was used to prevent possible ionic interactions between adsorbed molecules
and resin. NH4C1 was frequently used in IMAC as an elution reagent because NH4+ might
form complex with metal ions and therefore elute adsorbed molecules from the column
when it appears in the elution buffer. NH4C1 is not suitable to elute the protein from IDA-
Fe3+ column.
With the introduction of OBDG, the endotoxin-protein complex might be broken
down. However, the linkage of Fe3+ and IDA is also broken, which causes the leaching
of Fe3+ . This result is reasonable. As a surfactant, OBDG can reduce the affinity between
ligand Fe3+, and the support group IDA, which causes the leaching of Fe 3+ . As a result,
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the addition of OBDG to buffer B has no practical effect on the selective removal of
endotoxin from the protein solutions in IMAC processes. New elution buffers should be
investigated in order to elute the adsorbed proteins from the IDA-Fe 3+ column.
The phosphate ions are very efficient to elute the adsorbed molecules from the
IMAC column. This may be because the affinity of ferric to phosphate ion is much
higher than to the protein or endotoxin. Therefore this elution can be described as
displacement of adsorbed molecules with phosphate ions. Ionic strength and pH
conditions were also investigated to get the optimal elution conditions. The protein yield
and endotoxin removal efficiency were almost independent on the ionic strength and pH.
This confirmed the adsorption mechanism put forward in previous chapters.
To obtain more efficient application of IDA-Ferric in removal of endotoxin from
protein solutions, the following topics also need to be consulted from previous chapters.
First, the ligand capacity and ferric amount immobilized in the column, which was
determined in Chapter 6. Second, endotoxin and protein adsorption capacities to the
IMAC column under different pH and ionic strength conditions were determined by
frontal analysis in Chapters 6 and 8. Third, adsorption isotherms of proteins and
endotoxins were determined in previous chapters.
9.5 Summary
Chromatography employing traditional affinity resins leads to significant protein loss and
low protein yield in the process of endotoxin removal from protein solutions. At low
solution ionic strength, the adsorption capacity of both endotoxin and protein are very
high. As the ionic strength increases, the adsorption of the protein and endotoxin
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decreases simultaneously. Adsorption mechanism of protein and endotoxin to traditional
resins are ion exchange and affinity, mainly ion exchange.
IDA-Fe3+ ligand can selectively remove the endotoxin from the protein solution.
Different washing and elution strategies for removing endotoxin from protein solutions
in an IDA-Fe3+ IMAC column are reported in this chapter. Although NH4C1 is frequently
used in IMAC as an elution agent, it is not effective to elute protein from the IDA-Fe3+
column. OBDG can dissociate endotoxin-protein complex. However, it might cause the
leaching of the ligand, Fe 3+, because it reduces the interactions between the ligand and
support. Phosphate ion has been proved to be an efficient elution reagent for proteins.
The IDA-Fe3+ IMAC column was exploited to efficiently remove endotoxin from the
mixture of bovine serum albumin and endotoxin (BSA-LPS), and from the mixture of
human hemoglobin Ao and endotoxin (HbAo-LPS) as well as from the mixture of Goat
Immunoglobulin (IgG) and endotoxin (IgG-LPS). More than 95% protein recovery and
above 99% endotoxin removal efficiency are found in author's newly developed process
in the range of ionic strength = 0~1.0 M and pH=3.5~5.5.
The high ionic strength (0.5 M to 1.0 M) in mobile phase indicates that
interaction mechanism between the adsorbed protein or LPS and IDA-Fe 3+ is not
electrostatic interaction. This IMAC behavior was explained by its adsorption
mechanism mentioned in previous chapters.
CHAPTER 10
LEACHING STUDY OF IDA-Fe3+ IMAC COLUMN
10.1 Introduction
Leaching is an important issue for affinity chromatographic columns and should be
investigated in the validation of chromatographic process. Low ligand leaching is
required for an effective chromatographic column. For IDA-Fe 3+ IMAC column, the
ligand is ferric ion. Under some conditions ferric ion could be eluted and cause ligand
leaching problem. The objective of this chapter is to investigate the leaching of ferric ion
from IMAC column under different elution solution conditions and to get optimal
operational conditions to prevent leaching in elution process. Blank runs were
conducted. Operational conditions were obtained.
10.2 Experimental Methods
10.2.1 Materials
NaCl, NH4C1, FeC13 , H3PO4 , NaH2PO4 , NaH2PO4 , NaAc and EDTA were purchased from
Sigma. All solution transfers were performed by endotoxin free devices. Sterile,
disposable plastic ware was used at all times to prevent endotoxin contamination. All
solutions were prepared with Milli-Q water generated by a water purification system
(Millipore Corp., Bedford, MA). The endotoxin concentration in Milli-Q water was
below 0.05 EU/ml based on author's test.
IMAC Column and Adsorbent Resin A 0.7 x 2.5 cm HiTrap chelating column was
purchased from Amersham Pharmacia Biotech (NJ, USA). The column was packed with
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Pharmacia chelating Sepharose High Performance resin consisting of highly cross-linked
agarose beads to which iminodiacetic acid (IDA) was coupled by a stable spacer arm.
Buffer System. Buffer A, start buffer is 0.5 M NaC1 in 0.02 M acetate buffer at pH 5.5.
The first elution buffer, buffer B, was 0.5 M NH 4C1 in 0.02 M acetate buffer at pH 5.5,
which was used to remove the loosely bound metal ion in the column. The second elution
buffer, buffer C, was 0.06 M sodium phosphate buffer (pH 3.5, 5.5, and 7.5), which was
used to elution the protein products and in this experiment was used to test the metal ion
leaching of the column. The stripping buffer, buffer D, was 0.05 M EDTA
(ethylenediaminetetraacetic acid) in buffer A. All buffers were filtered through a 0.22
pm filter and degassed under vacuum for at least 40 min prior to being applied to the
column.
10.2.2 Column Preparation and Operation
The HiTrap chelating column was stored in 20% ethanol when purchased. The column
was first washed with 5 ml Milli-Q water at a flow rate of 1 ml/min to remove the
ethanol. Then the column was loaded with 0.5 ml of 0.1 M FeCl 3 solution at 1 ml/min to
charge Fe3+ to the resin. Finally, the column was washed with 5 ml Milli-Q water at 1
ml/min to remove the unbound Fe3+ from solution. The washed out Fe 3+ solution was
collected to determine the concentration of unbound ferric ion. The column was now
charged with metal ion and ready for use. Before applying the feed, a blank run was
performed to elute nonspecifically bound metal ions that might otherwise be eluted
during desorption, the eluent was also collected. The column was washed with 2.5 ml of
buffer A at 2 ml /min followed by 5m1 of buffer B at 1 ml/min. The column was then
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equilibrated with 2.5 ml of buffer A at 1 ml/min. The feed (start buffer solution) was
applied to the column at 1 ml /min. This procedure was considered to be a blank run.
The column was then washed with the starting buffers (buffer A) at 2 ml/min for 10min.
Finally, the column was eluted by buffer C at 1 ml/min using step gradients, the eluant
was collected for the determination of leached ferric ion. The column was then
regenerated by washing with buffer D to strip all the metal ions, followed by washing
with 5 ml of Milli-Q water, both at a flow rate of 1 ml/min.
10.2.3 Fe3+ Ion Determinations
The amount of immobilized Fe3+ was calculated as the difference between the total
amount of Fe 3+ applied to the column and the Fe3+ amount, which was washed out as the
excess. The leaching of the column can be investigated by determination of the ferric ion
concentration in all elution fractions. Total iron ion concentration was determined by the
Sigma ferric kits (Sigma Chemical Company, St. Louis, MO, USA).
The procedure for total iron using Sigma kits was modified by author. The
modified protocol is as follows.
1) Add 1.5 ml iron buffer reagent, catalog No. 565-1, to cuvets labeled Blank,
Standard and Test.
2) Add 0.3 ml iron free water to Blank, 0.3 ml Iron, catalog No. 565-5, standard to
Standard and , 0.3 ml sample to Test. Mix each cuvet thoroughly.
3)	 Read and record absorbance (A) of Test and Standard vs. Blank as reference at
560 nm. This is initial A.
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4) To each cuvet add 0.03 ml (30µl) iron color reagent, catalog No. 565-3. Mix
thoroughly and place them at room temperature for 10 minutes.
5) Read and record absorbance (A) of Test and Standard vs. Blank as reference at
560nm. This is final A.
6)	 Calculations:
Δ Atest= Final Atest -Initial Atest
Δ Astandard = Final Astandard -Initial Astandard
Total iron (µg/dL) = (Δ
 Atest / ΔAstandard) X 500
Total iron (µmol/dL)= Total  iron (µg/dL) x 0.175
10.3 Results and Discussion
The experimental results were tabulated in Table 10.1. The amount of ferric ion applied
to the column for immobilization is 41.4 µmol. The extra unbound ferric ion was washed
out with MilliQ water, the amount of which was listed in the first row. Then the ferric
amount immobilized in the column was shown in the second row. The products were
collected in certain volumes and corresponding ferric concentrations were determined.
The ferric amount in the product was shown in the fifth row. The leaching of column is
defined in the last row as the ratio of the amount of ferric in the product to that
immobilized, which is expressed in percentage.
As shown in Table 10.1, the pH of elution solution has a great effect on the
leaching of ferric ion from the column. At pH 3.5, no leaching was found in product
collection. As pH of elution buffer increased to 5.5, 0.06% ferric ion was leached into
the product. With the further increase of the pH of elution to 7.5, 0.7% of the ferric ion
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was eluted out from the column. Considering the leaching effects, it is necessary to keep
pH of the elution solution under 4.0 in the protein elution process from the IMAC
column.
Table 10.1 The effect of elution buffer pH on the ferric ion leaching, ferric ion amount in
the feed: 41.4 µmol.
pH pH 3.5 pH 5.5 pH 7.5
Fe3+ washed out
(µmol)
7.913 4.207 6.745
Fe 3+ in the column
(mop
33.490 37.193 34.650
Fe3+ conc. in the product
(µmol /ml )
0 9.144 x10 -3 48.634x10-3
Product volume
(ml)
5.0 2.8 5.0
Fe3+ in the product
(µmol)
0 0.026 0. 243
Leaching
(%)
0 0.06 0.7
10.4 Summary
The leaching experimental results were summarized in this chapter. As pH increased
from 3.5 to 7.5, the ferric leaching percentage was increased from 0 to 0.7%. To avoid
the leaching of ferric into the product, it is necessary to control the elution at pH < 4.0.
CHAPTER 11
FINAL CONCLUSIONS AND RECOMMENDATIONS
11.1 Conclusions
In the biotechnology industry, Gram negative bacteria are widely used to produce
recombinant DNA products such as peptides and proteins. The removal of endotoxins
from protein solutions has always been a challenge. The novel IMAC-Fe 3+ method was
developed to remove endotoxins from different protein solutions with a high capacity and
high selectivity. More than 99% of endotoxin was removed. The protein yield is higher
than 90%. Compared with traditional methods, it has the advantage of high efficiency,
low cost and easy regeneration.
The endotoxin content detection method was developed considering the effects of
different factors such as protein and buffer components on LAL test. Proper dilution is
good way to remove the inhibition to endotoxin assay.
The adsorption mechanism of endotoxin on IDA-Fe 3+ IMAC resin was
determined by frontal analysis. The adsorption of endotoxin to the column includes two
periods. First, endotoxin is adsorbed to Fe 3+, which is due to the interaction between
Fe3+ and the phosphate group of lipid A in the endotoxin. Second, additional endotoxin
is adsorbed on the already adsorbed endotoxin because of the strong interaction among
endotoxin molecules. In the first step it is reasonable to assume Langmuir adsorption
mechanism. The adsorption capacity is 1.43 x 10 4 EU/ml gel. In the second step the
adsorption continues, and more endotoxin will be adsorbed. Therefore the adsorption
capacity of endotoxin on IDA-Fe 3+ IMAC column is very high.
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It was found that endotoxin was bound mainly by interactions between the
phosphate group in endotoxin and ligand Fe 3+ on the beads. The interaction mechanism
is believed to be the metal chelating. The adsorption of endotoxin to the IMAC-Fe 3+
column may be also due to the hydrophobic property of the lipid A, and the net negative
charge of the endotoxin. The properties of the endotoxin are important in discussing the
mechanism of its adsorption on the IDA-Fe 3+ IMAC beads. Interactions among the
endotoxin molecules are very important in discussing the adsorption of the endotoxin to
IMAC column. The interactions result in multi-layer adsorption of endotoxin on the
beads. Steric effect should be considered in process development of endotoxin removal,
since endotoxin aggregate is a big molecule.
In the loading period of endotoxin removal process, in order to get low
endotoxin adsorption and higher protein adsorption, a higher pH buffer condition should
be chosen. During elution period a buffer with a lower pH will be used to prevent the
endotoxin from eluting from the column together with protein targets.
Frontal adsorption studies have been shown to be an effective means of
characterization of the effects of buffer conditions on an BSA adsorption process as well
as Fe3+-BSA interactions. The Langmuir isotherm cannot satisfactorily predict the
adsorption behaviors of BSA. The Freundlich isotherm model provides very good
predictions of the BSA adsorption behavior in IMAC-Fe 3+ . It was found that BSA was
bound mainly by metal chelating interactions between BSA and ligand Fe 3+ . The effects
of buffer ionic strength and pH conditions on the BSA adsorption behaviors indicate that
ion exchange mechanism might be involved in process.
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To prevent possible ion exchange interactions, the higher ionic strength should be
maintained. The adsorption of BSA on the IDA-Fe 3+ IMAC beads was mainly due to
histidine group in the BSA and the interaction mechanism was essentially metal
chelating. Electrostatic forces might also be involved at the low solution ionic strength.
In the loading period of endotoxin removal process, in order to get high BSA adsorption
capacity, buffer with a very high pH should be avoided.
BSA is a typical model protein. Its adsorption on IMAC-Fe 3+ is due to metal
chelating interaction between BSA and Fe 3+ . Since the IMAC bead pore size is very big,
steric effect on BSA adsorption can be eliminated. Other proteins, such as HbAo
(neutral protein) and IgG (alkaline protein) were known for strong endotoxin binding. It
is very difficult to remove endotoxin from these protein solutions. All these proteins
also have histidine group(s) on the surface, which could contribute the metal chelating
interactions. This indicates that IDA-Fe 3+
 IMAC column can be used to purify HbAo
and IgG and at same time remove endotoxins. IDA-Fe 3+
 IMAC method is quite
different.
As shown in the comparison study, the traditional affinity chromatographic
methods cannot remove the endotoxin from protein solutions. Adsorption mechanism of
protein and endotoxin to traditional resins are ion exchange and affinity, mainly ion
exchange.
The phosphate ions are very efficient to elute the adsorbed molecules from the
column. The possible reason is that the affinity of ferric to phosphate ion is much higher
than to the protein. Therefore this elution can be described as displacement of adsorbed
molecules with phosphate ions. Ionic strength and pH conditions were also investigated
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to get the optimal elution condition. The protein yield and endotoxin removal efficiency
were almost independent on the ionic strength and pH.
For IMAC-Fe3+
 column, the ligand is ferric ion. Under some conditions ferric ion
could be eluted and cause ligand leaching problem. The investigation of the leaching of
ferric ion from IMAC column at different elution conditions was conducted. As the pH
increased from 3.5 to 7.5, the ferric leaching percentage was increased from 0 to 0.7%.
To avoid the leaching of ferric into the product, it is necessary to control the elution pH <
4.0.
11.2 Recommendations
Endotoxin removal from protein solutions with IDA-Fe 3+
 IMAC column is a new and
promising method. A few recommendations in this area are offered here for the future
work.
Methods for endotoxin removal from protein solutions depend on the origin,
structure and molecular weight of endotoxins, as well as the nature and molecular weight
of proteins. The structure and toxic effects of endotoxins from the Gram positive bacteria
and fungi should be investigated. The relationship between the biological activity and the
size of endotoxin has to be elucidated first. The interaction mechanism between proteins
and endotoxins need further investigation.
During this study, it was found that as ET concentration in the feed was higher
than 500 µg/ml, the IMAC column was blocked. The possible reason is the precipitation
of endotoxins on the IMAC bead surface. The solubility of endotoxin in the adsorption
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on IMAC process should be further investigated. It might be helpful to use activity
coefficient to discuss the endotoxin adsorption process with IMAC.
Other elution methods could be further investigated to prevent possible ferric
leaching. According to the principles of IMAC, the histidine and imidazole are very
good candidates as elution reagents.
The modeling of IMAC process is very complex. However, it is worth
investigations. First, it is very important to identify the rate-limiting step. Second, the
model can be established considering mass balance, diffusion in the pore, rate of mass
transfer through the fluid film and equilibrium. Diffusion coefficients, axial dispersion
coefficients can be obtained by studying the column response to pulse inputs.
The endotoxins from different origins could be tried. It is not a bad idea to
include cell lysate from fermentation process as the feed to this developed IMAC column.
To demonstrate the advantages of Fe3+ as a chelating metal ion over other metal
ions, such as IDA-Cu2+ , could be investigated.
Since the small scale of IDA-Fe3+
 IMAC process for endotoxin removal from
protein solutions is very successful, the next step is process development. Scale-up of
IDA-Fe3+
 IMAC process should be investigated to get it finally commercialized.
APPENDIX
ABBREVIATIONS
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ABBREVIATIONS
ABS:	 Absorbance
BSA:	 Bovine serum albumin
DAH:	 Diaminohexane
DMAPAA: N, N-dimethylaminopropylarylamide
DOC:	 Deoxycholate
ERE:	 Endotoxin removal efficiency
ET:	 Endotoxin
EU:
	
Endotoxin units
FDA:	 Food and Drug Administration
HbAo:	 Human hemoglobin Ao
Him:	 Histamine
His:	 Histidine
ICU:	 Intensive care unit
IDA:	 Iminodiacetic acid
IgG:	 Immunoglobulin G
IMAC:	 Immobilized metal affinity chromatography
LAL:	 Limulus Amebocyte Lysate
LPS:	 lipopolysaccharides
MOF:	 Multi organ failure
NTA:	 Nitriloacetic acid
OBDG:	 N-octyl-β-D-glucopyranoside
200
ABBREVIATIONS
(Continued)
PAN:	 Polyacrylonitrile
PEI:	 Poly(ethyleneimine)
PEPA:	 Polyester polymer alloy
PLL:	 Poly-L-lysine
PMB:	 Polymyxin B
PS:	 Polysulfone
PVA:	 Polyvinyl alcohol
SOD:	 Superoxide dismutase
USP:	 The United States Pharmacopoeia
TED:	 Tris(carboxymethyl) ethylene diamine
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